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ABSTRACT
Lung adenocarcinoma and squamous cell carcinoma are the deadliest cancers worldwide. Smok-
ing and ionizing radiation are potent carcinogens affecting strongly both lung cancer subtypes.
Several biological analyses have been performed to characterise the genetic mutations lead-
ing to adenocarcinoma and squamous cell carcinoma, and different genomic spectra have been
observed. Biological markers of smoking related damage could be found, leading to a deep
knowledge of cellular smoking effects. Less is known about the biological effects of radiation
in human carcinogenesis. Risks have been quantified with epidemiological studies of these car-
cinogens. Based on the biologically substantiated assumption that the number of mutations is
linearly related to the dose, in radiation epidemiology it is standard to model effects linearly.
These models do however not have a biological interpretation and are disconnected from gen-
eral statistical methods. Here we fill both gaps. First we apply statistical generalised additive
models to examine the functional relation between risk and smoking and radiation effects. Sec-
ondly, with mechanistic multi-scale models we integrate molecular biology and epidemiology to
describe the carcinogenesis of lung adenocarcinoma and squamous cell carcinoma.
To investigate the incidence of lung adenocarcinoma and lung squamous cell carcinoma we anal-
ysed two cohorts: first the Life Span Study cohort of atomic bomb survivors of Hiroshima and
Nagasaki, and second the Eldorado cohort of Canadian Uranium miners. Exposures differed
strongly between cohorts. Residents of Hiroshima and Nagasaki were exposed to a relative high
dose of γ radiation for a short time, while the miners were exposed to a protracted and lower
exposure to γ and α radiation. Information about smoking habits is available only for the
former cohort.
Three types of models were applied to analyse the effects of radiation and smoking: state-of-
the-art statistical risk models of radiation protection, statistical generalized additive models
and mechanistic risk models. Although there were quantitative differences in effect size and
significance, each result is presented below only for a single model.
For lung adenocarcinoma the best mechanistic model was a two pathway model. Smoking and
radiation effects showed markedly different patterns: both acted on the apoptosis rate of pre-
cancerous cells but on different pathways without any interaction. A linear radiation effect
was found in one pathway and a linear-exponential smoking effect in the other pathway. In-
dependently of these results we analysed genomic data of American patients. It is known that
the genetic damage of people with adenocarcinoma can be grouped into three pathways: the
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receptor mutant (RMUT ) pathway, the transducer mutant pathway (TMUT ), and other signa-
tures (OWT ). We could show that signatures of TMUT and the OWT pathways do differ much
less from each other than both differed to the RMUT pathway. Therefore, there is also genetic
evidence that adenocarcinoma fall into two main classes. The two pathways of the mechanistic
model could be associated to the RMUT and RMUT+OWT pathways by their risk patterns in
age and smoking.
On the other hand, for squamous cell carcinoma one pathway was sufficient to describe the
incidence data. Although effects of radiation appeared to be highly significant, they could be
traced back to arise only from the first five years of follow up (11 cases therein). When the first
five years were excluded, no significant radiation effect could be found. Interestingly, for lung
squamous cell carcinoma the mechanistic models could fit the effects of cigarette smoking in
initiation and promotion. This was different for lung adenocarcinoma, where the main effect
of smoking was a promotion of already existing pre-cancerous clones. For both, lung adenocar-
cinoma and squamous cell carcinoma, no interaction between radiation and smoking could be
fitted for the Life Span Study cohort.
Results from analysis of the Eldorado cohort were in line with the results presented above. For
lung adenocarcinoma both, the state-of-the-art statistical risk models and the generalised addi-
tive models, could find only a significant effect of γ radiation exposure. For lung squamous cell
carcinoma, vice versa, both models could find only a significant effect of α radiation exposure.
Concluding, we showed that lung cancer cannot be investigated as a single endpoint but the
different subtypes have to be analysed separately. Different radiation qualities act differently
to the different subtypes, indicating different biological processes. Analogously, although smok-
ing is an important risk factor for all subtypes, its effects were different and with different
magnitudes.
ZUSAMMENFASSUNG
Adenokarzinome und Plattenepithelkarzinome der Lunge sind die tödlichsten Krebsarten weltweit.
Rauchen und ionisierende Strahlung wirken auf beide Lungenkrebs-Subtypen stark karzinogen.
Die genetischen Mutationen, die zu Adenokarzinom und Plattenepithelkarzinom führen, sind
aus biologischen Untersuchungen bekannt. Dabei wurden unterschiedliche genomische Spek-
tren beobachtet. Mehrere biologische Marker für Lungenkrebs in Rauchern konnten gefunden
werden, was zu einem fundierten Wissen über die von Rauchen verursachten zellulären Effekte
geführt hat. Weniger ist allerdings über die biologischen Effekte der Strahlung in der Karzino-
genese der Lunge bekannt. Epidemiologische Studien erlauben die Quantifizierung der Risiken
durch diese Karzinogene. Basierend auf der biologisch fundierten Annahme, dass die Anzahl der
Mutationen linear mit der Strahlungsdosis ansteigt, ist es in der Strahlen-Epidemiologie üblich,
das Risiko als lineare Funktion zu modellieren. Auch wenn die Linearität biologisch motiviert
ist, haben diese Modelle ansonsten keine biologische Interpretation, unterscheiden sich dadurch
aber von den allgemein verwendeten statistischen Methoden, so dass neuere statistische Entwick-
lungen nicht in die Strahlen-Epidemiologie übernommen wurden. Diese Arbeit soll zu beiden
Richtungen beitragen. Einerseits wenden wir generalisierte additive Modelle an, um die funk-
tionale Beziehung von Rauchen und Strahlungseffekten zu untersuchen. Andererseits verwenden
wir molekulare Biologie und Epidemiologie, um mit mechanistischen Multi-Skalenmodellen die
Krebsentstehung von Adeno- und Plattenepithelkarzinomen der Lunge zu beschreiben.
Um die Inzidenz von Adeno- und Plattenepithelkarzinom zu untersuchen, wurden zwei Kohorten
analysiert: die Life Span Study der Atombombenüberlebenden in Hiroshima und Nagasaki sowie
die Eldorado-Kohorte von kanadischen Uran-Minenarbeitern. Die Expositionen unterscheiden
sich zwischen den Kohorten stark. Die Bewohner von Hiroshima und Nagasaki waren einer
relativ hohen Dosis an γ-Strahlung in kurzer Zeit ausgesetzt, während die Minenarbeiter einer
Langzeitexposition mit geringerer Dosis an α- und γ-Strahlung ausgesetzt waren. Informatio-
nen zum Rauchverhalten der Teilnehmer sind nur von der ersten Kohorte bekannt.
Der Effekt von Strahlung und Rauchen wurde mit drei Arten von Modellen analysiert: mit den
im Strahlenschutz derzeit üblichen und mit generalisierten additiven statistischen Risikomod-
ellen, sowie mit mechanistischen Risikomodellen. Auch wenn es quantitative Unterschiede in
den Effektgrößen und Signifikanzen gab, werden die Ergebnisse im Folgenden jeweils nur für ein
Modell präsentiert.
Das beste mechanistische Modell für Adenokarzinome der Lunge war ein Modell mit zwei
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Pfaden. Rauchen und Strahlungseffekte zeigten deutlich unterschiedliche Muster: zwar wirkten
beide auf die Apoptose-Rate von intermediären, präkanzerösen Zellen, jedoch im jeweils an-
deren Pfad ohne jegliche Interaktion. Ein linearer Strahlungseffekt wurde in dem einem Pfad
und ein linear-exponentieller Effekt des Rauchens im anderen Pfad gefunden. Unabhängig von
diesen Ergebnissen haben wir genomische Daten von amerikanischen Patienten untersucht. Es
ist bekannt, dass Erbgutschäden von Menschen mit Adenokarzinom in drei Pfade gruppiert wer-
den können: dem Rezeptor-Mutations-Pfad (RMUT ), dem Transducer-Mutations-Pfad (TMUT )
und anderen Signaturen (OWT ). Wir konnten zeigen, dass TMUT und OWT sich voneinander
deutlich weniger unterscheiden als vom RMUT Pfad. Es gibt also auch genetische Evidenz, dass
Adenokarzinome in zwei Hauptgruppen aufgeteilt werden können. Die zwei Pfade im mecha-
nistischen Modell konnten mit den den biologischen Pfaden an Hand der Abhängigkeiten des
Risikos von Alter und Rauchen in Beziehung gesetzt werden.
Für Plattenepithelkarzinome war ein Pfad ausreichend, um die Inzidenzdaten zu beschreiben.
Der Effekt der Strahlung erschien zwar hochsignifikant, aber der Effekt bezog sich nur auf
die ersten fünf Jahre der Beobachtungszeit (und damit 11 Fälle). Wenn die ersten fünf Jahre
ausgeschlossen wurden, konnte kein signifikanter Effekt der Strahlung gefunden werden. Be-
merkenswerterweise ergab der beste Fit mit dem mechanistischen Modell Effekte des Rauchens
in Initiation und in Promotion des Plattenepithelkarzinoms. Dies war anders als beim Ade-
nokarzinom, wo der Haupteffekt des Rauchens in der Promotion bereits existierender präkanz-
eröser Klone lag. Für beide Suptypen konnte keine Interaktion zwischen Strahlung und Rauchen
in der Life Span Study beobachtet werden.
Die Ergebnisse der Eldorado-Kohorte waren im Einklang mit den oben beschriebenen Ergeb-
nissen. Für Adenokarzinome der Lunge konnten sowohl das im Strahlenschutz derzeit übliche,
als auch das generalisierte additive statistische Risikomodell nur einen signifikanten Effekt der
γ-Strahlung finden. Für Plattenepithelkarzinome konnten beide Modelle nur einen signifikanten
Effekt durch α-Strahlung feststellen.
Wir konnten also zeigen, dass Lungenkrebs nicht als ein einzelner Endpunkt analysiert werden
kann, sondern dass die Subtypen unterschieden werden müssen. Unterschiedliche Strahlungsarten
wirken sich auf die unterschiedlichen Subtypen verschieden aus, was auf unterschiedliche biolo-
gische Prozesse schließen lässt. Ebenso, auch wenn Rauchen ein wichtiger Risikofaktor für alle
Subtypen ist, unterscheiden sich auch hier die Effekte und haben unterschiedliche Stärke.
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CHAPTER
1
INTRODUCTION
The aim of this Thesis is to analyze carcinogenesis and the related risk in the lung under the
effects of smoking and two types of ionising radiation. This Chapter will hence start with a
bio-epidemiological introduction of lung cancer and his histological types. It will be illustrated
that the histological types are different in position, genetic profile and cell structure and can be
considered as distinct diseases. This motivated our decision to analyse the different subtypes
of lung cancer separately. Two cohorts will be considered: the first cohort is the Japanese Life
Span Study of atomic bomb survivors of Hiroshima and Nagasaki exposed to a mixed field of
neutrons, gamma waves and smoking. Secondly, the Eldorado cohort of Canadian uranium mine
workers, exposed to both radon and gamma radiation. To better understand the modelling of
these three different exposures brief introductions of their effects will be given. This Chapter
will then conclude with a general overview of the Thesis.
1
2 1.1. LUNG CANCER
1.1 Lung cancer
In 2012 around 1.8 million new lung cancer cases occurred, about 13% of the total cancers diag-
nosed, becoming worldwide the leading cause of death for males and the second one for females,
after breast cancer [25, 59]. There are many known risks factors for lung cancer: asbestos,
arsenic, radon, outdoor pollution and smoking [53]. Lung cancer rates differ a lot between
countries and this can be related to the different smoking behaviour [7]. Since a very large part
of lung cancers could be avoided by smoking cessation, lung cancer can be considered one of
the most preventable cancers [59].
Lung cancer can be characterised by two main properties:
• histology: cells under a microscope, and
• molecular profile (also signature profile, genomic profile, or bio-marker profile): signatures
found in cancer tissue [39].
Each patient is treated depending on these two factors, in order to minimize side effects and
maximize the efficiency of treatments.
Histologically considered, about 15% of lung cancers are small cell lung cancer, while about 85%
are non-small cell lung cancers (NSCLC) [14, 39]. NSCLC can again be differentiated between:
• Adenocarcinoma (LADC),
• Squamous cell lung cancer (also called epidermoid carcinoma) (SQUAM), and
• Large cell lung cancer.
In this Thesis we will look only on NSCLC and more precisely only on LADC and SQUAM.
The classification of lung cancer on the molecular level is performed by gene mutation in cancer
tissue. The molecular spectrum of the histological types of lung cancer differs a lot [3, 9, 10, 44].
In the next sections a brief discussion of the biology of LADC and SQUAM will be presented.
1.1.1 Biological characterisation of lung adenocarcinoma
LADC is the deadliest cancer worldwide: 42% of all lung cases in women and 28% in men
were classified as LADC [63]. The shape of the tumour is highly variable and can develop
multiple centers. LADC tumours often appear in the periphery of the lung and develop in
smaller airways, such as bronchioles (see Figure 1.1).
LADC is mostly driven by tobacco smoke, often causing mutations in the KRAS oncogene
[10, 63]. While these mutations are found in different frequencies in Caucasian and Asian LADC
patients and while KRAS mutations are more frequent in smokers, other risk factors (e.g. onco-
gene links) are unknown and molecular risk prediction models are missing [3, 9, 42, 57].
Most LADC cases occur in smokers, but compared to other histological types it is more fre-
quently found in never smokers, particularly in women [56, 63]. Based on markedly different
molecular profiles, LADC in never smokers develops completely different than in ever smokers.
LADC in never smokers is the common lung cancer form in young patients and its causes are
still not clear [56]. Since the female portion in LADC in never smokers is much higher than in
other types, there is also the possibility that gender-dependent hormones could play a role in
the development of LADC [56].
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Figure 1.1: Histology and position in the lung of LADC. Histology provided by I. Gipanou [24].
The Cancer Genome Atlas Research [10] analysed LADCs from 230 patients and did a whole
exome sequencing of the tissues. The molecular profile can be found in Figure 1.2. Columns
represent patients, rows the analyzed variable (gender, smoking status and gene). The most
Figure 1.2: Mutational spectra from whole exome sequencing of 230 LADCs. Columns represent
patients, rows the analyzed variable (gender, smoking status and gene). Figure taken from [10].
frequently mutated genes compared with normal tissue are: TP53, KRAS, KEAP1, STK11,
EGFR, NF1 and BRAF. Looking at the columns of the table one can notice that, although all
patients had LADC, there are patients with a lot of mutations and patients with just few muta-
tions. Analysing the rows, it is clear that some genes are more frequently mutated than others.
For the same histology, subtypes can be distinguished on a DNA level by different molecular
profiles. Since the molecular form of these subtypes is different there must be also a different
pathway leading to the endpoint.
4 1.1. LUNG CANCER
1.1.2 Biological characterisation of lung squamous cell carcinoma
Forming 30% of all lung cancers, SQUAM is the second most common type and the gender
proportion is reversed compared to LADC: 44% of lung cancers in men, and 25% in women
[63]. Generally SQUAM tumours are of large size and may cavitate. A cavity is defined as
a gas/fluid-filled space within a tumor mass or nodule. SQUAM is described as a malignant
epithelial tumour that can show intercellular bridges coming from the bronchial epithelium [63].
SQUAM is usually positioned in the central part of the lung or in the main airways (bronchi)
(see Figure 1.3). Due to location symptoms can be cough, trouble in breathing, blood in the
sputum and chest pain [63].
Figure 1.3: Histology and position in the lung of SQUAM. Histology figure provided by I. Gipanou
[24].
SQUAM is the subtype of NSCLC that is more strongly associated with smoking: over 90% of
SQUAMs occur in current or past smokers [63]. Other risk factors are age, genetic predisposi-
tion, exposures to passive smoke, mineral and metal dusts, asbestos and radon gas [63].
The TCGA consortium [44] analysed 178 SQUAMs by whole exome sequencing of cancer tis-
sue. The mutational spectrum can be found in Figure 1.4. The most frequrntly mutated genes
Figure 1.4: Significatly mutated genes of 178 SQUAMs. Columns represent patients, rows the
analyzed genes. Figure taken from [44].
compared with normal tissue are: TP53, CDKN2A, PTEN and PIK3CA. Apart from TP53
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all other genes differ from the mutated genes found for LADC (compare Figure 1.2). Looking
at the columns of Figure 1.4 one can notice that the figure can be split in two groups: in the
first group patients have a TP53 mutation and an additionally one (two mutational hits), in
the second group patients have one or more mutations excluding TP53. For the first group
this would mean that a TP53 mutation in necessary but not sufficient for SQUAM to arise,
another mutation has to be present [43]. For the second group TP53 in not present, pointing
to a different pathway to cancer.
This diversity in mutational spectra can be attributed to the fact that smoking damage is a
complicated and extended process acting in different ways on the cells and on the DNA. The
damage can hence be notably different from one patient to the other.
1.2 Exposure of biological tissue to ionising radiation
Radiation is defined as the energy emitted from a given source. Some examples are: sunlight,
microwaves from an oven, medical X-rays and γ-rays from radioactive elements [1, 60]. In this
Thesis we consider only ionising radiation (IR), which is radiation with sufficient energy to
remove electrons from an atomic orbit, leaving the atom in a charged/ionized status. IR can
be described either as particles or waves (particle wave dualism) [60].
In particulate radiation, consisting of (sub-)atomic (electrons, protons, etc.) the energy is car-
ried in the form of kinetic energy or mass in motion. α-particles are ionising directly because
they carry a charge and interact directly with the DNA when passing through a tissue [27].
The energy of electromagnetic radiation is carried by oscillating electrical/magnetic fields trav-
eling through space with the speed of light. Forms of electromagnetic radiation are classified
by wave length, especially X-rays and γ-rays of high energy are ionising. They are high energy
waves with short wave length and high frequency. γ- and X-rays are considered as indirect IR
because they are electrically neutral and do not interact with the DNA directly but mostly with
the H2O molecule producing free radicals, that then damage the DNA [27].
We consider only IR from γ-rays (atomic bombs of Hiroshima and Nagasaki, miner exposure)
and α-particles radiation (miner exposure).
Independently from the type of IR, the damage caused to DNA are strand breaks and loss of
base pairs [4]. The different types of DNA damage are represented in Figure 1.5, right panels.
Figure 1.5: Left: Representation of DNA damage of low LET vs. high LET tracks. Right:
Schematic representation of different types of strand breaks. Figure taken from [37].
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Single strand breaks are breaks in only one strand of the DNA, the other one remains intact.
The mechanism of DNA repair can normally reconstruct the original DNA in a very short time
using the still intact part [4]. When double strand breaks occur, the repair of the DNA can be
complicated and it is possible that wrong parts of DNA are glued together giving rise to the so
called chromosomal aberration [4].
When IR comes into contact with tissue energy is transferred from particles/waves to the tis-
sue itself. The release of energy along the covered path is called track. To quantify the energy
transferred from IR per unit distance along a charged-particle track the concept of linear energy
transfer (LET) was introduced [60]:
LET∆ = −
(
dE
dx
)
∆
, (1.1)
where ∆ is the maximal energy loss. LET∆ is also called restricted stopping power.
γ-waves are characterized also for their low LET power, where α particles for their high LET
one. This means that γ-waves produce spread damage but for a long track, where α particles
cannot cover a long path but they release almost all energy in a restricted area creating huge
local damage [32, 37]. A graphical representation of the DNA damage produce by high and low
LET can be found in Figure 1.5, left panel.
Since the effect of γ rays and α particles to the tissue are physically and biologically different,
this is a hint that carcinogenesis arising from this two types of radiation fields can be different
for both LADC and SQUAM.
1.3 Exposure to cigarette smoke
Cigarette smoke is the main cause not only of lung cancer, but also of chronic lung and vascular
diseases, and oral disease [35, 63]. Several toxins present in cigarette smoke have immunomodu-
latory effects. These components, together with other minor ones, induce chronic inflammation
at the mucosal surfaces and modify the response of the host to external agents. One of the
cigarette smoke components is also 210Po, an α particle emitter [13, 28, 41]. Smokers can hence
be considered exposed to ionizing radiation, although a dose quantification is difficult.
Reactive oxidative particles are produced in the burning cigarette, which inhalation can not
be prevented by cigarette butt filters. These particles, also contained in the gaseous phase,
are often short-lived, affecting primarily the epithelial cells lining in the upper airways induc-
ing DNA damage [35]. Cigarette smoke components activate hence epithelial cell intracellular
signaling cascades, leading to inflammatory processes (chronic immune cell recruitment and in-
flammation) [35]. Cigarette smoke can induced several toxic effects, particularly the induction
of carcinogenesis as a result from direct genetic or epigenetic effects, denoted by altered gene
functions (e.g. cell cycle, DNA repair, and tumor suppressor genes) [35].
1.4 Outline of the Thesis
The central question of this Thesis is the understanding of carcinogenesis and the related risks in
lung adenocarcinomas and squamous cell carcinomas under the exposures of ionising radiation
and cigarette smoke. To improve this understanding two different cohorts with information
about these two lung carcinoma subtypes were analysed. The first one is the Japanese Life
Span Study cohort of atomic bomb survivors of Hiroshima and Nagasaki. We only considered
exposures to a mixed field of γ and neutron ionising radiation and to cigarette smoke. For about
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40% of the cohort’s members the smoking information were unknown and hence imputed. A
complete descriptive analysis of this cohort can be found in Section 2.2. The second analysed
cohort is the Eldorado cohort of mine workers. Most workers were uranium miners and mill
workers employed at two mine sites (Port Radium and Beaverlodge, Canada) and workers
employed at the radium and uranium refining and processing plant (Port Hope, Ontario). These
people were exposed to radon gas, therefore to α particles and to γ waves. No information about
cigarette smoke exposure is given for this cohort. A descriptive analysis of the Eldorado cohort
can be found in Section 2.3.
The Life Span Study cohort was analysed using three different types of models
• state-of-the-art statistical risk models for radiation protection,
• generalised additive models, and
• biology-based mechanistic models.
A formal description of these three different methods can be found in Sections 3.3.2, 3.3.1 and
3.4, respectively. As we have seen in the paragraphs before, there are compelling reasons to
consider lung adenocarcinoma and squamous cell carcinoma as different diseases. Therefore,
for each subtype all three models were developed and compared. The effects of both cigarette
smoke and ionizing radiation exposures were taken into account as influencing variables modi-
fying the spontaneous cancer rate. Results and comments for the analysis of adenocarcinoma
and squamous cell carcinoma can be found in Chapters 4 and 5, respectively.
From biology it is clear that smoking has a heavy impact in the development of lung cancers.
Since for the Eldorado cohort no information about cigarette smoke exposure was provided, we
decided not to apply biology-based mechanistic models to this cohort. Without this information
no biological description of carcinogenesis can be provided. The models applied to this cohort
were therefore
• state-of-the-art statistical risk models for radiation protection, and
• generalised additive models.
The effects on radiation risks estimates of α-particles and of γ waves were tested in different
ways for both subtypes of lung cancer. Also for these analyses, results and comments for ade-
nocarcinoma and squamous cell carcinoma can be found in Sections 6 and 7, respectively.
In Figure 1.6 the mind map of this Theses is represented. In the middle the central question:
lung cancer risks in its subtypes. Left and right the two analysed cohorts with information
about cigarette smoke exposure and/or ionising radiation exposure. This information were pro-
cessed by the different models (yellow arrows), ending with new radiation and smoking risks for
lung adenocarcinoma and small cell carcinoma (top and bottom central boxes).
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Figure 1.6: Outline of the Thesis. In the middle the central question: lung cancer risks in
its subtypes. Left and right the two analysed cohorts with information about cigarette smoke
exposure and/or ionising radiation exposure. This information were processed by the different
models (yellow arrows), ending with new radiation and smoking risks for lung adenocarcinoma
and small cell carcinoma (top and bottom central boxes).
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CHAPTER
2
THE COHORTS
This chapter in dedicated to the descriptive data analysis of the cohorts analysed in this Thesis.
The first section describes the Japanese Life Span study cohort of atomic bomb survivors of Hi-
roshima and Nagasaki. Cohort members were both exposed mostly to a mixed field of neutron
and γ waves and to cigarette smoke. Since for around 40% of the data the smoking information
was missing, methods of imputation data were applied with both endpoints lung cancer (gen-
eral) and squamous cell carcinoma. The importance of the endpoint by imputation processes
will be demonstrated. A comparison of the original dataset with the imputed ones will be pre-
sented. Only results/analyses of imputed data are presented in this Thesis.
The second cohort taken into account is the Eldorado cohort, which is composed of only male
mine workers of two mine sites (Port Radium and Beaverlodge, Canada) and workers employed
at the radium and uranium refining and processing plant (Port Hope, Ontario). These workers
were exposed to radon gas, therefore to α particles and to γ waves. No information about
cigarette smoke exposure is given for this cohort. The definition of lagged dose will be intro-
duced and explained. It will be shown how only from the raw data an association of LADC to
γ waves and of SQUAM to α particles radiation exposure is visible.
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2.1 Data shape
Epidemiologist investigate associations between exposure to possible detrimental risk factors
and health effects in the general population. They use observational data of disease incidence
characterised by covariables such as location, time and gender. This type of analyses can be
described as a cohort design [23, p. 378]. In cohort studies people are recruited because their
exposure status, independently of any knowledge about future disease risk, and followed up
for disease occurrence after exposure. The cohort studies normally have a large number of
participants in order to ensure enough cases for meaningful analysis [23, p. 203, p. 345].
For both cohorts observational data were available in grouped form as person-years tables,
stratified buy different variables as, e.g., sex, city/facility, calendar year, age at exposure, age
at end of followup, exposure intensity, smoking status. Person years (PYRs) quantify the time
at risk which members have accumulated in a given stratum. A stratum does not correspond to
an individual but is defined as a cell in the data space spanned by the covariables of the cohort
[23, p. 701].
The following chapters give a detailed analysis of the two cohorts.
2.2 The Life Span Study of Japanese atomic bomb survivors
The Life Span Study cohort (LSS) of Japanese atomic bomb survivors has been the primary
epidemiological basis for evaluating the long-term health effects of IR, dominated by γ rays of
low LET in the range between 0-4 Gy. The LSS includes about 94,000 survivors who were in
Hiroshima and Nagasaki at the time of bombing and about 27,000 people who were temporarily
away from the cities at that time, and their mortality and cancer incidence have been followed
up since 1950 and 1958, respectively [26, 45]. Cohort members experienced radiation exposure
in all age groups and were not selected for pre-existing illness. The current analysis used the
lung cancer incidence data [18, 21], for which lung cancer diagnoses and histological types were
derived from a pathology review carried out during the follow-up period between 1958 and 1999
but no genotyping of cancer tissue was performed. The data used in this analysis consisted of
a table of case counts and person years finely cross-classified by city, gender, radiation dose,
follow-up period, attained age, age at exposure, and distance from the hypocenter.
2.2.1 Dosimetry
After the bombings of Hiroshima and Nagasaki studies have been performed, to collect data
on survivor locations and shielding and to create systems to estimate individual doses from
neutrons and γ rays [15].
Individual survivor dose estimation requires information on location and shielding at the time
of the bombings. These data came mostly from detailed shielding histories obtained for proxi-
mal survivors and Master File cards created during the 1950s and 1960s for each person [15].
Like other methods of dosimetry for radiation epidemiology, atomic bomb survivor dosimetry
assumes that a suitable measure of radiation for estimating quantitative relationships to health
effects is the absorbed dose in relevant tissues, which is defined as the amount of energy de-
posited in the tissue from interactions of a specific type of ionizing radiation per unit mass of
tissue. The unit is grays (1 Gy = 1 Jkg). To convert the rates at which neutrons or γ rays of a
specified energy lose energy in, e.g., air or tissue, so called conversion factors are used [15].
Dose categories were defined in terms of weighted absorbed DS02 colon dose, which was cal-
culated as the γ-ray dose plus 10 times the neutron dose in Gy, with additional adjustment to
reduce bias in risk estimates due to the uncertainty involved in individual dose estimation.
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A summary of the LSS can be found in Table 2.1.
Table 2.1: Summary of mean values for different covariables of the LSS cohort data broken down
by gender.
Women Men Total
Subjects 62515 42889 105404
Person years 1749254 1053713 2802967
Cases 731 1072 1803
Cases LADC 321 315 636
Cases SQUAM 76 254 330
Cases other lung cancers 334 503 837
Case-weighted
attained age (years) 71.78 70.61 71.09
Case-weighted
age at radiation exposure (years) 34.63 35.64 35.23
PYRs-weighted
age at radiation exposure (years) 24.11 20.73 22.84
Case-weighted
radiation dose (Gy) 0.184 0.139 0.157
PYRs-weighted
radiation dose (Gy) 0.096 0.101 0.098
2.2.2 Imputation of smoking information
While data on radiation dose were virtually complete in this cohort, data on smoking histories
were available for about 60% of the members, which were mainly obtained from a series of mail
surveys (at most three surveys for each individual) conducted between 1965 and 1991. The
questionnaire at each data collection included a question about the smoking status (never, cur-
rent or past categories). In addition, the age at starting smoking and the intensity (the average
number of cigarettes smoked per day) were asked to ever-smokers and the age at quitting to
past-smokers. For analyses, multiple survey sources of smoking data were combined and sum-
marized as a relatively simple set of variables (start age, intensity, and quit age) to describe
the smoking history for each individual having any information of smoking [18, 21]. In total,
about 40% of the study subjects had no information on smoking habits due to non-response to
all surveys, and the proportion of subjects with missing smoking data varied depending on sex,
birth-year and radiation exposure [22]. In addition, the majority (about 60%) of the survey
respondents had data from only one or two sources. In the earlier analyses [8, 18, 21, 26, 46],
subjects with no smoking data were treated as having unknown smoking status throughout
their time at risk. For those with smoking data, the smoking status during the period up to the
first survey response was treated as ‘unknown’, and the status at the last response was carried
forward to the end of follow-up. With a concern on potential impact of the incompleteness in
smoking data, Furukawa et al. [22] applied a common missing data approach of multiple impu-
tation (MI) (e.g., Sterne et al. [55]) to individual smoking histories in the LSS cohort and used
the imputed data in analysis to evaluate the joint effects of radiation and smoking on LADC
and SQUAM incidence. Two different sets of imputed data were used, each one composed of
50 imputed data sheets: one imputed with endpoint lung cancer and the other with endpoint
SQUAM. A data set with a longer follow-up 1958-2009 could not be used since it lacked infor-
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mation on histological types, and smoking imputation was not performed [8].
A comparison of the imputed data sheets vs. the original dataset containing missing values
can be found in Table 2.2 (the row data used to calculated percentages can be found in Ap-
pendix A.1). In the following the original dataset containing missing information will be called
original dataset.
Table 2.2: Comparison of cases after imputation (Imp) with the cases of the original dataset
(OD) containing the category "unknown smoking information". Second and third columns sum-
maries imputed data with endpoint lung for the lung cancer types lung in general and LADC,
respectively. The last column is a summary of the imputed data with endpoint SQUAM for the
subtype SQUAM.
Lung total LADC SQUAM
Cases in OD 1803 636 330
% never smokers in OD 17 26 5
% ever smokers in OD 45 41 58
% cases without 38 33 37
smoking info in OD
% imputed never smokers 44 35 50
% imputed ever smokers 35 31 35
Never smokers OD
Ever smokers OD
0.37 0.64 0.08
Never smokers after Imp
Ever smokers after Imp
0.43 0.69 0.11
The LSS has almost as double LADC cases than SQUAM (636 vs. 330 cases), where in the
original dataset the amount of never smokers in much higher for the first subtype than for the
second one (26% vs. 5%). This is a substantial difference between SQUAM and LADC that
we have already seen in Chapter 1.1: a lot of LADC cases arise in never smokers, SQUAM is
instead a smokers disease. For approximately 40% of the lung cancers no smoking information
is available. A difference in percentage of imputed cases in never smokers can be observed
between subtypes: lung and LADC have around 40% with no relevant difference between them,
for SQUAM we have 50%. This discrepancy has to be attributed to the fact that the amount
of never and ever smokers, and their smoking behaviours, differs a lot between subtypes. The
last two rows of the table represent the shares of (n)ever smokers in the original dataset and,
as average, in the imputed data sheets. Since the information are missing at random the shares
before and after imputation should stay similar.
A summary of the LSS cohort data broken down by sex and smoking status for LADC (red) and
SQUAM (blue) can be found in Table 2.3. The percentage of females never smokers in LADC
case is approximately 5 time higher as in SQUAM cases, while for males there is almost no
difference between subtypes. For current smokers a reversed behavoiur can be noticed: almost
as double SQUAM cases than LADC cases in males, whereas almost no difference is noticeable
for females. This is a substantial difference between SQUAM and LADC that we have already
seen in Chapter 1.1: many LADC cases arise in never smokers, SQUAM is a smokers disease.
For both subtypes the majority of never smokers were females. SQUAM cases are generally
older than LADC cases with an increased smoking duration. Looking at the smoking variables
Age at begin smoking, Years since quitting and Smoking intensity no relevant difference between
LADC and SQAM can be noticed. SQUAM cases have a cumulative smoking amount higher
than LADC cases, especially for female current smokers and male past smokers (26 vs 17 Pack-
years and 37 vs 32 Packyears, respectively). Since Packyears are calculated as the product
Smoking duration and Smoking intensity, the diversity in smoking amount between SQUAM
and LADC can be seen as the result of the combination of these two variables. The radiation
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Table 2.3: Summary of mean values for age and exposure-related co-variables of the LSS cohort
data broken down by smoking status and lung cancer subtype. For smoking related co-variables
the means are taken over 50 data sheets with imputed smoking information, for LADC (in red)
and SQUAM (in blue).
Women Men
Smoking status Never Past Current Never Past Current
Cases (% of 636) 234 (37) 19 (3) 68 (11) 23 (4) 72 (11) 220 (35)
Cases (% of 330) 24 (7) 14 (4) 38 (12) 9 (3) 48 (15) 197 (60)
Age at diagnosis (years) 68.1 72.0 70.4 71.1 68.9 67.7
74.5 69.1 74.0 73.3 70.4 70.6
Age at begin - 32.7 34.3 - 21.6 21.9
smoking (years) - 29.0 32.0 - 21.7 22.1
Smoking - 29.3 36.0 - 34.4 45.7
duration (years) - 27.1 42.0 - 37.8 48.5
Years since - 10.0 - - 12.8 -
quitting (years) - 13.0 - - 10.5 -
Cumulative smoking - 14.6 16.8 - 32.4 43.3
amount (pack-years) - 16.6 26.2 - 37.5 44.9
Smoking intensity - 9.1 9.3 - 19.2 19.4
(cigarettes/day) - 10.9 12.3 - 20.1 18.9
Age at radiation 29.4 31.9 35.4 32.6 27.6 30.8
exposure (years) 38.7 32 38.6 42.7 33.1 37.7
Radiation dose (Gy) 0.194 0.085 0.213 0.041 0.113 0.143
0.169 0.134 0.348 0.053 0.110 0.144
related variable age at exposure is much higher for SQUAM cases than for LADC cases with a
relevant increase in dose, especially for past and current female smokers.
In the following the variation between data sheets and the difference between data sheet and
original dataset will be analysed.
2.2.3 Original vs. imputed data sets
As we have seen in the section before, two different imputation data sets have been created
for the analysis of LADC and SQUAM in the LSS. In this chapter we want first to analyse
the differences between imputated and original data set (with and without unknown smoking
information) and then we will proceed with the analysis of the variation between the 50 data
sheets, variation in imputation outcome.
All previous studies that until now dealt with effects of smoking and radiation exposures to
lung cancer in the LSS considered the unknown data as a special category, extrapolating in
this way risk estimates for these two external effects [8, 18, 21]. Furukawa et al. [22] however
showed that the best way to analyse this data is either to discharge the unknown data or to
use imputed data sets. In the next figures we address this problem analysing the different data
sets.
Form Figure 2.1 we can see that the deletion of unknown data would introduce a bias in the
data: the crude rates of the reduced dataset (light blue) are in each category higher than that
of the complete dataset and of the imputed data sheets. The crude rates of imputed and com-
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plete data sets are almost identical, since the number of cases remains the same. The small
difference has to be attributed to the small variation in the person years during the imputation
process. The biggest bias can be found for both subtypes in the male category, indicating that
the majority of the deleted data are healthy males. A higher crude rate denotes a deletion of
person years but not of cases.
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Figure 2.1: Cases per 104 persons per year for LADC (a) and SQUAM (b) by gender comparing
the three data sets: the original data set without unknown smoking information (light blue), the
original data set with unknown smoking information (dark blue) and the 50 imputed data sheets
(in orange). The orange bar is the person years weighted mean over the 50 imputed datasets.
Until now we just had a look to the difference between the original data set and the imputed data
sheets, but we did not consider the variation between the imputed data sheets. In Figures 2.2
and 2.3 the huge bias between reduced data set and the imputed ones is detectable in each
category. The variation of the related deviation from original value is relatively small and is
maximal for SQUAM never smokers, both sexes. This behaviour has to be attributed to the
fact that for SQUAM the amount of never smokers is small. The statistical power is therefore
low causing less stability for imputation procedures.
Similar analysis were done for the imputed variables
• smoking status (never, current and past smoker),
• smoking duration,
• smoking intensity (cigs/day), and
• years since quitting
and for the not imputed variables, split by imputed smoking status (never and ever smoker
categories as the sum of past and current smokers)
• attained age, and
• lung dose (Gy).
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Graphical representations can be found in Appendix A. Neither substantial differences between
LADC and SQUAM nor major problems could be found in the data sets.
Furukawa et al. [22] addressed the problematic of handling the unknown smoking category.
He could show that the best results can be obtained analysing imputed data. This is in line
with the results from our above analysis. The analysis of LSS data will hence be done only with
imputed data.
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Figure 2.2: Cases per 104 persons per year for LADC by gender and by smoking status (never
smokers left panels and ever smokers right panels) comparing two data sets: the original dataset
without unknown smoking information (light blue) and the 50 imputed data sheets (in orange).
Panels (a) and (b), for never and ever smokers respectively, describe the difference of the in-
cidence between the original dataset and the 50 imputed data sheets. The orange bars are the
person years weighted mean over the 50 imputed data sheets. Panels (c) and (d) represent the
relative deviation of the imputed data sheets from the original dataset. The relative deviation is
calculated as incidence-ratio between original and imputed dataset. The boxplots represent the
distribution of the relative deviations of the 50 imputed data sheets. The blue horizontal line
represents the value one, it means a correspondence between original and imputed dataset.
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Figure 2.3: Cases per 104 persons per year for SQUAM by gender and by smoking status (never
smokers left panels and ever smokers right panels) comparing the two data sets: the original
dataset without unknown smoking information (light blue) and the 50 imputed data sheets (in
orange). Panels (a) and (b), for never and ever smokers respectively, describe the difference of
the incidence between the original dataset and the 50 imputed data sets. The orange bars are
the person years weighted mean over the 50 imputed data sheets. Panels (c) and (d) represent
the relative deviation of the imputed dataset from the original dataset. The relative deviation is
calculated as incidence-ratio between original and imputed dataset. The box-plots represent the
distribution of the relative deviations of the 50 imputed data sheets. The blue horizontal line
represents the value one, it means a correspondence between original and imputed dataset.
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2.3 The Eldorado cohort
The 17,660 male subjects of the Eldorado cohort were collected from the personnel records
provided by the mines and processing sites operated by Eldorado Nuclear Ltd. The Eldorado
Nuclear Ltd company was started in 1927 as Eldorado Gold Mines Limited to develop a gold
mine in Manitoba. In 1930 radioactive deposits at Great Bear Lake were found. The Eldorado
Mine at Port Radium was therefore developed. In 1933 a state-of-the-art refinery was built
in Port Hope, Ontario. Between 1933 and 1940 radium was produced, together with silver,
copper, and uranium salts. The mine at Port Radium was reopened in 1942 to supply the
United States military with uranium products. The company was taken over by the Canadian
Government in 1943, and in early 1944 the name was changed to Eldorado Mining and Refining
Limited. With the discovery of the Port Radium deposits, the Beaverlodge Mine at Uranium
City, Saskatchewan, was opened entering production in 1953. In the 1960s the Unated States
military stopped purchasing of Canadian uranium ores for the purpose of atomic weapons, and
from then on uranium was produced for power plants. The company was dismantled in 1988 and
merged with assets of the Saskatchewan Mining Development Corporation (SMDC) to become
Cameco Corporation [33].
The major part of the workers were uranium miners or mill workers employed at the two
mine sites Port Radium (Northwest Territories, Canada) and Beaverlodge (northern Alberta,
Canada) and workers employed at the radium and uranium refining/processing plant in Port
Hope (Ontario) [33]. A small part of subjects were employed in "other sites" as for example
head officers, aviators and researchers. The followup of the data analysed in this Thesis started
in 1969 and ended in 1999 [33]. To be included in the study a subject had to fulfill the following
characteristics:
• age at employment between 15 and 75 years,
• year at first employment between 1932 and 1980,
• end of followup after 1940, and
• being alive in year 1969.
People of all three facilities were exposed to both α and γ radiation. The α exposure derived
from radon decay products and uranium. γ rays normally follow after α decay. Exposure to
cigarette smoke is recorded for this cohort.
The individual annual exposures for this cohort is calculated in working level month (WLM)
[68]. To calculate WLMs first a working level is calculated. A working level is the concentration
of radon decay products per liter of air that would result in the ultimate release of 1.3 · 105
MeV of potential α-particle energy. One WLM is equivalent to one working month (170 h) in a
concentration of 1 working level [68].
The exposure intensity differs between facilities: people in Port Hope were mostly subjected to
γ radiation with very low α dose, all other facilities had and opposite major exposure to α with
low γ radiation. The correlation of the different exposures for the three facilities are presented
in Figure 2.4. A summary of the Eldorado cohort can be found in Table 2.4.
Please note that in previous analysis (e.g. [33]), where statistical models were applied, only
lagged dose exposures were taken into account. A graphical description of lagged and non-lagged
dose exposure is given in Figure 2.5. Let us consider the case in which a worker started working
in a facility at age Age at first employment and stopped working at age Age at last employment.
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Figure 2.4: Gamma5 exposure as a function of Radon5 exposure in the Eldorado cohort dif-
ferentiating between the different facilities: Port Hope (brown), Port Radium (green), Beaver
Lodge (purple) and others (orange). The coloured lines represent linear regressions with γ inten-
sity (mGy) as command variable and α intensity (WLM) as causing variable for the respective
coloured facility.
Only if the end of followup happens in orange-marked age-interval we have a difference between
lagged and non-lagged cumulative dose, that can be appreciated in the orange-marked region.
The same plot can be done for γ radiation exposure. The idea behind a lagged dose is the
assumption that any kind of exposure needs time in order to change the exposed environment
and since descriptive models do no take into account any biological development, the latent
period has to be introduce per hand [23, p. 673]. The impact between lagged and non-lagged
dose in this data is really small (see Figure B.1).
As seen in Chapter 1.1, γ and α exposures damage tissues in different ways: γ waves go deep in
the tissue while α particle stay on the surface. With this knowledge it is interesting to see if this
association is visible in the raw data of this special cohort, where both exposures are known.
The graphical representation of this association is presented in Figure 2.6. Cases (LADC in red
and SQUAM in blue) are represented in dependency of both radiation exposures. A tendency
of LADC to develop with γ and of SQUAM with α exposure is clearly identifiable. Since the
majority of people were exposed to α particles (cf. Figure 2.4) it is clear that in this cohort the
predominant lung cancer subtype is SQUAM (see Figure 2.7). In this case it is interesting to
see how for both subtypes the raw rate decreases for higher age (cf. Figures A.2 and A.3 for
LSS LADC and SQUAM, respectively). This fact can be attributed to a possible harvesting
effect from an unknown smoking behaviour. Cases in smokers arise in younger ages, while older
cases are not affected by smoking. The increment only for younger ages determines the decreas-
ing behaviour. Since smoking information is not given for this cohort, only statistical models
will be applied. A biological approach would not be reasonable without information about this
important cause of lung cancer.
Different variables of the Eldorado cohort were analysed before model application. The re-
sults can be found in Appendix B.
Model results for to this cohort can be found in Chapters 6 and 7 for LADC and SQUAM,
respectively.
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Table 2.4: Summary of mean values for different covariables of the Eldorado cohort.
Total LADC SQUAM
Subjects 15348 102 199
Person years 367079 1944 3469
Cases 593 102 199
Case-weighted
attained age (years) 62.85 62.52 63.23
Case-weighted
γ radiation dose (mGy) 56.23 76.37 48.99
PYRs-weighted
γ radiation dose (mGy) 23.95 73.06 41.12
Case-weighted
α radiation dose (WLM) 163.18 116.43 202.83
PYRs-weighted
α radiation dose (WLM) 39.63 96.96 188.99
Figure 2.5: Description of the accumulation of WLM over age for a worker that started working
in a facility at age Age at first employment and stops working at age Age at last employment.
The blue(pink) line represents the cumulative WLM for this worker without(with) lag time. Only
if the end of followup happens in orange-marked age-interval we have a difference between lagged
and non-lagged cumulative dose, that can be appreciated in the orange-marked region.
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Figure 2.6: Incidence of the Eldorado cohort in relation to the variables Gamma5 and Radon5.
LADCs are represented in red and SQUAMs in blue.
Figure 2.7: Age distribution of cases per 104 persons per year for LADC (red) and SQUAM
(blue). The dashed lines represent the weighted mean values of the corresponding cancer types.
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CHAPTER
3
METHODS OF DATA ANALYSIS
This chapter is dedicated to the models used for the analysis of Life Span Study and Eldorado
cohort. The first part deals with epidemiology and statistical methods to compare models, while
the second part is about the actual models used to fit the data.
The chapter starts with definitions of the survival and the hazard function. With these defini-
tions Poisson regression is introduced, which allows us to test different models against the data.
After a brief introduction of this regression method, the formula for the Poisson deviance will
be derived. It is a measure for the discrepancy between the fitted and the real values of the
response variable. Next, the definition of the Akaike’s Information Criterion will be introduced,
to allow us for comparison of non-nested models.
Having obtained the instruments to evaluate models, next the models themselves will be intro-
duced. Two different classes of models are applied in this Thesis. Members of the first class we
call "statistical models", as understanding and quantification of covariate effects to the outcome
are established purely by statistical association. In contrast, the "biologically based molecular
models" take into account biological knowledge for definition and covariate analysis. Within the
class of statistical models, standard generalized additive models and explicit risk models that
represent the state-of-the-art in radiation protection will be presented. Within the biologically
based models the two stage clonal expansion model and the three stage clonal expansion model
will be introduced. In the first model normal stem cells undergo two transformations to become
malignant, in the second model three transformations.
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3.1 Concepts of survival analysis
The motivation for this Thesis is to improve the understanding of carcinogenesis and the re-
lated risks in LADC and SQUAM after exposure to ionising radiation and cigarette smoke.
One approach to this question involves the analysis of time periods from birth and exposures
to a potential final event (LADC or SQUAM), and can be treated statistically within Survival
analysis [23, p. 891].
Let us consider consider the non-negative random variables Ti as a description of the times
at which given final events ki occur. The distribution of Ti can be mathematically described by
the survival function S(t) [23, p. 893].
Definition 3.1.1: (Survival function)
The survival function S(t) describes the probability that at a given time t the investigated event
ki has not yet occurred
Si(t) = P (Ti > t) (3.1)
Of interest is also the probability that an event ki occurs in a given time interval t ≤ Ti < t+∆t.
This probability can be described with the so called hazard function h(t) [23, p. 893].
Definition 3.1.2: (Hazard function)
Let us consider the non-negative random variables Ti describing the time at which given events
ki occur. The hazard function or also failure rate h(t) describes the probability that defined
events ki to occur in the determined time interval [t, t+ ∆t]
h(t) = lim
∆t→0
P (t ≤ T < t+ ∆t | T ≥ t)
∆t . (3.2)
It is important to notice that the hazard function can be written as a function of the survival
function.
Theorem 3.1.3:
Let us consider the non-negative random variables Ti describing the time at which given events ki
occur with corresponding survival function S(t) and hazard function h(t). The hazard function
h(t) can hence be written as a function of the survival function S(t)
h(t) = − d
dt
ln(S(t)). (3.3)
The proof can be found in Appendix C.1.
Finally we are interested in numbers of people becoming sick, which is a count variable for
which a Poisson distribution is assumed. In the next section a detailed introduction of Poisson
regression is given.
3.2 Poisson regression
Let us consider observations y1, ..., yn for the respective independently Poisson distributed re-
sponse variables Y1, ..., Yn with means µ1, ..., µn [23]. The probability of observing yi observa-
tions in an interval is given by the equation
P (yi|µi) =
µyii e
−µi
y! . (3.4)
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Of interest is the estimation of λi with different regression models, which can be generally
described by the following form
µi = ηi(β) = η(x1i, ..., xki;β1, ..., βk), (3.5)
where η is some regression function with regression parameters β1, ..., βk, with each component
relating values xi1, ..., xik of explanatory variables to respective means [23].
Using equations (3.4) and (3.5) the log likelihood ` is thus given by the following equation [23]
`y(β) =
n∑
i=1
yi ln[ηi(β)]− ηi(β)− ln(yi!) (3.6)
The estimation of the model parameters β1, ..., βk can hence be performed by the maximization
of the (log)likelihood function. The statistic used in this Thesis to quantify the support of the
data to a particular model is the so called deviance [23].
Definition 3.2.1: (Deviance in a model)
Let us consider model (3.5) with log likelihood (3.6). As a measure of distance between the
model with the most likely parameters β̂ and the model described by the "real" parameters β,
the deviance is given as minus two times the logarithm of the normed likelihood L [23]
Dy(β) = −2 ln
(
Ly(β)
Ly(β̂)
)
= −2(`y(β)− `y(β̂)) (3.7)
= −2
n∑
i=1
yi ln
(
ηi(β)
ηi(β̂)
)
− ηi(β) + ηi(β̂) (3.8)
To have a measure of goodness of fit comparable to the residual sum of squares in normal linear
regression, the likelihood of the "real" model that perfectly fits the data can be compared to the
likelihood of model under the other following definition of deviance
devy(β̂) = −2
n∑
i=1
yi ln
(
yi
ηi(β̂)
)
− yi + ηi(β̂), (3.9)
where yi are the observations, here the number of people suffering from LADC or SQUAM
[23], and ηi are the predicted cases. Since our data are given in a stratified form, the following
relation between prediction and person years is given
ηi(β̂) = hi(β̂) · PY Rsi, (3.10)
where hi is the predicted hazard and PY Rsi the person years of each stratum.
During data analysis a lot of models have to be compared to each other in order to find the
"best" one, a parsimonious and well fitting model. The deviance is an appropriate statistic to
compare nested hierarchical models. Let us consider two models. The first one may have the
parameter set β̃ = [β1, ..., βn, r1, ..., rm]. The other one may be "smaller", in the sense that it
equals the first one but with m parameters set to zero ζ = [β1, ..., βn, 0, ..., 0]. Let us assume
that the small model is the correct one, then the difference in deviance is χ2 distributed with
m degrees of freedom. This is the so called likelihood ratio test with the null hypothesis for the
smaller model against the larger model as the alternative [23]. We consider an improvement
significant if the smaller model can be excluded on a 95% confidence interval.
To compare non-nested models the Akaike’s Information Criterion (AIC) can be used. Models
with a smaller AIC are preferred [47].
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Definition 3.2.2: (AIC - Akaike’s Information Criterion)
Let us consider a model η as defined in (3.5) with deviance dev (3.9) and k parameters. The
Akaike’s information criterion (AIC) is defined by
AIC = dev + 2k. (3.11)
Having introduced the Poisson regression, the remaining part of this chapter is devoted to
different models, instances of equation (3.5).
3.3 Statistical models
Two type of statistical models are described in this section. In this context the term "statistical
model" is intended to underline the fact that understanding and quantification of covariate
effects to the outcome are established purely by statistical association. In contrast, in the next
sections biologically based molecular models will be presented. The difference is that for the
latter models model definition and covariate analysis take into account biological knowledge.
3.3.1 The generalized additive models
This section is dedicated to the introduction of Generalized Additive Models (GAM). To have
a better understanding of this type of models we will shortly discuss additive models and their
characteristics. The peculiarity of GAMs is the usage of nonparametric functions (smoothing
splines) that can model patterns of covariables that would remain hidden with simple parametri-
sation.
Let us consider the following Linear Model (LM)
hi = β0 + β1x1i + . . .+ βpxpi + εi (3.12)
with the linear predictor
ζi = β0 + β1x1i + . . .+ βpxpi = xTi β, (3.13)
where hi denotes the counting response variable and β = (β0, β1, . . . , βp)T are coefficients of the
covariates x1i, ..., xpi with i.i.d. εi ∼ N(0, σ2) as error term.
The class of additive models is an extension of LMs, equation (3.12), where the linear predic-
tor (3.13) is generalized using smooth functions f(·)
hi = f1(z1i) + . . .+ fq(zqi) + β1x1i + . . .+ βpxpi + εi, (3.14)
where β = (β1, . . . , βp)T is a parameter vector of covariates assumed to have a linear effect [64].
Different smooth functions will be explained in the following.
A peculiarity of LM, and hence of additive models, is the additivity of the effects of the pre-
dictor. Due to assumptions of additivity and independence of the covariates, the effects of the
predictor can be investigated separately. Holding all but one predictor fixed, the variation of
the fitted response is independent of the other predictors. The functions of the covariates can
hence be analysed individually [64].
GAMs are additive models described by equation (3.14) with the response following any distri-
bution from the exponential family [64].
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3.3.1.1 Smoothing splines
The assumption that the relation between response and covariate is not linear, can be tested
with nonparametric functions. Since nonparametric functions per definition do not have a rigid
form of dependence between response hi and covariates x1i, . . . , xpi, some smoothing techniques
have to be introduced. This section is based on [64] and [29].
The first technique we introduce in this Thesis are Polynomial Splines.
Let us assume that a given data is given in the form of (hi, xi), i = 1, . . . , p, where hi are the
observations of the response variable and xi are the corresponding metric covariates. Let us
also assume that the response variable can be described by a function f(·) and an error term εi
hi = f(xi) + εi. (3.15)
The first idea is to approximate f(xi) with a polynomial function
f(xi) = γ0 + γ1xi + . . .+ γlxli, (3.16)
where l ∈ N and γk ∈ R, k ∈ {0, . . . , l}. The problem with a pure polynomial approach is that
if the polynomials have low degrees, the "true" relation of the data might not be sufficiently
explained. The other way around, if the degree is high, the model fit will be too wiggly.
Fahrmeir et al. [20] applied the idea to divide the codomain into m parts k0 < · · · < km and
approximate f(xij) in each interval [kj , kj+1), j ∈ {0, . . . ,m− 1} with l-th degree polynomials.
However, the resulting piecewise estimated f(xij) is not necessary continuous.
B(asic)-splines can be introduced as a construction to guarantee that piecewise estimated
functions on knots k1, ..., km−1 are composed in a sufficient, (l − 1)-times differentiable way.
The smoothing function f(.) can be estimated with B-splines so that y = f(x) + ε becomes a
linear model. This is done by choosing specific basic functions B1(x), . . . , Bd(x), d = m+ l− 1,
in formula
f(x) =
d∑
j=1
γjBj(x), (3.17)
where γj , j = 1, ..., d are the coefficients [20].
B-splines are defined as non-zero functions only on a few intervals [ki, kp], i,p ∈ 0, . . . ,m, with
i 6= p. We can hence rewrite equation (3.15) as the following linear model
y = Xγ + ε, (3.18)
with,
X =
 B1(x12) . . . Bd(x12)... . . . ...
B1(x(NV −1)NV ) . . . Bd(x(NV −1)NV )
 , γ =
γ1...
γd,

where y = (y12, . . . , y(NV −1)NV )T and ε = (ε12, . . . , ε(NV −1)NV )T .
The parameter vector γ can hence be estimated by the ordinary least square method
γ̂ = (X ′X)−1X ′y.
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The parameter vector γ can not be interpreted in a reasonable way, but the form of the estimated
function f̂(.),
f̂(x) = Bγ̂,
where B = (B1(x), . . . , Bd(x)), which is a result of γ̂, can be interpreted.
With B-splines we now reached continuous and differentiable functions. The problem of f(xij)
to be wiggly unfortunately persists [20].
The problem of having wiggly f(xij) functions can be bypassed with P(enalized) splines. The
difference in applying P-splines is that instead of minimizing the deviance function devy(β̂) (3.9),
we minimize the following equation
devy(β̂) + λ
∫
C
f ′′(x)2dx (3.19)
with respect to β̂. C represents the codomain of x and f ′′(x) is the second derivative of function
f(x). Since the second derivative of a function yields information of a curvature of the function,
the minimization of the second derivative penalizes models that are too wiggly. In order not to
loose the balance between model’s fit and smoothness the parameter λ can be adapted: λ = 0
correspond to a model without penalization, λ→∞ instead, leads to a linear regression of the
data [20].
In this Thesis we want to use deviance and AIC to compare different models. These statis-
tics are related only to likelihood and number of model parameters. P-splines additionally
minimise the second derivative of the function. To compare models with and without penal-
ization, for penalized models first a maximum likelihood estimate β̂ from equation (3.19) is
calculated. Then the evaluated deviance function devy(β̂) (3.9) at the point β̂ is given. This
value is comparable with the deviance function devy(β̂) (3.9) of non-penalized models.
3.3.2 State-of-the-art statistical risk models for radiation protection
State-of-the-art statistical risk models for radiation protection are explicit models commonly
used in radiation epidemiology. They were developed from Preston [48] and are much more
similar to models used in Cox regression, but with a flexible baseline rate [23]. Radiation effect
is assumed to follow an Excess Relative Risk model (ERR)
h(t, z, d) = h0(t, z)(1 + ρ(d)ε(t, z)) (3.20)
or an Excess Additive Risk model (EAR)
h(t, z, d) = h0(t, z) + ρ(d)ε(t, z), (3.21)
where t denotes attained age and other functions of time, z is a vector of dose independent
covariables and d is a vector of covariables describing the exposure. The function h0(·) describes
the background rates and is called baseline hazard, where ρ(d) is the dose response function
with effect modification ε(·). In the models applied in Chapters 4 to 7 the general forms for
h0(t, z), ρ(d) and ε(t, z) will be
h0(t, z) = ef0(Σ1,...,Σn,z1i,...,zni) (3.22)
ρ(d) = γ0 · d (3.23)
ε(t, z) = ef1(γ1,...,γn,z1i,...,zni) (3.24)
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with parameter vector β = [Σ1, ...,Σn, γ0, ..., γn] and covariates z1i, ..., zni. Analogously to the
model names, parameter γ0 is called excess relative risk in ERRs and excess absolute rate per
unit dose in EARs.
Since the LSS includes smoking-related information, risk models need to take into account
also cigarette smoke exposure. Therefore Furukawa et al. [21] extended this kind of models and
introduced also a term to describe synergistic effects of radiation and smoking. Equations (3.20)
became the so called Simple Multiplicative Model
h(t, z, d) = h0(t, z)(1 + ρ(d)ε(t, z))(1 + φ(smk)κ(t, z)) (3.25)
and (3.21) the so called Simple Additive model
h(t, z, d) = h0(t, z) + ρ(d)ε(t, z) + φ(smk)κ(t, z), (3.26)
where φ(smk) is the smoking-response function with effect modification κ(·). In the models
applied in Chapters 4 to 7 the general forms for φ(smk) and κ(·) will be
φ(smk) = φ0 · packyears (3.27)
κ(t, z) = ef2(φ1,...,φn,z1i,...,zni) (3.28)
with parameter vector β = [Σ1, ...,Σn, γ0, ..., γn, φ0, ..., φn] and covariates z1i, ..., zni. Models
with synergistic radiation-smoking effects he called Generalized Multiplicative Relative
Risk Models (GMRRM) and Generalized Additive Excess Risk Models (GAERM) and
are described by the following equations
h(t, z, d) = h0(t, z)(1 + ρ(d)ε(t, z) · ω(smk))(1 + φ(smk)κ(t, z)) (3.29)
and
h(t, z, d) = h0(t, z) + ρ(d)ε(t, z) · ω(smk) + φ(smk)κ(t, z)), (3.30)
respectively, where ω(·) is a function of smoking variables with the following form
ω(smk) = eω1·log(day packs +1)+ω2·log2(day packs +1). (3.31)
The final parametric vector for GMRRMs and GAERMs is hence
β = [Σ1, ...,Σn, γ0, ..., γn, φ0, ..., φn, ω1, ω2].
The parameters γ0 and φ0 are called excess relative risks for radiation and smoking in GMRRMs
and excess absolute rates for radiation and smoking in GAERMs.
Excess Relative Risks (ERR) for people with only one kind of exposure can be easily derived
solving model (3.20) for the parameter γ0 or φ0
ERRd = γ0 · ε(t, z) =
h(t, z, d)
h0(t, z)
− 1 (3.32)
ERRsmk = φ0 · κ(t, z) =
h(t, z, d)
h0(t, z)
− 1. (3.33)
The ERR is best explained using an example. Let us consider an hypothetical ERR of 1.2. It
means that per spontaneous case there were 1.2 exposure-induced cases. An ERR of 0 would
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mean no difference in amount of cases between exposed and not exposed cohort.
Excess Absolute Rates (EAR) can be calculated with model (3.21)
EARd = γ0 · ε(t, z) = h(t, z, d)− h0(t, z) (3.34)
EARsmk = φ0 · κ(t, z) = h(t, z, d)− h0(t, z). (3.35)
As the difference of total and baseline cases, the EAR describes the amount of exposure-induced
cases.
3.4 Multistage mechanistic models
So far we presented two types of empiric models for hazard rates. Empiric models do not take
into account any concrete biological process but are used to provide a parsimonious description of
covariates’ effects to ERRs and EARs. In this section we present mechanistic multistage models
which aim is to approximate disease processes latent in the data. In this Thesis we consider
two types of mechanistic models: the Two Stage Clonal Expansion Model (TSCE) and the
Three Stage Clonal Expansion Model (3SCE), that were first analysed by Moolgavkar and
Knudson [43]. Mechanistic multistage models describe carcinogenesis as a process with several
distinct stages of mutation of stem cells: the TSCE has two stages while the 3SCE has three.
3.4.1 The two stage clonal expansion model
We first start with the description of a TSCE, which is schematically presented in Figure 3.1.
The first transition may occur in any fraction of the large number of X healthy stem cells
becoming initiated cells with yearly rate ν. Initiated cells can hence differentiate (symmetric
division with rate α or inactivation with rate β) and grow into a clone (clonal expansion). Some
of these intermediate cells can also transform again with rate µ becoming malignant cells, that
after a time-lag Θt can create a detectable cancer lesion.
For mathematical implementation of the TSCE, mutation rates and rates of cell division or
healthy
cells
X(t)
 
initiated
cells
Y(t)
malignant
cells
Z(t)
β
α
μν
 
 
cancer
Θt
Figure 3.1: Schematic representation of the TSCE. Boxes represent cells in states with defined
molecular properties. Arrows represent transitions between cell states. Rates of transition are
denoted with Greek letters.
inactivation are treated as transient Poisson point processes of cell birth and death. Table 3.1
gives a summary of the possible transitions in a TSCE. Please note that the amount X of healthy
stem cell is assumed to be so large not to be affected by the transition to initiated cells.
Every model has some different states it can adopt. The different possible states the system
can take are described as the state space of the model.
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Table 3.1: Transition rates of the TSCE. Referred to Figure 3.1
Summary of the possible transitions in the TSCE
Rate Meaning
ν transition rate from healthy to initiated cells (increase Y )
α symmetric division rate of initiated cells (increase Y )
β inactivation/differentiation rate of initiated cells (decrease Y )
µ asymmetric division rate of initiated cells, with a malignant daughter cell (increase Z)
Θt time lag for malignant cells to become a tumor
Definition 3.4.1: (State space of the TSCE)
In the TSCE a cell may adopt three different states. The number of cell in each state is
represented by:
• X(t) = X : constant number of healthy stem cells (ignoring lung growth during childhood
for simplicity),
• Y (t) : number of intermediate cells at time t,
• Z(t) : number of malignant cells at time t.
It holds that X, Y (t), Z(t) ∈ N ∪ {0}.
Since we want to adopt the stochastic version of the TSCE, the state of the model at time t is
given by the probability that there are j intermediate and k malignant cells under the condition
that at the start time t0 we had j0 intermediate and k0 malignant cells, with j, k, j0, k0 ∈ N∪{0}.
Definition 3.4.2: (The state of the TSCE at time t)
Let j, k, j0 and k0 ∈ N ∪ {0} and let us consider the start time t0 were j0 intermediate and
k0 malignant cells are present. Then the probability P to have j intermediate and k malignant
cells at time t is defined by
P (j, k, t) = P (Y (t) = j, Z(t) = k|Y (t0) = j0, Z(t0) = k0). (3.36)
If we want to predict the number of intermediate cells starting from time t after a specific time
interval ∆t we have to analyze the evolution of the stages over time. To do so we have to take a
look at all possible transitions in the system that can happen until the time point t+∆t leading
to j intermediate and k malignant cells and the corresponding probabilities.
• initiation: X → Y with probability XνP (j − 1, k, t)∆t+ O(∆t)
• symmetric cell division: Y → 2Y with probability (j − 1)αP (j − 1, k, t)∆t+ O(∆t)
• inactivation: Y cell dies with probability (j + 1)βP (j + 1, k, t)∆t+ O(∆t)
• transition into malignant cell: Y → Z with probability jµP (j, k − 1, t)∆t+ O(∆t)
• nothing happens: (1−Xν∆t)(1− jα∆t)(1− jβ∆t)(1− jµ∆t)P (j, k, t) + O(∆t)
Taking only terms of first order into account it remains (1 − Xν∆t − jα∆t − jβ∆t −
jµ∆t)P (j, k, t) + O(∆t).
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The sum over these five different possibilities leads to the probability to have j intermediate
and k malignant cells at time t+ ∆t:
P (j, k, t+ ∆t) = XνP (j − 1, k, t)∆t+ (j − 1)αP (j − 1, k, t)∆t
+ (j + 1)βP (j + 1, k, t)∆t+ jµP (j, k − 1, t)∆t
+ P (j, k, t)− (Xν∆t+ jα∆t+ jβ∆t+ jµ∆t)P (j, k, t) + O(∆t). (3.37)
From equation (3.37) we can now derive the master equation of the system, which describes
the evolution of the system over time.
Definition 3.4.3: (The Master Equation of the TSCE)
Let us consider equation (3.37) for the case of no intermediate cells j0 = 0 and no malignant
cells k0 = 0 at time t0. The time evolution of the TSCE is hence given by the following master
equation
dP (j, k, t+ ∆t)
dt
= lim
∆t→0
P (j, k, t+ ∆t)− P (j, k, t)
∆t
=XνP (j − 1, k, t) + (j − 1)αP (j − 1, k, t)
+ (j + 1)βP (j + 1, k, t) + jµP (j, k − 1, t)
− (Xν + jα+ jβ + jµ)P (j, k, t), (3.38)
P (0, 0, t0) =1. (3.39)
Equation (3.38) defines the probability to have j intermediate and k malignant starting from
time t after a time ∆t. A variation in time of the number of intermediate and malignant cells is
analysed. Equation (3.38) is a first order ordinary differential equation (ODE) with the initial
condition (IC) (3.39) that describes the case in which no intermediate and no malignant cells
have already developed at time t0.
Introducing the definition of the probability generating function the problem (3.38) with IC (3.39)
can be rewritten as a partial differential equation (PDE) of first order, which can be solved as
presented in the following.
Definition 3.4.4: (The probability generating function of the TSCE)
The probability generating function of a discrete random variable is a power series representation
of the probability mass function of the random variable. Let us consider the TSCE with constant
number of healthy stem cells (X(t) = X = const). The corresponding probability generating
function for the random variables Y (t) and Z(t) is hence given by
Ψ(y, z, t) =
∞∑
j=0
∞∑
k=0
P (j, k, t)yjzk. (3.40)
Please note that since X(t) = X = const the probability generating function does not depend
on the number of the healthy stem cells X.
Considering the case in which at the beginning no intermediate and no malignant cells are
present, the initial condition of the probability generating function (3.40) has the following
form
Ψ(y, z, t0) =
∞∑
j=0
∞∑
k=0
P (j, k, t0)yjzk = P (j, k, t0)y0z0 = 1. (3.41)
3.4. MULTISTAGE MECHANISTIC MODELS 35
From the TSCE model we want to obtain a functional form describing the probability of having
any number intermediate cell Y (t), but no malignant ones. This can be connected to the
definition of the survival function S(t) (3.1). Written with probability generating functions it is
the sum over all states where any number intermediate cell Y (t) can develop, but no malignant
cells:
S(t) =
∞∑
j=0
∞∑
k=0
P (j, k = 0, t) =
∞∑
ji=0
P (j, 0, t). (3.42)
Proposition 3.4.5:
Let us consider master equation (3.38) with IC (3.39) and definition (3.4.4) of the probability
generating function. The equation (3.38) can hence be rewritten as the following PDE
∂
∂t
Ψ(y, z, t) = F (y, t)Ψ(y, z, t) +G(y, z, t) ∂
∂y
Ψ(y, z, t)
Ψ(y, z, t0) = 1 (3.43)
with
F (y, t) := (y − 1)Xν
G(y, z, t) := µyz + αy2 − [α+ β + µ]y + β
The proof can be found in Appendix C.2. Please note that since no transition departs from
the box of the malignant cells (see Figure 3.1), also no partial derivative with respect to the
variable z is present.
To solve PDE (3.43) the method of characteristics will be applied [36]. With this method
the PDE will be transformed into a system of ODEs, whose equations are the characteristic
curves of the PDE itself. For the definition of the characteristics a new variable is needed: s. s
is just an auxiliary variable needed for the method of characteristic and does not have a direct
interpretation.
Theorem 3.4.6:
Let us consider the PDE (3.43)
∂
∂t
Ψ(y, z, t) = F (y, t)Ψ(y, z, t) +G(y, z, t) ∂
∂y
Ψ(y, z, t)
Ψ(y, z, t0) = 1
with
F (y, t) := (y − 1)Xν
G(y, z, t) := µyz + αy2 − [α+ β + µ]y + β
of the corresponding TSCE depicted in Figure (3.1) with the definitions
A := −12
(
α− β − µ+
√
(α− β − µ)2 + 4αµ
)
(3.44)
B := 12
(
−(α− β − µ) +
√
(α− β − µ)2 + 4αµ
)
. (3.45)
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Then, PDE (3.43) with initial condition s1 on the characteristic has the following solution
Ψ(s) = e
Xν
α
[ln(f(s))−ln(f(s1))], (3.46)
with characteristic
y(s) = w(s)
α
+ 1, (3.47)
t(s) = s+ t0, (3.48)
z(s) = 0, (3.49)
where s1 is the starting point, with for generic initial conditions
w(s) = AB(e
A(s−s1) − eB(s−s1))− w(s1)(AeA(s−s1) −BeB(s−s1))
(B − w(s1))eA(s−s1) + (w(s1)−A)eB(s−s1)
(3.50)
f(s) = (B − w(s1))eA(s−s1) + (w(s1)−A)eB(s−s1). (3.51)
and for the specific initial condition w(s1) = 0
w(s) = AB(e
A(s−s1) − eB(s−s1))
BeA(s−s1) −AeB(s−s1)
(3.52)
f(s) = BeA(s−s1) −AeB(s−s1). (3.53)
Proof. To solve PDE (3.43) the method of characteristics will be applied. We look hence for
the characteristic curves of the analysed equation (3.46). Therefore we introduce a new system
of ODEs with the new variable s
• generating function:
d
ds
Ψ(s) = (y(s)− 1)XνΨ(s) (3.54)
Ψ(s0) = Ψ0 = 1 (3.55)
⇒ Ψ(s) = Ψ0e
(∫ s
s1
(y(s′)−1)Xνds′
)
= e
(∫ s
s1
(y(s′)−1)Xνds′
)
(3.56)
• t variable:
d
ds
t(s) = 1→ t(s) = s+ t0, t0 = constant
• z variable:
d
ds
z(s) = 0→ z(s) = z1 = 0
• y variable:
d
ds
y(s) = −G(s) = −αy(s)2 + [α+ β + µ]y(s)− β (3.57)
Introducing the following transformation
y(s) = w(s)
α
+ 1 (3.58)
3.4. MULTISTAGE MECHANISTIC MODELS 37
we can rewrite the equation (3.57) in a standard form of a so called Riccati equation
d
ds
w(s) = −w(s)2 − γw(s) + δ (3.59)
with
γ = α− β − µ (3.60)
δ = αµ. (3.61)
The Riccati equation (3.59) can be solved with standard methods [30]:
First we calculate a particular solution of it equating the right hand side of equation
(3.59) to zero
w(s)2 + γw(s)− δ = 0
⇒ A,B = −γ ∓
√
γ2 + 4δ
2 (3.62)
A and B are the static solutions for constant w.
Then we introduce the following transformation
v(s) := 1
w(s)−B . (3.63)
Applying the transformation (3.63) to equation (3.59) we obtain the following first order
linear ODE
d
ds
v = [γ + 2B]v + 1, (3.64)
that can be solved using the standard method of variation of constants. The solution of
equation (3.64) for an arbitrary initial condition reads
v(s) = e(γ+2B)(s)c̃− 1
γ + 2B . (3.65)
To get rid of the constant c̃ we rewrite it in terms of the general IC v(s1) = v1. Using
equations (3.64) and (3.65) it follows
v(s1) = es1(γ+2B)c̃−
1
γ + 2B
!= 1
w(s1)−B
↪→ c̃ = γ +B + w(s1)(w(s1)−B)(γ + 2B)
e−s1(γ+2B) .
A further simplification can be obtained using A already defined in (3.62):
−γ −B = −γ + γ2 −
√
γ2 + 4δ
2 = −
(
γ +
√
γ2 + 4δ
2
)
= A
↪→ c̃ = w(s1)−A(w(s1)−B)(γ + 2B)
e−s1(γ+2B).
The solution v(s) therefore reads
v(s) = (w(s1)−A)e
(s−s1)(γ+2B) − (w(s1)−B)
(w(s1)−B)(γ + 2B)
. (3.66)
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Now (3.66) can be transformed back to the original variable w(s) using definition (3.63)
w(s) = AB(e
A(s−s1) − eB(s−s1))− w(s1)(AeA(s−s1) −BeB(s−s1))
(B − w(s1))eA(s−s1) + (w(s1)−A)eB(s−s1)
. (3.67)
In equation (3.67) we see that the numerator is the derivative in s of the denominator.
With
f(s) := (B − w(s1))eA(s−s1) + (w(s1)−A)eB(s−s1)
it holds that
w(s) = ∂
∂s
f(s) · 1
f(s) =
∂
∂s
ln(f(s)), (3.68)
Finally equation (3.56) reads
Ψ(s) = eXν
∫ s
s1
(y(s′)−1)ds′ = e
Xν
α
∫ s
s1
w(s′)ds′ = e
Xν
α
∫ s
s1
d
ds′ ln(f(s
′))ds′
= e
Xν
α
[ln(f(s))−ln(f(s1))] (3.69)
Ψ(y, z, t0) = 1 (3.70)
For the specific initial condition w(s1) = 0 the functions w(s) and f(s) read
w(s) = AB(e
A(s−s1) − eB(s−s1))
BeA(s−s1) −AeB(s−s1)
f(s) = BeA(s−s1) −AeB(s−s1)
Remark 3.4.7:
Please note that Ψ(s) is the survival function for the TSCE. We calculated it using probability
generating functions as the sum over all states where any number of intermediate cells Y (t)
can develop, but no malignant cells. Equation (3.70) gives hence the probability that no
intermediate and no malignant cells have already developed from normal healthy cells.
Using theorem 3.1.3 the hazard function can be derived out of the survival function
h(t) = − d
dt
ln(S(t)).
Taking the logarithm of equation (3.70)
ln(Ψ(t)) = ln(S(t)) = Xν
α
[ln(f(t))− ln(f(t0))] (3.71)
and inserting the relevant integration boundaries t (attained age) and t0 = 0 (birth) one gets
the final formula
ln(S(t)) = Xν
α
[ln(B −A) + Bt − ln(Be(B−A)t −A)]. (3.72)
The next and last step to the final hazard function is to take the derivative of equation (3.72)
with respect to t
h(t) = − d
dt
ln(S(t)) = Xνµ
[
e(B−A)t − 1
Be(B−A)t −A
]
. (3.73)
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Table 3.2: Identifiable parameters of the TSCE. Referred to Figure 3.1
Summary of the identifiable parameters in the TSCE
Parameter Meaning
C := Xνµ Initiation rate
γ := α− β − µ Clonal expansion rate of the intermediate cells
δ := αµ Stochasticity parameter
The TSCE has only three identifiable parameters, shown in Table 3.2. Parameter C describes
the so called initiation rate, which describes the turn over to malignant cell in the absence of
clonal expansion. Parameter γ is the so called clonal expansion rate of the intermediate cells.
It describes the net increase of the intermediate cells. δ is a so called stochasticity parameter
and has no direct biological meaning.
So far we modeled the probability of a person to get a malignant cell without any external
influence on it. If we want to build in the effects of external exposures (e.g. irradiation and
smoking) on the hazard function, the parameters are assumed to depend on there exposures
and thus vary with time.
Let us consider the case in which a person gets exposed to ionizing radiation at age Age at
bombing, begins to smoke at age Age begin smoking and does not quit. Let us also assume that
the irradiation exposure is a rather acute one with biological effects lasting for one week. Fi-
nally we assume that irradiation and smoking will affect the identifiable parameters. Figure 3.2
represents exemplary changes to the clonal expansion γ.
Figure 3.2: Schematic representation of the clonal expansion rate γ under the effects of ionising
irradiation (red) and smoking (blue). The ionizing irradiation-exposure is acute and is assumed
to have an effect of one week. Smoking is assumed to be continued at a fixed rate.
Within each of the age-intervals the parameters are assumed to be constant (piecewise-constant
parameters). Therefore the hazard function can be derived as shown in the sections before for
every single interval and then summed up.
The logarithm of the survival function with piecewise-constant parameters with k age-intervals
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can be written similarly to equation (3.72)
ln(S(t)) =
k∑
i=1
Xνi
αi
∫ si
si−1
wi(s)ds =
k∑
i=1
Ci
αiµ0
∫ si
si−1
wi(s)ds
=
k∑
i=1
Ci
δi
∫ si
si−1
wi(s)ds, (3.74)
with
• i = 1, ..., k
• Ci := Xνiµ0,
• γi := αi − βi − µi,
• δi := αiµ0,
• Ai = −12(γi +
√
γ2i + 4δiθi),
• Bi = 12(−γi +
√
γ2i + 4δiθi),
• θi = µiµ0 .
A new identifiable parameter θi is needed since in the expressions Ai and Bi the piecewise-
constant parameter δi do not contain the piecewise-constant parameter µi. All identifiable
parameters for the piecewise constant TSCE are presented in Table 3.3.
Table 3.3: Identifiable piecewise-constant parameters of the TSCE. For definition of parameters,
see Figure 3.1
Summary of the piecewise-constant parameters in the TSCE
Parameter Meaning
Ci := Xνiµ0 Piecewise-constant initiation rate
γi := αi − βi − µi Piecewise-constant clonal expansion rate of the intermediate cells
δi := αiµ0 Piecewise-constant stochasticity parameter
θi = µiµ0
In order for the survival function (3.74) to be a continuous function, boundary conditions for
every interval of piecewise constant parameters are needed
wi−1(si−1) =
αi−1
αi
wi(si−1) =
δi−1
δi
wi(si−1).
Remembering equations (3.51) and (3.53) of Theorem 3.4.6 it is known that the form of the
function f(s) differs for different initial conditions. In the first step of the recursion over all
age-intervals it holds w(si) = 0. Therefore the formula for the function fi(s) is given by
fi(si) = (Bi − wi(si))eAi(si−si) + (wi(si)−Ai)eBi(si−si) = Bi −Ai for i = k
For all other steps it holds that wi(si) =
δi
δi−1
wi−1(si−1), the formula for fi(s) is hence given
by:
fi(si−1) = (Bi − wi(si))eAi(si−1−si) + (wi(si)−Ai)eBi(si−1−si) for i 6= k
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By inserting this result in equation (3.74) and applying equation (3.68) of w(s)
w(s) = ∂
∂s
ln(f(s)),
the final formula of the survival function for the piecewise-constant reads
ln(S(t)) =
k∑
i=1
Ci
δi
∫ si
si−1
d
ds
ln fi(s)ds =
k∑
i=1
Ci
δi
ln
(
Bi −Ai
fi(si−1)
)
For the explicit formula of the hazard function for piecewise-constant parameters one has to
take the derivative with respect to t again. The hazard function for the TSCE with piecewise-
constant parameters is hence given by
h(t) = − d
dt
ln(S(t)) =
k∑
i=1
Ci
δi
1
fi(si−1)
d
dt
fi(si−1). (3.75)
A backward recursion algorithm for the hazard function with piecewise-constant parameters
can be found in Appendix C.3.
3.4.2 The three stage clonal expansion model
For certain cancer types two consecutive initiation steps might be necessary before cells gain a
proriferative advantage. This model concept can be seen in Figure 3.3. As in the TSCE, despite
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Figure 3.3: Schematic representation of the 3SCE. Boxes represent cells in states with defined
molecular properties. Arrows represent transitions between cell states. Rates of transition are
denoted with Greek letters.
the large number of healthy stem cells X, early molecular changes with yearly rate ν0 leading to
pre-initiated cells are rare. Pre-initiated cells may hence mutate again with rate ν1 becoming
initiated cells. Initiated cells can either divide symmetrically with rate α2 or become inacti-
vated with rate β2. The final transformation stage summarizes a sequence of complex processes
with effective rate µ2. After a time-lag Θt2 malignant cells can create a detectable cancer lesion.
With the same procedure as for the TSCE one can obtain ODEs for the variables x1(s) and
x2(s) (cf. equation (3.57))
∂
∂s
x1(s) = −ν1 · (x2(s)− 1)x1(s) (3.76)
∂
∂s
x2(s) = −α2x2(s)2 + (α2 + β2 + ν2) · x2(s)− β2 (3.77)
with IC
x1(s1) = 1 and x2(s1) = 1.
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As before, s runs over the domain of the characteristic curve. Analogously to equation (3.71)
the logarithm of the survival function S(t) is given by the following equation
ln(S(s)) =
∫ s
0
X · ν0 · (x1(s′)− 1)ds′ (3.78)
Now we introduce two transformations
x1(s) = w1(s) + 1 (3.79)
x2(s) =
1
α2
w2(s) + 1. (3.80)
Inserting equation (3.79) and (3.80) into the formulas (3.76) and (3.77), respectively, we get
two new ODEs in w1 and w2
d
ds
w1(s) =−
ν1
α2
· w2(s) · (w1(s) + 1) (3.81)
d
ds
w2(s) =− w22(s)− (α2 − β2 − ν2) · w2(s) + α2ν2. (3.82)
with the IC
w1(s1) =0 (3.83)
w2(s1) =0. (3.84)
Equation (3.78) can hence be rewritten to:
ln(S(s)) = X · ν0
∫ s
0
w1(s′)ds′ (3.85)
As for the TSCE there are identifiable parameters that can be introduced. They are presented
in Table 3.4.
Table 3.4: Identifiable parameters of the 3SCE. Referred to Figure 3.3
Summary of the identifiable parameters in the 3SCE
Parameter Meaning
C2 := X · ν0 · ν1 · µ2 Initiation rate
γ2 := α2 − β2 − µ2 Clonal expansion rate of the intermediate cells
r1 := ν1 · µ2 First stochasticity parameter
δ2 := µ2α2 Second stochasticity parameter
With equations (3.81), (3.82) and (3.85) w1(s), w2(s) and ln(S(s)) can be written as
d
ds
w1(s) =−
r1
δ2
· w2(s) · (w1(s) + 1) (3.86)
w1(s1) =0
d
ds
w2(s) =− w22(s)− γ2 · w2(s) + δ2 (3.87)
w2(s1) =0
ln(S(s)) =C2
r1
∫ s
0
w1(s′)ds′. (3.88)
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The ODE (3.87) is again a Ricatti equation and can be solved with the same procedure as for
equation (3.59) in the proof of Theorem 3.4.6. The solution of the Riccati equation (3.87) has
the following form
w2(s) =
∂
∂s
ln(l(s)) (3.89)
with
l(s) = (E − w2(s1))eD(s−s1) + (w2(s1)−D)eE(s−s1), (3.90)
for generic initial conditions, and
l(s) = EeD(s−s1) −DeE(s−s1), (3.91)
for the specific initial condition w2(s1) = 0
D =
−γ2 −
√
γ22 + 4δ2
2 (3.92)
E =
−γ2 +
√
γ22 + 4δ2
2 , (3.93)
for specific initial conditions w2(s1) = 0 .
The system composed of equations (3.86), (3.89) and (3.88) has to be solved and has the
following form
d
ds
w1(s) =−
r1
δ2
· w2(s) · (w1(s) + 1)
w1(s1) =0
w2(s) =
∂
∂s
ln(l(s))
ln(S(s)) =C2
r1
∫ s
0
w1(s′)ds′.
Since the solution of w2(s) (3.89) depends on variable s, equation (3.86) is not easy to solve
and there is no convenient solution for the logarithm of the survival function (3.88). Therefore
a numerical solution is necessary.
As in the case of the TSCE, one can next introduce the effects of external agents and make
the parameters variable in time, for example with piecewise-constant parameters. Since for
the 3SCE a closed solution could not be found for constant parameters, this holds true for
piecewise-constant ones. We prefer at this point to introduce a simplification of the 3SCE
for which a closed solution could be found: the Hybrid Three Stage Clonal Expansion Model
(H3SCE). This model will be introduced in the next section and used for data analysis in this
Thesis instead of the 3SCE.
3.4.3 The hybrid three stage pre-initiation model
The H3SCE is intended to be an approximation of the 3SCE. It is assumed that the first
transition can be approximated by the expected number of pre-initiated cells at time t: E[X1(t)].
This model is called hybrid because the first step is modeled deterministic when all other
transitions are modeled in a stochastic way. Figure 3.4 depicts a comparison of 3SCE and
H3SCE.
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Figure 3.4: Schematic representation of the H3SCE in comparison with the 3SCE. Boxes repre-
sent cells in states with defined molecular properties. Arrows represent transitions between cell
states. Rates of transition are denoted with Greek letters.
The ODEs for the variables x1(s, t), equation (3.76), and x2(s, t), equation (3.77), can be
adopted from 3SCM
∂
∂s
x1(s, t) = −ν1 · (x2(s, t)− 1)x1(s, t)
x1(t, t) = 1
∂
∂s
x2(s, t) = −α2x2(s, t)2 + (α2 + β2 + µ2) · x2(s, t)− β2
x2(t, t) = 1.
Only the logarithm of the survival function, eqaution (3.78), changes a bit, from
ln(S(t)) = X · ν0
∫ t
0
(x1(s, t)− 1)ds
to
ln(S(t)) =
∫ t
0
E[X1(s)](x1(s, t)− 1)ds (3.94)
with
E[X1(t)] = Xν0 · t (3.95)
Therefore equation (3.94) becomes
ln(S(t)) = Xν0
∫ t
0
s(x1(s, t)− 1)ds. (3.96)
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Equation (3.77) was already solved in the section before and its solution reads
w2(s, t) =
∂
∂s
ln(l(s, t))
l(s, t) = (E − w2(s1, t))eD(s−s1) + (w2(s1, t)−D)eE(s−s1)
D =
−γ2 −
√
γ22 + 4δ2
2
E =
−γ2 +
√
γ22 + 4δ2
2
δ2 = µ2α2
γ2 = α2 − β2 − µ2,
remembering the application of transformation (3.80)
x2(s, t) =
1
α2
w2(s, t) + 1.
Now we analyze the ODE (3.76) for the x1(s, t) variable. It is a first order linear equation, the
solution is therefore given by
x1(s, t) = eν1
∫ t
s
(x2(s′,t)−1)ds′ .
Assuming small values for the exponential function, we apply a Taylor expansion to it
x1(s, t) = 1 + ν1
∫ t
s
(x2(s′, t)− 1)ds′ +
ν1
2
(∫ t
s
(x2(s′, t)− 1)ds′
)2
+ .... (3.97)
Inserting the terms of maximal first-order of equation (3.97) into equation (3.96) leads to
ln(S(t)) = Xν0ν1
∫ t
0
s(x2(s, t)− 1)ds. (3.98)
The integral of equation (3.98) can be solved by the method of integration by parts and the
solution reads
ln(S(t)) = Xν0ν1t
∫ t
0
x2(s′, t)− 1ds′. (3.99)
Recalling theorem 3.1.3, the hazard function can be easily calculated from the logarithm of the
survival function
h(t) = − d
dt
ln(S(t)).
The hazard function of the H3SCE-model hence reads (for specific initial conditions)
h(t) = C2
δ2
t
d
ds
ln(l(s, t)) (3.100)
l(s, t) = EeD(s−t) −DeE(s−t) (3.101)
D =
−γ2 −
√
γ22 + 4δ2
2 (3.102)
E =
−γ2 +
√
γ22 + 4δ2
2 (3.103)
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Remark 3.4.8:
Please note that the final solution (3.100)- (3.103) of the hazard function for the H3SCE is equal
to the final solution (3.73) of the hazard function for the TSCE just with different identifiable
parameters and an additional factor linear in age.
As before, effects of external agents are introduced with the assumption that the parameters
are constant in each interval. Accordingly, the linear dependence on s is approximated by its
mean value on each interval.
si + si+1
2 .
The hazard function for piecewise-constant parameters for the H3SCE hence reads
h(t) =
k∑
i=1
C2i
δ2i
(si−1 + si)
2
1
li(si−1, t)
d
dt
li(si−1, t). (3.104)
A backward recursion of the hazard function in the case of piecewise constant parameters in
the H3SCE is provided in Appendix C.4.
3.5 Combining parameter estimates from imputed data sheets
Applying the above presented methods to imputed data sheets, the definition of a MI overall
point estimate has to be given. The gold standard for combining parameter estimates from
imputed data sheets into one MI estimate is the so called Rubin’s rule [40, 50]. Let us consider
m imputed data sheets with single regression coefficients Q̂1, ..., Q̂m and associated variances
U1, ..., Um. The MI overall point estimate Q̄ is the average of the m estimates of Q from the
imputed data sheets
Q̄ = 1
m
m∑
i=1
Q̂i. (3.105)
The corresponding total variance T for the overall MI estimate Q̄ is
T = Ū +
(
1 + 1
m
)
·B, (3.106)
where
Ū = 1
m
m∑
i=1
Ui (3.107)
is the estimated within imputation variance and
B = 1
m− 1
m∑
i=1
(Q̂i − Q̄)2 (3.108)
is the between-imputation variance [40, 50].
The between-imputation variance is scaled by a factor 1/m, reflecting the extra variability as
a consequence of imputing the missing data using a finite number of imputations instead of
an infinite number of imputations. If B dominates Ū , m can be increased to improving the
accuracy of estimates [40, 50].
These procedures can be extended in matrix form to combine k regression coefficients, where Q̂
is a k × 1 vector of these estimates and U is the associated k × k covariance matrix [40, 50].
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The confidence interval (CI) of the parameters can hence be calculated with the standard
formula
CI =
[
Q̄− z1−α2
T√
m
, Q̄+ z1−α2
T√
m
]
, (3.109)
where z1−α2 is the
(
1− α2
)
-quantile of the standardised normal distribution.
With this procedure, the CI is per definition symmetric.
The aim of this Thesis is the understanding of the risks for LADCs and SQUAMs under the
exposures of ionising radiation and cigarette smoke. From the models presented in the above
sections, risks estimates will be derived, whose CI may not be necessarily symmetric. An ex-
tension of the Rubin’s rule, which includes the parameter correlation matrix, will hence be used
in this Thesis. The extended procedure is depicted in Figure 3.5. As in the Rubin’s rule, from
Figure 3.5: An extension of the Rubin’s rule to calculate CIs of a MI overall point estimate.
m data sheets m maximum likelihood estimates will be fitted by Poisson regression, calculating
also the respective correlation matrices. The MI overall point estimate Q̄ is hence calculated
as in equation (3.105). For the calculation of the CI, differently as in the the Rubin’s rule, the
correlation matrices play a role. Let us consider only one dataset D1 with maximum likelihood
estimate µ1 and correlation matrix σ1. From a multivariate normal distribution with inputs µ1
and σ1 1000 simulated parameter sets are hence calculated. These procedure is hence applied
to all m dataset, ending up with m · 1000 simulated parameter sets. The parameter sets are
hence put together in one single matrix having m · 1000 rows and as many columns as the num-
ber of parameters contained in the parameter sets. From this matrix the 0.025 and the 0.975
quantiles are taken, giving a 95% CI for each parameter of the maximum likelihood estimate.
The same procedure can be applied to calculate CI for baseline hazards, hazards, EARs and
ERRS. With the simulated parameters sets 1000 curves per data sheet will be calculated and
hence the CI will be taken, as presented above. The asymmetry of the CI is not so much of
interest for the parameters itself but more for the calculated risks.
In this extension of the Rubin’s rule, all components presented in the Rubin’s rule itself are
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used. The within and the between imputation variances play both a role in the simulation of
the parameter sets due to the correlation matrix. Since all parameters are hence merged into a
single matrix and the quantiles are taken, number of imputed data sheets and variation in the
imputation keep playing a role.
To compare models, cumulative deviance and AIC will be calculated as the sum of all de-
viances and AICs, respectively. A mean value and a descriptive representation via boxplots of
the variation between deviances will be presented for each model in the respective appendix
chapter. We preferred to present the total deviance and not to the mean value of the deviances
in the main part of the Thesis since the deviance as a mean value would be difficult to interpret.
The imputed data sheets differ in number of strata (number of rows in the tables). This is
due to the fact that the imputed smoking information was also used to group the data sheets.
Since the smoking information varies between data sheets, also the number of created strata
varies. The difference in deviance between data sheets derives primarily from the number of
strata/rows and not from a different goodness of fit of the model. The mean value contains all
the information as the total deviance, but it would be difficult to interpret.
The best model to calculate the CI would be a Markov-Chain-Monte-Carlo simulation, which
we decided however be a too complex and time costly method for our purposes.
Remark 3.5.1: (MI estimate of GAMs)
For GAMs the overall MI estimate is given as mean value over the 50 estimates coming from the
imputed data sheets. Instead of the CI calculated from the correlation matrices, the standard
deviation of the 50 parameters will be given. The variation between the calculated risks is given
as boxplots over the 50 risks values for each point of the variable analysed (for attained age one
boxplot for each age, for lung dose one boxplot for each dose).
3.6 Software
In this section we describe the software used to implement and fit the data.
• State-of-the-art statistical risk models were implemented and fitted with MATLAB (ver-
sion R2017b) using the minimising algorithm fminunc already implemented in the pro-
gram. The code is not presented in this Thesis since it is trivial: it just includes the
equations given for each model in a Poisson regression.
• GAMs were implemented and fitted with R (version 3.3.0) using the mgcv package and
the already implemented function gam. A code for this models is given for each analysis
as output of the model.
• Mechanistic models were implemented and fitted with MATLAB (version R2017b) using
the minimising algorithm fminunc already implemented in the program. The code for the
recursion is presented in Appendix D.
For each model Poisson regression was performed. The different models give different estima-
tions of the considered cases. To compare results from R and MALTAB it was ensured that
both programs deliver the same estimates and deviance (AICs) for simple baseline models of
state-of-the-art statistical risk models and GAMs (no usage of penalised splines in GAMs).
Results
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CHAPTER
4
LUNG ADENOCARCINOMA IN THE
LIFE SPAN STUDY COHORT
In this chapter we combine molecular and observational data to develop the first molecular mech-
anistic model for lung adenocarcinoma. Using two comprehensive genomic data sets from East-
ern and Western patient populations, we determine that there are two broad molecular path-
ways to lung adenocarcinoma: one unique to EGFR-, EML4/ALK-, and other transmembrane
receptor-mutant (RMUT ) patients and one shared between KRAS-, BRAF-, NF1-, PIK3CA-,
and other sub-membrane transducer-mutant (TMUT ) patients. Deploying information of smoke
and irradiation exposure from the Life Span Study of Japanese atomic bomb survivors, we
develop a mechanistic model to estimate the risk for lung adenocarcinoma by molecular path-
way. The molecular mechanistic model accurately reproduces the observed incidence in the Life
Span Study with moderately improved goodness-of-fit compared to standard epidemiological
models. Amazingly, the molecular mechanistic model predicts for the first time the EGFR and
KRAS mutation frequencies actually observed in different populations, a fact open to direct
validation since for the Life Span Study genomic data are not jet available. Importantly, the
molecular mechanistic model supports firm biological evidence for a close association between
RMUT cases with environmental radiation and TMUT cases with smoking for the explanation
of observational data.
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4.1 State-of-the-art statistical risk models
In any mechanistic analysis, state-of-the-art statistical risk models are indispensable to put
the results of mechanistic models into perspective. Here, the state-of-the-art statistical risk
model model for LADC in the LSS (StatLADCLSS ) is inspired by the ERR model of Egawa et al.
[18], applying additive interaction of smoking and radiation with the lowest AIC. Based on
AIC, the additive action of smoking (S = S(packyr, smkdyr, smkdqyr, smkint)) and radiation
(R = R(D)) is slightly favored, the EAR of Section 3.3.2. This action leads to a total hazard
function
h = h0 · (1 + ρ(R) + Ψ(S)) (4.1)
which applies the baseline hazard h0 and the corresponding ERR ρ(R) and Ψ(S) according to
h0 = eβ1+β2·(city−1)+β3·agexp+β4·ln(age)+β5·ln(age)
2
,
ρ(R) = β6 ·D · eβ7·ln(age),
Ψ(S)f,m = β8 · packyr · eβ9·smkdyr+β10·ln(smkdqyr+1)+β11f,m·smkint. (4.2)
The meaning of the variables introduce in the previous system of equations (4.2) is explained
in Table 4.1.
The baseline hazard depends on city of residence (Hiroshima or Nagasaki), age at exposure
and attained age. The radiation-related ERR ρ(R) depends linearly on the lung dose and is
modified by attained age.
The smoking-related ERR Ψ(S) depends linearly on the cumulative smoking amount and is
modified by years smoked, years since quit smoking, and smoking intensity. Only the last
modifier was found to be sex-dependent.
Table 4.1: Explanatory variables for StatLADCLSS . In the baseline hazard h0 age at exposure is
equivalent to birth year (birth year = 1945.7 - age at exposure). A pack contains 20 cigarettes.
The only sex-dependent parameters β11f,m are related to smoking intensity. For the other pa-
rameters the sex-difference was found to be not statistically significant based on likelihood ratio
tests on the 95% level.
Variable Unit Meaning
city - Hiroshima (1) or Nagasaki (2)
agexp - (age at exposure - 30 yr)/10 yr
age - attained age/70 yr
D Gy lung dose
packyr packs/day× yr cumulative amount of cigarette packs
(packs smoked per day × years smoked)/50 yr
smkdyr - years smoked/50 yr
smkdqyr - years since quit smoking/50 yr
smkint cigs/day smoking intensity (cigs smoked per day)
MI overall point estimate with 95% Confidence Intervals (CI) for StatLADCLSS is presented in
Table 4.2 (see section 3.5 for methodology). The deviances of all 50 data sheets can be found
in Figure E.1.
A visualisation of risk estimates for StatLADCLSS is given in Section 4.2 for comparison with
mechanistic models.
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Table 4.2: MI overall point estimate for the state-of-the-art statistical risk model StatLADCLSS
with 12 parameters. Central estimates are given as means from 50 imputed data sets with 95%
CI simulated from multi-variate normal uncertainty distributions conditioned with the param-
eter correlation matrix (see section 3.5). Cumulative deviance/AIC are the sum over the 50
deviances/AICs.
Parameter estimates of the state-of-the-art statistical risk model StatLADCLSS
Name Meaning MI Mean (95% CI)
β1 baseline 1.07 (0.95, 1.18)
β2 baseline, city 0.23 (0.11, 0.35)
β3 baseline, age at exposure -0.26 (-0.32, -0.21)
β4 baseline, attained age 4.19 (3.47, 4.90)
β5 baseline, attained age (squared) -4.58 (-6.08, -3.08)
β6 radiation, linear resp. (Gy−1) 1.11 (0.62, 1.60)
β7 radiation, attained age -2.08 (-3.92, -0.23)
β8 smoking, linear resp. (day× yr/packs) 5.82 (3.38, 8.57)
β9 smoking, years smoked 0.91 (-0.18, 2.06)
β10 smoking, years since quitting -0.33 (-0.63, -0.08)
β11f smoking, smoking intensity females -0.055 (-0.094, -0.018)
β11m smoking, smoking intensity males -0.025 (-0.045, -0.005)
Cumulative deviance 252885
Cumulative AIC 254090
4.2 Molecular mechanistic models
In this section, we will first start with an analysis of biological data in order to give the motiva-
tion for the model design of the final molecular model. The biological data used here is already
published in [9]. They compared the somatic profiles of LADCs and SQUAMs to identify novel
genetic alterations. 660 LADC/normal paired exome sequences (including 274 previously un-
published cases, 227 previously described from [10] were analysed for LADC. We downloaded
and analysed the same data of [9] concerning LADC.
Section 4.2.1 was developed in collaboration with G. T. Stathopoulos of the Comprehensive
Pneumology Center (Ludwig-Maximilian University and Helmholtz Zentrum Muenchen.
4.2.1 Biological analysis
To identify possible clinical and/or molecular clusters of patients with LADC, we initially ana-
lyzed all data available from 660 Caucasian patients with LADC classified by driver oncogene
[9]. In addition to the available clinical information (smoking status, age, sex, etc.), total single
nucleotide variant (SNV) rates, insertion/deletion (indel) rates, copy number alteration (CNA)
indices (calculated as the square root of the sum of all CNA squares of each tumor), as well as
the contribution of established genomic signatures of environmental exposures were examined.
These included a UV-related signature of C>T at TpCpC or CpCpC (COSMIC Signature 7,
abbreviated SI7), a smoking-related signature of C>A transversions (SI4), a DNA mismatch
repair signature of C>T at GpCpG (SI15/SI6), two APOBEC-related signatures of C>G or
C>T at TpCpT or TpCpA (SI13 and SI2), and a COSMIC signature 5 (SI5) with putative
"‘molecular clock"’ properties [9, 3]. In addition, we calculated the indel-SNV ratios, since such
high ratios were found elsewhere to represent a direct molecular imprint of iatrogenic γ-IR [6].
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Grouping of the 660 patients by the most frequent drivers (every driver with n ≥ 10 patients
available was examined) revealed that patients with EGFR (n = 86), ERBB2 (n = 17), MET
(n = 22), and ALK/RET/ROS1 (pooled to achieve n = 14) mutations (hereafter collectively
referred to as receptor-mutant (RMUT )) were different from patients with KRAS (n = 210),
BRAF (n = 37), ARHGAP35 (n = 13), and NF1 (n = 58) mutations (hereafter collectively
referred to as transducer-mutant (TMUT )).
RMUTpatients displayed lower SNV and indel rates, and decreased smoking exposure evident
by lower transversion rates and decreased activity of the smoking-related SI4 compared with
TMUTpatients. At the same time, RMUTpatients were more frequently female, and displayed
increased activities of UV light-related SI7, of DNA mismatch repair-related SI15/SI6, and of
SI5 putatively reflecting molecular clock properties compared with TMUTpatients.
Interestingly, RMUTpatients had higher indel-SNV ratios compared with TMUTpatients, indicat-
ing a molecular signature of γ-IR exposure [6]. Copy number alteration indices were comparable
across patients with different drivers, except from
ALK/RET/ROS1-fused patients that collectively displayed lower copy number alteration indices
compared with all other patients (Figures 4.1, 4.2).
Figure 4.1: SNV rates, indel rates, CNA indices, smoking exposure, sex, genomic signatures
of environmental carcinogen-induced base changes in the trinucleotide context (SI), indel/SNV
ratios, and transversion status of 660 patients with LADC from the USA [9] grouped by the
most frequent driver mutations. Significances P ≥ 0.05, P < 0.05, P < 0.01, and P < 0.001
are coded as ns, ?, ??, and ? ? ?, respectively. Data are given as raw data points, median ±
Tukey’s whiskers (lines: median; boxes: interquartile range; bars: 50% extreme quartiles). P ,
probabilities by Kruskal-Wallis test. Significances for comparison with EGFR-mutant control
group (c) by Dunn’s post-tests.
Based on this finding, we grouped US patients [9] and 101 LADC obtained from Asian pa-
tients [65] into RMUT , TMUT , and oncogene wild-type (OWT ; patient without RMUT or TMUT )
groups, hypothesizing that these three groupings may represent distinct molecular pathways to
LADC (Figure 4.3(a)). Individual mutation prevalence varied widely between East and West,
translating into different frequencies of these pathways in Caucasian and Asian LADC (Fig-
ure 4.3(b)). A fact that has to be taken into account since the molecular analysis is done with
American patients and the model analysis with a Japanese cohort.
We next sought to compare the molecular profiles of the three candidate molecular pathways
LADC to identify potential similarities and differences. Interestingly, RMUTLADC appeared
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Figure 4.2: SNV rates, indel rates, CNA indices, smoking exposure, sex, genomic signatures of
environmental carcinogen-induced base changes in the trinucleotide context, indel/SNV ratios,
and transversion status of 660 patients with LADC from the USA [9] grouped by the most
frequent driver mutations. Significances P ≥ 0.05, P < 0.05, P < 0.01, and P < 0.001 are
coded as ns, ?, ??, and ? ? ?, respectively. Data are given as number of patients (n). Color
scale indicated frequency per row. P , probabilities by χ2 test. Significances for comparison with
EGFR-mutant control group (c) by χ2 or Fischer’s exact tests. Sample sizes were EGFR (n =
86), ERBB2 (n = 17), MET (n = 22), ALK/RET/ROS1 (pooled n = 14), KRAS (n = 210),
BRAF (n = 37), ARHGAP35 (n = 13), and NF1 (n = 58).
(a) (b)
Figure 4.3: (a) Proposed grouping of US LADC patients [9] according to driver mutation into
receptor-mutant (RMUT ), transducer-mutant (TMUT ), and oncogene-wild type (OWT ) molecular
pathways. (b) Mutation rates and molecular pathway classification of 660 US LADC patients
[9] and 101 LADC patients from China [65]. P , probability by χ2 test.
distinct, while TMUT and OWTLADC were similar by all parameters examined except copy num-
ber alteration index (Figures 4.4, 4.5). This was also evident from univariate multinomial logis-
tic regression analyses that showed a general pattern of OWTLADC trending with TMUTLADC
(Figure 4.6). In the case of RMUTLADC, 13 of the 18 analyzed covariables trended differently
from the reference category TMUTwith high significance (Figure 4.6).
These findings indicated the existence of two distinct molecular pathways to LADC that bear
different genomic marks of environmental exposures: one unique to RMUTpatients that features
robust imprints of γ-IR and the associated DNA mismatch repair [52], and one shared between
TMUT and OWTpatients (hereafter referred to as TMUT ) with genomic marks of smoking expo-
sure (Figure 4.7). Interestingly, the RMUTpathway contained patients with ALK/RET/ROS1-
fusions, which were recently shown to dose-dependently culminate from γ-IR in thyroid cancer
[17].
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Figure 4.4: Single nucleotide variant (SNV) rates, insertion/deletion (indel) rates, copy num-
ber alteration (CNA) indices, smoking exposure, sex, genomic signatures of environmental
carcinogen-induced base changes in the trinucleotide context, indel/SNV ratios, and transver-
sion status of 660 patients with LADC from the USA [9] grouped by receptor-mutant (RMUT ),
transducer-mutant (TMUT ), and oncogene-wild-type (OWT ) molecular pathways. Significances
P ≥ 0.05, P < 0.05, P < 0.01, and P < 0.001 are coded as ns, ?, ??, and ? ? ?, respectively.
Data are given as raw data points, median ± Tukey’s whiskers (lines: median; boxes: interquar-
tile range; bars: 50% extreme quartiles). P , probabilities by Kruskal-Wallis test. Significances
are given for the indicated comparisons by Dunn’s post-tests
Figure 4.5: SNV rates, indel rates, CNA indices, smoking exposure, sex, genomic signatures of
environmental carcinogen-induced base changes in the trinucleotide context, indel/SNV ratios,
and transversion status of 660 patients with LADC from the USA [9] grouped by receptor-mutant
(RMUT ), transducer-mutant (TMUT ), and oncogene-wild-type (OWT ) molecular pathways. Sig-
nificances P ≥ 0.05, P < 0.05, P < 0.01, and P < 0.001 are coded as ns, ?, ??, and ? ? ?,
respectively. Data are given as number of patients (n). Color scale indicated frequency per
row. P , probabilities by χ2 test. Significances are given for the indicated comparisons by χ2 or
Fischer’s exact tests. Sample sizes were EGFR (n = 86), ERBB2 (n = 17), MET (n = 22),
ALK/RET/ROS1 (pooled n = 14), KRAS (n = 210), BRAF (n = 37), ARHGAP35 (n = 13),
and NF1 (n = 58).
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Figure 4.6: Points represent regression coefficients divided by their standard errors in univariate
multinomial regression. 18 clinical and molecular variables of 660 US patients with LADC [9]
stratified by molecular pathway were analyzed. Position on x-axis denotes deviation from the
estimate in reference group TMUT . Significance of deviation from the reference is color-coded
(red: RMUT ; black: OWT ): ns, ?, ??, and ? ? ?: P ≥ 0.05, P < 0.05, P < 0.01, and P < 0.001,
respectively, for the indicated variables.
Figure 4.7: Schematic of the two proposed molecular pathways to LADC and the main risk
factors for each pathway.
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4.2.2 Development of the molecular mechanistic model
State-of-the-art epidemiological risk estimates from smoking and radiation exposure merely es-
tablish statistical associations without explicitly considering pathogenic processes and molecular
data: molecular biology and epidemiology lack a common interface. Here we bridge this gap
by applying molecular mechanistic models (M3) of carcinogenesis as tools to harness molecular
data of LADC.M3 treat carcinogenesis as a progression of cell-based key events on the pathway
to malignancy and can detect in cancer incidence imprints from molecular events on recorded
hazard or survival rates [51].
The two molecular pathways (RMUT vs. TMUT ) to LADC determine the conceptual model
design as fundamental feature. With this constraint and due to the fact that Tomasetti et al.
[58] argue that two/three driver mutations are involved in LADC, we considered only two- and
three-stage clonal expansion models as candidates for both molecular pathways. The goodness
of fit of the different models can be found in Table 4.3.
Table 4.3: Model pairs fitted for model selection of the RMUT pathway (subscript R) and of the
TMUT pathway (subscript T ).
Imputed AIC of last two candidate models
data set no. TSCER-3SCET TSCER-TSCET
AIC
2 5076.9 5075.6
9 5037.4 5036.9
11 5082.3 5082.2
18 5033.3 5033.8
23 4937.7 4938.7
28 5099.5 5100.1
39 4949.4 4950.2
43 5085.5 5084.7
45 5023.7 5024.6
50 5039.1 5038.2
Cumulative AIC 50364.8 50365.0
To speed up the selection process, model pairs were fitted to 10 (out of 50) randomly chosen
LSS data sets with imputed smoking information. Model selection was based on goodness-of-fit
measured by the cumulative AIC for the 10 data sets. For the RMUT pathway only a TSCE
survived the test phase. For the TMUT pathway a TSCE and 3SCE yielded the same AIC, when
paired with the TSCE for the RMUT pathway. Compared to the TSCE the 3SCE contains an
additional mutational stage before clonal expansion but has the same number of parameters.
The TSCE was chosen for the TMUT pathway because it required substantially less computation
time, nevertheless the 3SCE is also biologically plausible and cannot be excluded. The impact
of this choice on the results is negligible. The conceptual design of the final preferred two-path
molecular mechanistic model for LADC (MLADC3 ) is shown in Figure 4.8.
Smoking and radiation exposure are assumed to change biological parameters in mechanistic
risk models. We tested actions on the rate ν of initiating mutations and the net clonal expansion
rate γ using several functional forms: linear, linear-quadratic and linear-exponential responses.
For smoking, model parameters were increased at smoking initiation and remained elevated
for current smokers until end of follow-up. Baseline values were retained when past-smokers
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quit. Judged by goodness-of-fit, the main biological effects of both smoking and radiation are
represented by enhanced clonal expansion.
In the TMUT pathway, smoking intensity (S) linearly enhances the clonal expansion rate
γT (S) = αT − βT (S)− µT = γT0 [1 + gSf,m S exp(−κf,m S)] (4.3)
during a period of constant smoking intensity with an attenuated effect for high smoking inten-
sity. The smoking parameters gSm,f and κm,f depend strongly on sex.
In the RMUT pathway, a radiation dose D linearly enhances the clonal expansion rate
γR(D) = αR − βR(D)− µR = γR0 [1 + gRD] (4.4)
after exposure for life. Since both pathways apply the same constant value of the stochasticity
parameter δ = αRµR = αTµT , increase of clonal expansion is solely caused by reduced cell
inactivation β.
The MI overall point estimate of the MLADC3 is presented in Table 4.4. The deviances of
all 50 data sheets can be found in Figure E.1. Parameters XR = NνRµR and XT = NνTµT
(where N is the number of healthy cells) are modified by city and age at exposure with the
same functional form as in StatLADCLSS (4.1).
Table 4.4: Parameter estimates (95% CI) for the preferred mechanistic model M3LADC with 12
parameters which consists of two TSCE models pertaining to pathways RMUT (subscript R) and
TMUT (subscript T ). Parameter definitions correspond to Figure 4.9. Central estimates are
given as mean values from 50 imputed data sets with 95% CI simulated from multi-variate nor-
mal uncertainty distributions conditioned on the parameter correlation matrix (see section 3.5).
Cumulative deviance/AIC are the sum over the 50 deviances/AICs.
Parameter estimates of the preferred mechanistic model M3LADC
RMUT pathway TMUT pathway
Name Unit MI Mean (95% CI)
ccity 0.23 (0.11, 0.35)
cagexp -0.24 (-0.29, -0.18)
XR, XT 10−9 cells/yr2 0.48 (0.11, 2.26), 4.64 (1.20, 18.9)
γR0, γT0 cells/yr 0.19 (0.16, 0.22), 0.092 (0.048, 0.128)
gR 10−2 Gy−1 0.58 (0.39, 0.77) -
gSf day/cigs - 0.32 (0.057, 0.68)
gSm day/cigs - 0.086 (0.013, 0.180)
κf day/cigs - 0.14 (0.21, 0.078)
κm day/cigs - 0.031 (0.042, 0.021)
δ 10−7 cells/yr2 2.73 (0.92, 8.06)
Cumulative deviance 252520
Cumulative AIC 253720
The cumulative AIC from 50 imputed data sets is 370 points lower compared to StatLADCLSS
(corresponding to 7.4 point per data set). M3LADC would hence be preferred against StatLADCLSS .
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MLADC3 clearly revealed the two molecular pathways (RMUT versus TMUT ) in observational
incidence data of the LSS (Figure 4.9) although no genomic information of the LSS is available.
Crude rate and predicted hazard (LADC cases in 10,000 persons per year) from MLADC3 were
plotted in 5 year-age groups from 40-45 up to 80-85 years. The hazard of RMUT -related LADC
cases peaks at age 70 yr, while the hazard in the TMUT pathway becomes dominant at old ages.
For cigarette smoke, clonal expansion in the TMUTpathway was identified as the main biolog-
ical target: smoking-related inactivation of initiated cells increased the net clonal growth rate
γT for pre-neoplastic lesions. Sex-specific response curves exhibited markedly different shapes
(Figure 4.10). For men (Figure 4.10 upper panel), the growth rate increased almost linearly up
to a smoking intensity of 20 cigarettes/day and flattened thereafter. Clonal growth in women
(Figure 4.10 lower panel) reacted much stronger to low-smoking intensity. The growth reduction
after a peak at about 10 cigarettes/day is biologically not plausible but might be caused by a
reporting bias. The main radiation effect occurred in the RMUTpathway. An acute radiation
pulse yielded a linear permanent increase of the net clonal expansion γR pointing to lifelong
radiation-induced inflammation caused by genetic damage.
Next we analysed MLADC3 estimates for the breakdown of 636 LADC cases (% of 636 cases)
from the LSS cohort in modeled molecular pathways RMUT and TMUT , cross-tabulated with ex-
posure groups for smoking and radiation (Table 4.5). Refined resolution in exposure subgroups
of low (5-100 mGy) and moderate (100+ mGy) radiation dose, and light (1-10 cigs/day), mod-
erate (11-20 cigs/day) and heavy (20+ cigs/day) smoking intensity is made. Female smokers
fall mostly in the light category. In each subgroup observed cases are estimated well by the
model. Exposure group numbers (bold-faced) add up to total numbers (bold-faced) in the bot-
tom line. Exposure subgroup numbers add up to group numbers. Interestingly, 60% of the
total number of cases were estimated as spontaneous cases. A value that is comparable with
the study presented by Takamochi et al. [57]. Only 6% of the total number of cases could be
defined as radiation induced, compared to 34% for smoking. The baseline includes again the
major amount of cases in the RMUT pathway, where in the TMUT the 80% of the cases were
estimated as smoking induced. Please note that MLADC3 estimates are derived from LADC
incidence data in the LSS without genotyping. Model estimations for numbers and shares of
cases in each molecular pathway would be directly accessible to measurements.
Summarizing, the main impact of smoking and radiation took effect in distinct molecular path-
ways without noticeable synergistic effects. Now we proceed with risk assessment.
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Figure 4.8: Top: Histological progression from normal cells over atypical adenomatous hyper-
plasia (AAH) as precursor lesions to invasive LADC [modified figure from Yatabe et al. [66]].
Bottom: Model implementation with two distinct molecular pathways pertaining to either TMUT
or RMUT with two versions of the TSCE model. Boxes represent cells in states with defined
molecular properties. Arrows represent rates of transition between cell states. Both agents of
smoking and radiation cause the acceleration of clonal expansion by reduced cell inactivation. See
model details and mathematical model derivation in Chapter 3.4. Parameter estimates are given
in Table 4.4. The model algorithm and model implementation can be found in Appendix C.3
and Table D, respectively.
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Figure 4.9: Crude rate and predicted hazard (LADC cases in 10,000 persons per year) from the
preferred mechanistic model (Mech) for the LSS cohort in 5 year-age groups from 40-45 up to
80-85 years. The model clearly distinguishes pathway-specific hazards. The hazard of RMUT -
related LADC cases peaks at age 70 yr. The hazard in the TMUT pathway becomes dominant at
old ages. This is a model prediction of the LSS cohort without any genomic data.
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(a) TMUT pathway
(b) RMUT pathway
Figure 4.10: Clonal expansion rates for the two pathways TMUT and RMUT in M3LADC . (A)
In the TMUT pathway smoking intensity smkint linearly enhances the clonal expansion rate γT
with an attenuated effect for high smoking intensity. The implausibly strong attenuation of the
clonal expansion rate for females smoking more the 10 cigs/day is possibly caused by a reporting
bias. (B) In the RMUT pathway a radiation dose D linearly enhances the clonal expansion rate
γR(D), which remains permanently elevated after exposure for the whole life.
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4.2.3 Risk assessment
Before presenting EARs and ERRs forMLADC3 and for StatLADCLSS , let us start with a comparison
of baseline hazard rates and hazard rates between the two molecular pathways.
(a) Baseline hazards
(b) Baseline hazard and hazard from radiation ex-
posure in the RMUT pathway
(c) Baseline hazard and hazard from smoking in
the TMUT pathway
Figure 4.11: (A) Baseline hazards in pathways RMUT and TMUT for radiation-induced LADC
in the LSSCt. To eliminate the influence for city of residence person-year weighted city means
are used. For comparison with the baseline hazard from StatLADCLSS (Desc) the total baseline
hazard (as the sum of pathway-specific hazards) from the preferred mechanistic model M3LADC
is shown. (B) Baseline hazard and hazard from radiation exposure in the RMUT pathway for a
person exposed at 30 yr to a lung dose of 1 Gy (C) Baseline hazard and hazard from smoking in
the TMUT pathway for lifelong smokers starting at age 20 yr with smoking intensity 20 cigs/day
(male) and 5 cigs/day (female).
From Figure 4.11(A) we can see that the total baseline hazard (as the sum of pathway-specific
hazards) from the preferred mechanistic model M3LADC and from the state-of-the-art statistical
risk model 4.1 are of similar magnitude, where the blue line (the baseline of the TMUT since
no radiation-induce cases arise in this pathway) is really small. In Figure 4.11(B) the amount
of case coming from radiation, compared to the baseline cases, is really small. Figure 4.11(C)
the baseline is so small that it is almost not visible. The curve for female and males smoker are
very similar, although the smoking intensity is four time higher for males.
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We can also notice that the hazard rates for smokers are much higher than those for the RMUT ,
indicating a strong relation between smoking and LADC. Another difference between the two
pathways is the flattening of RMUT , which is not present in the TMUT .
Since for risk assessment the biological action presented in MLADC3 of the previous chapter
is better reflected in the EARs compared to ERRs, all respective ERRs will not be discussed in
the main part of this Thesis but can be found in Appendix E.
4.2.3.1 Excess absolute rates for radiation
In the case of a two path model, where the pathways are mutually exclusive, the radiation-
related EAR has the following form (to compare with equations 3.35)
EARrad = htot(nGy, ·
sigs
day
)− htot(0Gy, ·
sigs
day
) (4.5)
= hRMUT (nGy) + hTMUT (·
sigs
day
)− hRMUT (0Gy)− hTMUT (·
sigs
day
) (4.6)
= hRMUT (nGy)− hRMUT (0Gy) (4.7)
with n > 0, where htot, hRMUT and hTMUT represents the total hazard of the model, the hazard
in the RMUT pathway and the hazard in the TMUT pathway, respectively. This formula applies
only because radiation and smoking act separately on two different pathways independently.
Figure 4.12 depicts the EAR (as cases in 10,000 persons per year) for radiation-induced LADC
for a person exposed at 30 yr. The EAR is determined by the linear permanent response
to an acute radiation pulse, which increases the clonal expansion rate in the RMUT pathway
independent of sex and smoking status (see Figure 4.10). To eliminate the influence for city
of residence, person-year weighted city means are used. Figure 4.12(a) presents the bivariate
EAR dependence on attained age and lung dose. The radiation risk maximizes at about 55
years for high lung dose. Figure 4.12(b) shows cross-sectional cuts to panel (a) for attained
ages 50, 60 and 70 years. Over the dose range 0-4 Gy the EAR responds non-linearly to a
lifelong radiation-induced linear response of the clonal expansion rate in the RMUT pathway.
Figure 4.12(c) instead shows cross-sectional cuts to panel (a) for lung doses 0.5, 1 and 2 Gy.
The radiation-induced EAR peaks at decreasing age with increasing value. In each plot the
EAR from StatLADCLSS (Desc) is shown for comparison.
The corresponding radiation-related ERR can be found in Appendix E.2, Figure (E.2).
4.2.3.2 Excess absolute rates for smoking
As for the radiation-related EAR, also the smoking-related EAR has a special structure in the
case of a two path model, where the pathways are mutually exclusive
EARS = htot(·Gy,m
cigs
day
)− htot(·Gy, 0
cigs
day
) (4.8)
= hRMUT (·Gy) + hTMUT (m
cigs
day
)− hRMUT (·Gy)− hTMUT (0
cigs
day
) (4.9)
= hTMUT (m
cigs
day
)− hTMUT (0
cigs
day
) (4.10)
with m > 0, where htot, hRMUT and hTMUT represents the total hazard of the model, the hazard
in the RMUT pathway and the hazard in the TMUT pathway, respectively. This formula applies
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only because radiation and smoking act on two different pathways independently.
Figure 4.13 depicts the smoking-related EAR (as cases in 10,000 persons per year) for smoking-
induced LADC for lifelong smokers starting at age 20 yr. The EAR is determined by the
sex-dependent linear-exponential response to the smoking intensity which increases the clonal
expansion rate in the TMUT pathway independent of radiation (see Figure 4.10). To eliminate
the influence for city of residence person-year weighted city means are used. The bivariate EAR
dependence on attained age and smoking intensity for female and male smokers is presented
Figures 4.13(a) and 4.13(b), respectively. The implausibly strong attenuation of the clonal
expansion rate for females smoking more the 10 cigs/day is possibly caused by a reporting bias.
Panels (c) and (d) depict cross-sectional cuts to panels (a) and (b) for attained ages of 50, 60
and 70 yr. Panels (e) and (f) depict cross-sectional cuts to panels (a) and (b) for 5 cigs/day
(males and females) and 20 cigs/day (males only). Female smokers of 5 cigs/day and male
smokers of 20 cigs/day possess about the same risk. The EAR from StatLADCLSS (Desc) is shown
for comparison.
The corresponding smoking-related ERR can be found in Appendix E.3, Figure (E.3).
In Figures E.4 (females) and E.5 (males) the additive effect or radiation and smoking on
the EAR is shown. The effect is additive since radiation and smoking act on differently path-
ways without any synergistic effect. Comparing Figures E.4 and E.5 with Figures 4.13(a) and
(b) only the small increase in the EAR coming from radiation is detectable.
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(a)
(b) (c)
Figure 4.12: EARs (as cases in 10,000 persons per year) from MLADC3 (Mech) for radiation-
induced LADC for a person exposed at 30 yr. (a) Bivariate EAR dependence on attained age
and lung dose. (b) Cross-sectional cuts to panel (a) for attained ages 50, 60 and 70 years. (c)
Cross-sectional cuts to panel (a) for lung doses 0.5, 1 and 2 Gy. The EAR from StatLADCLSS
(Desc) is shown for comparison.
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(a) (b)
(c) (d)
(e) (f)
Figure 4.13: EARs (as cases in 10,000 persons per year) from MLADC3 (Mech) for smoking-
induced LADC for lifelong smokers starting at age 20 yr. Bivariate EAR dependence on attained
age and smoking intensity for female smokers (a) and male smokers (b). Panels (c) and (d)
depict cross-sectional cuts to panels (a) and (b) for attained ages of 50, 60 and 70 yr. Panels
(e) and (f) depict cross-sectional cuts to panels (a) and (b) for 5 cigs/day (males and females)
and 20 cigs/day (males only). The EAR from StatLADCLSS (Desc) is shown for comparison.
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4.3 Generalized additive models
In model StatLADCLSS (4.2) the functional forms of attained age in the baseline and of radiation
and smoking ERRs are postulated to be specific functions (linear quadratic and linear, respec-
tively). For a more comprehensive analysis of those variables, a GAM for for LADC in the
LSS (GAMLADCLSS ) was developed on the basis of model StatLADCLSS presented in the previous
Section 4.1. The preferred GAMLADCLSS has the following form
LADC_gam <− gam( adeno~1+I ( c i ty −1)+e30+s ( I ( age/70) , d10gy)+s ( I ( age/70) ,
I ( packyrs/50))+ I ( smkyrs/50)+smkqyrs ,
of fset = log (0 .0001∗PYR) ,
data = imput_dat_39 ,
family = poisson ( l ink = " log " ) , method = "ML" ,
opt imize r = c ( " outer " , " newton " ) )
In model GAMLADCLSS parameters for baseline, city of origin and age at exposure (e30) were
fitted linearly. Sex did not have any statistical significance. The variables for years smoked
(smkyrs) and for years since quitting (smkqyrs) turned out to have a linear response. Two
penalised splines were fitted to explore the functional form of radiation dose and attained
age (s(I(age/70), d10gy)) and of cumulative smoking amount (packyrs) and attained age. In
Table 4.6 the central estimates as means (Standard deviation) from 50 imputed data sets are
given together with the total deviance/AIC (see chapter 3.5). The AIC was calculated following
definition (3.11) for linear terms. The deviances of all 50 data sheets can be found in Figure E.1.
For smoothing functions the contribution is given by 2 · edf , where is edf , the estimated degrees
of freedom, describes the complexity degree of the fitted spline. Only the edf parameters show a
large standard deviation. Boxplots of the 50 values are presented in Appendix F.1, Figure F.1.
This fact has to be attributed to the variability of the multiple imputation process and to the
flexibility of splines, that adapt to different data sets. The cumulative AIC from 50 imputed
data sets is 999 points higher compared to MLADC3 (corresponding to ca. 20 points per data
set). MLADC3 would also in this case be the preferred model.
Table 4.6: Parameter estimates for the GAMLADCLSS . Central estimates are given as means from
50 imputed data sets with the standard deviation between the 50 best estimates (see chapter 3.5).
edf , the estimated degrees of freedom, describe the complexity degree of the fitted polynomial.
Parameter estimates of GAMLADCLSS
Meaning Mean (Standard deviation)
Intercept (10−3) -3.14 (5.72)
City 0.23 (1.43 10−5)
Age at exposure -0.26 (2.12 10−5)
Smoking duration (10−1) 9.24 (0.23)
Years since quitting (10−2) -1.88 (1.92 10−3)
edf s(I(age/70), d10gy) 8.57 (25.23)
edf s(I(age/70), I(packyrs/50)) 6.50 (29.73)
Cumulative deviance 252713
Cumulative AIC 254719
To underline the features of the GAMLADCLSS plots of linear predictions of age and lung dose and of
age and cumulative smoking amount are presented in Figure 4.14. The imputed dataset 39 was
chosen here as an example. In Appendix F, Figure F.4, the respective functions of age and lung
dose s(I(age/70), d10gy) and of age and smoking amount (packyears) s(I(age/70), I(packyrs/50))
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are presented. Figure 4.14(a) shows that the linear predictor is not linear in age, nor in lung
(a) (b)
Figure 4.14: Results of GAMLADCLSS for the imputed data set 39. (a) The linear prediction (a) as
a function of age and lung dose and (b) as a function of age and smoking amount (packyears).
dose but has a monotonic increasing shape. From Figure 4.14(b) we can notice again the mono-
tonic increasing in age, but a peak in the cumulative smoking amount variable. The functional
form of age is well modelled by the quadratic form of StatLADCLSS , while the peak in the in the
cumulative smoking amount variable would be missed.
To compare the model results of GAMLADC predictions for different exposure scenarios were
considered: unexposed never smokers (the baseline), exposed never smokers, unexposed smok-
ers and exposed ever smokers. Radiation/smoking related hazards and baseline hazards are
presented in Figure 4.15 for the scenarios. The boxplots represent the model predictions of the
50 imputed data sheets for LADC.
Figure 4.15: Baseline hazard and hazards from radiation and/or smoking for radiation-smoking
induced LADC in the LSSC predicted from GAMLADCLSS . To compare with Figure 4.11. Age at
exposure was fixed at age 30 yr and lung dose to 1 Gy. A smoking person began to smoke at age
20 yr and never stopped. The boxplots represent the variance of the 50 data sets.
The curves of Figure 4.15 are similar to the results of MLADC3 presented in Figure 4.11. The
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increase of radiation-related hazards compared to the baseline hazard is indeed a bit higher in
GAMLADCLSS . The smoking-related hazard is also predicted higher in GAMLADCLSS than inMLADC3 .
Now we proceed with the analysis of excess risks. EARs for radiation and smoking are presented
in Figures 4.16 and 4.17 (the respective ERRs can be found in Appendix F.2, Figures F.2 and
F.3).
Both radiation and smoking EAR for the GAMLADCLSS are similar to the results of StatLADCLSS
(see Figures 4.12 and 4.13 for more details). The peak modeled from MLADC3 is however also
not present in GAMLADCLSS .
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(a) EAR from GAMLADCLSS for radiation induced LADC as a
function of attained age (yr)
(b) EAR from GAMLADCLSS for smoking induced LADC as a func-
tion of lung dose (Gy)
Figure 4.16: Excess absolute rates (EARs as cases per 10.000 persons per year) from GAMLADCLSS
for radiation-induced LADC for (a) a person exposed to 1 Gy lung dose at age 30 yr as a function
of age, (b) a 70 years old person exposed at age 30 yr as a function of lung dose (Gy). The
boxplots represent the variance of the 50 datasets by GAMLADCLSS . StatLADCLSS is presented in
black, while MLADC3 in blue for comparison.
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(a) EAR from GAMLADCLSS for smoking induced LADC as a func-
tion of attained age (yr)
(b) EAR from GAMLADCLSS for smoking induced LADC as a func-
tion of smoking intensity (cigs/day)
Figure 4.17: Excess absolute rates (EARs as cases per 10.000 persons per year) from GAMLADCLSS
for smoking-induced LADC for a current smoker that began at age 20 yr, never stopped (a) with
smoking amount of 1 packyear as a function of attained age, (b) with varying smoking intensity.
The boxplots represent the variance of the 50 datasets by GAMLADCLSS . StatLADCLSS is presented
in black, while MLADC3 in blue for comparison.
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4.4 Summary of results
Result 1: LADC in the LSSC
In this Chapter we analysed the outcome of LADC in the LSSC and following results could
be achieved
• Detection of two molecular pathways to LADC applying biological analysis to the
Campbell data [9]: the RMUT and TMUT pathways
• Detection of RMUT and TMUT pathways using the molecular mechanistic model
MLADC3
• Radiation and cigarette smoke exposure affect RMUT and TMUT pathways separately
• No synergistic effects of radiation and cigarette smoke exposures could be detected,
neither in the state-of-the-art statistical risk model StatLADCLSS nor in model MLADC3
• Detailed functional description of effects using GAMs. An interaction of smoking and
radiation (s(smoking, radiation)) was tested but resulted not significant.
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CHAPTER
5
LUNG SQUAMOUS CELL CARCINOMA
IN THE LIFE SPAN STUDY COHORT
This chapter is dedicated to the analysis of squamous cell carcinoma in the Life Span Study
cohort. Of major interest is the understanding of the complex influence of smoking on this
disease.
In the first section a state-of-the-art statistical risk model is developed and explained. Of fun-
damental importance is the finding that only the younger calendar year category was found
radiation sensitive, with only 11 cases. Since it is not plausible that the radiation risk estima-
tion of the whole cohort is based on one specific category with so less cases, this category was
excluded from the analysis. A radiation related risk estimation for this type of lung cancer was
possible but not significant.
The second part is about mechanistic risk models, that describe carcinogenesis on a cellular
level. An effect of smoking could be found in initiation and promotion, with sex dependence
for the latter process. For past smokers an extra gender-independent parameter for promotion
could be found, that indicated a partial recovery of lung tissue.
Finally, generalised additive models were hence developed, to explore the functional form of the
different effects.
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5.1 State-of-the-art statistical risk models
State-of-the-art statistical risk models are the gold standard in radiation epidemiology and for
each analysis this type of models are interesting to develop, since for each cohort different fea-
tures of the models explained in Section 3.3.2 can be examined. For SQUAM in the LSS the
state-of-the-art statistical risk models are based on [18, 21]. Looking at Table 4 in Egawa et al.
[18] we noticed that for SQUAM the sex-averaged radiation-related ERR is relatively small,
suggesting weak statistical support. We also notice an unexpected high value for the age at ex-
posure parameter. At the same time the attained age parameter has a markedly negative value.
This means that the radiation risk is maximal after exposure at young age. The combined
dependence on age at exposure and attained age can be interpreted as a calendar year effect.
To explore this hypothesis we analysed the original complete data set and first reproduced the
results of Furukawa et al. [21] and Egawa et al. [18]. Than we did the same analysis as in [18]
only for SQUAM but deleting all Poisson records containing the first calendar year category
(from January, 1st 1958 to December 31st 1960, cal1). Only 11 cases were here excluded from
the analysis, which all had unknown smoking information. Deviances and AICs can be found
in Table 5.1. The model used for the analysis of Table 5.1 is the Simple Additive Model of
Table 5.1: Deviance and AIC from the state-of-the-art statistical risk model applied to the not
imputed original dataset (second column) and to the not imputed original dataset without the
first calendar year category, cal1 (third column). Five models were applied: only the baseline
model, the baseline model with an extra parameter for the radiation-ERR, the baseline model
with radiation-ERR and dose modifiers, the baseline model with only the full smoking function
and finally the simple additive model. For a detailed description see model (G.1) in Appendix G.1
Total dataset Dataset nor cal1
Dev AIC ∆ Dev Dev AIC ∆ Dev
Baseline 2757 2777 2667 2687
Rad. ERR 2748 2770 9 2661 2683 6
Rad. fucntion 2734 2762 15 2655 2683 12
Smk. only 2586 2630 171 2499 2543 168
simple Add. 2566 2618 191 2492 2544 175
Egawa et al. [18]. We choose this model with dose effect modifiers, since we wanted to see if
the effects of attained age and age at exposure changed without the first calendar year category.
An explanation of the model can be found in Appendix G.1, model (G.1).
For the data set without cal1 the model fitting only the smoking function would be preferred
under the AIC. Together with K. Furukawa we concluded that it is implausible that the total
radiation response of a cohort can be supported by only 11 cases. The complete radiation-risk
analysis would be determined by one category. We therefore proceed the analysis of SQUAM
excluding people with calendar year cal1. A radiation-related risk analysis was performed for
SQUAM in the LSS, but without significant results.
The derivation of the preferred statistical model for SQUAM in the LSS cohort was done using
one imputed data sheet. The sequence of steps for this derivation is presented in a reduced
form in Table G.1. The preferred state-of-the-art statistical risk model for SQUAM in the LSS
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(StatSQUAMLSS ) ended up to have the following form
hSQUAMLSS = hSQUAMLSS0 · (1 + ERR
SQUAMLSS
smk ) (5.1)
hSQUAMLSS0 = eβ0+β1log(
age
70 )+β2F/3M log
2(age70 ) (5.2)
ERRSQUAMLSSsmk = β4
packyrs
50 · e
β5log(years Quitting+1), (5.3)
with the parameters reported in Table 5.2. The deviances of all 50 data sheets can be found in
Figure G.1.
Table 5.2: Parameter estimates for StatSQUAMLSS 5.3 with 6 parameters. Central estimates are
given as means from 50 imputed data sets with 95% CI simulated from multi-variate normal
uncertainty distributions conditioned with the parameter correlation matrix (see section 3.5).
Cumulative deviance/AIC are the sum over the 50 deviances/AICs.
Parameter estimates of StatSQUAMLSS 5.3
Name Meaning MI Mean (95% CI)
β0 baseline -0.55 (-0.91, -0.21)
β1 baseline, attained age 4.91 (4.26, 5.55)
β2F baseline fem., attained age (squared) -23.50 (-32.52, -14.69)
β3M baseline mal., attained age (squared) -10.33 (-13.96, -6.73)
β4 smoking, linear resp. (day·yrpacks ) 22.52 (14.41, 32.91)
β5 smoking, years since quitting -0.29 (-0.43, -0.16)
Deviance 145396
AIC 145996
We could detect a markedly sex-dependent attained age response. Only the years since quitting
modifier was found significant for the smoking ERR. Results will be visualised together with
the mechanistic model M2 for SQUAM (MSQUAM2 ) in Chapter 5.2.
5.2 Mechanistic model
For the development ofMSQUAM2 we did not consider multiple pathways for two reasons: firstly,
90% of DQUAM patients were smokers, suggesting a single pathway of cancer development;
secondly, we found no hint for multiple pathways in the molecular data (see Chapter 1.1.2,
Figure 1.4) although a through analysis is still lacking. We looked however for a more detailed
description of the smoking damage. Compared to LADC this was only possible because in
SQUAM the statistical power for smoking influence was much higher, since almost all peo-
ple were smokers (see Table 2.3 in blue). A description of the preferred mechanistic model
MSQUAM2 can be found in Figure 5.1.
MSQUAM2 is a TSCE with smoking responses in the clonal expansion γSQUAM and in the
initiation XSQUAM , with the following forms
γSQUAM = γ0f/m · (1 + γSf/m · smkint · eκf/m·smkint + γpast · packyears), (5.4)
XSQUAM = X0 · (1 +XS · smkint). (5.5)
Pack years are defined as cigarette packs (one pack contains 20 cigarettes) times the years
smoked. Figure 5.2 depicts parameters γSQUAM and XSQUAM . In γSQUAM smoking inten-
sity (smokint) linearly enhances the clonal expansion rate during a period of constant smoking
80 5.2. MECHANISTIC MODEL
Figure 5.1: Schematic description of the preferred mechanistic model MSQUAM2 . An effect of
smoking on initiation and promotion could be found with the following forms: γ = γ0f/m · (1 +
γSf/m · smkint · eκf/m·smkint + γpast · packyears) and X = X0 · (1 +XS · smkint), respectively.
intensity with an attenuated effect for high smoking intensity. Note, that this is the same func-
tional form found in the clonal expansion of MLADC3 , TMUT pathway. Baseline values were
not retained when past-smokers quit, but an extra parameter (γpast) linearly dependent the cu-
mulative smoking amount (packs) could be fitted. The initiation parameter XSQUAM depends
linearly on smoking intensity. Only parameters of γSQUAM were sex dependent. An effect for
radiation was tested but was not significant.
Parameter estimates ofMSQUAM2 can be found in Table 5.3. The deviances of all 50 data sheets
can be found in Figure G.1. The cumulative deviance from the 50 imputed data sets is 92 points
Table 5.3: Parameter estimates for the preferred mechanistic model MSQUAM2 with 10 parame-
ters. Central estimates are given as means from 50 imputed data sets with 95% CI simulated
from multivariate normal uncertainty distributions conditioned with the parameter correlation
matrix (see section 3.5). Cumulative deviance/AIC are the sum over the 50 deviances/AICs.
Parameter estimates of the mechanistic model MSQUAM2
Name Unit MI Mean (95% CI)
γ0f cells/yr 0.17 (0.12, 0.23)
γ0m cells/yr 0.22 (0.15, 0.29)
γSf day/cigs 0.14 (0.09, 0.20)
γSm day/cigs 0.035 (0.010, 0.066)
κf day/cigs -0.060 (-0.083, -0.037)
κm day/cigs -0.034 (-0.048, -0.019)
γpast
packs
day·yr -0.49 (-0.73, -0.25)
δ 10−7cells/yr2 0.443 (0.025, 6.143)
X0 10−10cells/yr2 0.393 (0.016, 7.424)
XS day/cigs 0.49 (0.23, 0.86)
Deviance 145478
AIC 146478
higher compared to StatSQUAMLSS (corresponding to 1.8 points per data set). The cumulative AIC
is 482 points higher, corresponding to 10 points per data set. The cumulative deviances are
very similar but the cumulative AIC is higher for MSQUAM2 . The higher AIC is caused by the
large number of parameters in MSQUAM2 , which describe smoking-induced carcinogenesis. Ap-
parently, the state-of-the-art descriptive model can describe this process effectively, with only
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Figure 5.2: Upper panels: clonal expansion rates for female (left) and male (right) smoker
person in MSQUAM2 . Smoking intensity smkint linearly enhances the clonal expansion rate
γS(smkint) = γ0f,m [1 + γSm,f smkint exp(−κm,f smkint) + γpast · packyears] with an attenu-
ated effect for high smoking intensity and an extra parameter for the quitting smoking period.
Pack years are defined as cigarettepacks (one pack contains 20 cigarettes) times the years
smoked. Lower panel: sex-independent initiation rate linearly enhanced by smoking intensity
Xtot = X0 [1 +XS smkint]. Past smokers quit after 40 years of smoking.
two parameters. Only with MSQUAM2 we can represent the complicated and of multiple facets
action of smoking. An effects of smoking on the initiation parameter X can be biologically
interpret as a mutational effects. The effect on γ as an inflammatory effect (see Chapter 1.3).
We analysed crude rate and predicted hazard (SQUAM cases in 10,000 persons per year) from
MSQUAM2 , plotted in 5 year-age groups from 40-45 up to 80-85 years (see Figure 5.3). In each
group observed cases are estimated well by the model. Never and past smokers do not present
a flattening for higher ages, that is however markedly present in current smokers.
Next we analysed MSQUAM2 estimates for the breakdown of 319 SQUAM cases (% of 319 cases)
in smoking-induces and spontaneous cases, cross-tabulated with exposure groups for smoking
(Table 5.4). Refined resolution in exposure subgroups of light (1-10 cigs/day), moderate (11-20
cigs/day) and heavy (20+ cigs/day) smoking intensity is made. Also in this case in each sub-
group observed cases are estimated well by the model. Exposure group numbers (bold-faced)
add up to total numbers (bold-faced) in the bottom line. Exposure subgroup numbers add up
to group numbers. In contrast to LADC, for SQUAM almost 30% of the total number of cases
were estimated as spontaneous cases, the half as found in LADC.
Summarizing, the effect of smoking could be quantified on initiation and promotion rates, with
a sex dependence only on the second one. A specific rate for past smokers after quitting could
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Figure 5.3: Crude rate and predicted hazard (SQUAM cases in 10,000 persons per year) from
the MSQUAM2 for the LSS cohort in 5 year-age groups from 40-45 up to 80-85 years.
be fitted as sex independent in the promotion. The most part of cases can be attributed to
cigarette smoke exposure. Now we proceed with risk assessment.
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Figure 5.4: MSQUAM2 estimates for the breakdown of 319 SQUAM cases (% of 319 cases) from
the LSS cohort cross-tabulated with exposure groups for smoking. Refined resolution in smoking
status subgroups of never current and past smokers, and light (1-10 cigs/day), moderate (11-20
cigs/day) and heavy (20+ cigs/day) smoking intensity is made. In each subgroup observed cases
are estimated well by the model. Exposure group numbers (bold-faced) add up to total numbers
(bold-faced) in the bottom line. Exposure subgroup numbers add up to group numbers.
5.2.1 Risk assessment
Next we sought to analyse baseline hazards and smoking-related hazards for StatSQUAMLSS (black
lines) and mechanistic models (females in green and males in blue) MSQUAM2 (see Figure 5.5).
Age at begin of smoking was taken as 20 yr and age for stop smoking 60 yr. The smoking
intensity was of 20 cigs/day.
The baseline hazard function is very low for both females and males in both mechanistic and
state-of-the-art statistical models. The male baseline differs also strongly between the two type
of models. Looking at the smoking-related hazards for past smokers we can see that compared
to current smokers there is a decrease in the hazards, but we can also notice that the values
never go down to the baseline hazard. Although in both models there is a sex dependency in
the parameters (see Tables 5.2 and 5.3), the curves for female and males are quite similar. Only
for current females smokers in state-of-the-art statistical risk model we can notice a decrease
for higher ages, which is not present in the mechanistic models. All in all, both models agree
with almost no sex-dependency detectable in the baseline hazard curves, although the model
parameters suggest a strong sex-dependency.
For risk assessment in the main part of this Thesis there will be only EARs presented be-
cause of two reasons: the first one is that the biological action presented in MSQUAM2 of the
previous chapter is better reflected in the EARs compared to ERRs, the second one is that
since the baselines are really small and uncertainty affected, the division by these quantities for
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the calculation of ERRs will be problematic. All respective ERRs can be found in Appendix G.4.
5.2.1.1 Excess absolute rates for smoking
Figures 5.6 and 5.7 present the EARs from MSQUAM2 (Mech, females in green and males in
blue) and StatSQUAMLSS (black lines) for smoking-induced SQUAM for lifelong and past (fe-)male
smokers (left and right panels, respectively) starting at age 20 yr and for past smokers at quit-
ting age 60 yr. In Figures 5.6 and 5.7(a) the EARs are presented as a function of age attained
for different smoking intensities: 5, 10 and 20 cigs/day. For both lifelong and past smokers the
EAR increases with smoking intensity. For past smokers a kink at age of quit smoking is visible,
the EAR increases hence again. Past smokers have clearly lower risks as lifelong smokers. In
Figures 5.6 and 5.7(b) the EARs are conversely presented as a function of smoking intensity
(cigs/day) for different ages: 60, 70 and 80 years. For both lifelong and past smokers the EAR
increases with age. Also in this cases past smokers have clearly lower risks as lifelong smok-
ers. A sex difference in EARs is clearly visible only for past smokers, although also for current
smokers the model parameters were significantly different and the past smoker parameter was
gender-independent (see Table 5.3). The state-of-the-art statistical risk model (black lines)
differs relevantly from the mechanistic one only for females, for which the statistical power is
lower and hence the variability higher.
The corresponding smoking-related ERRs can be found in Appendix G.4, Figures G.2 and
G.3.
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(a) Baseline hazards
(b) Baseline hazards and smoking-related hazards
Figure 5.5: Baseline hazard (a) and smoking-related hazards (b) for state-of-the-art statistical
risk model (Desc, black lines) and mechanistic model (females in green and males in blue)
MSQUAM2 . Age at begin of smoking was taken as 20 yr and age for stop smoking 60 yr. The
smoking intensity was of 20 cigs/day. Solid lines denote never, dotted lines current and dashed
lines past smokers.
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(a)
(b)
Figure 5.6: EARs (as cases in 10,000 persons per year) from MSQUAM2 (Mech) for smoking-
induced SQUAM for lifelong and past female smokers (left and right panels, respectively) start-
ing at age 20 yr and for past smokers at quitting age 60 yr. (a) EARs as a function of age
attained for different smoking intensities: 5, 10 and 20 cigs/day. (b) EARs as a function of
smoking intensity (cigs/day) for different ages: 60, 70 and 80 years.
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(a)
(b)
Figure 5.7: EARs (as cases in 10,000 persons per year) from MSQUAM2 (Mech) for smoking-
induced SQUAM for lifelong and past male smokers (left and right panels, respectively) starting
at age 20 yr and for past smokers at quitting age 60 yr. (a) EARs as a function of age attained
for different smoking intensities: 5, 10 and 20 cigs/day. (b) EARs as a function of smoking
intensity (cigs/day) for different ages: 60, 70 and 80 years.
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5.3 Generalized additive models
The development of GAMs for SQUAM in the LSS (GAMSQUAMLSS ) was based on model Stat
SQUAM
LSS
and the preferred model has the following form
SQUAM_gam <− gam(squam~1 + s ( I ( ageMen/70)) +s ( I (ageWomen/70))
+s ( I ( packyrs/50)) +s ( smkqyrs ) ,
of fset = log (PYR/10000) ,
data = data_l s s_squam ,
family = poisson ( l ink = " log " ) ,
method = "ML" ,
opt imize r = c ( " outer " , " newton " ) )
with the parameters presented in Table 5.4. The deviances of all 50 data sheets can be found in
Figure G.1. The cumulative deviance (see section 3.5) from 50 imputed data sets is 359(267)
Table 5.4: Parameter estimates of GAMSQUAMLSS . Central estimates are given as means from 50
imputed data sets with the standard deviation between the 50 best estimates (see section 3.5).
edf , the estimated degrees of freedom, describe the complexity degree of the fitted penalised spline.
Parameter estimates of GAMSQUAMLSS
Meaning Mean (Standard deviation)
Intercept -1.05 (0.02)
edf s(I(ageMen/70)) 3.84 (0.05)
edf s(I(ageWomen/70)) 3.14 (0.52)
edf s(I(packyrs/50)) 5.08 (0.15)
edf s(smkqyrs) 1 (7.19 10−10)
Cumulative deviance 145119
Cumulative AIC 146525
points lower compared to MSUQAM2 (Stat
SQUAM
LSS ) (corresponding to ca. 7(5) points per data
set). The cumulative AIC from 50 imputed data sets is however 47(529) points higher com-
pared to MSUQAM2 (Stat
SQUAM
LSS ) (corresponding to ca. 0.9(11) points per data set), indicating
a high complexity of the fitted penalised spline.
All variables gave better fits with the application of spline functions instead of linear terms.
Please note that for s(smkqyrs) the fitted edf is equal one, it means a linear form. Fitting
s(smkqyrs) linearly showed a high correlation of this variable with the function s(I(agewomen/70)),
corrupting the whole fit. The usage of splines for the variable smkqyrs is however not increasing
the AIC of the model since for splines we calculate the AIC as 2 · edf . A graphical description
of the polynomials fitted for one selected imputed dataset (pydat− smk− imp−C23) are given
in Appendix G.5.
To better characterise the properties of model GAMSQUAMLSS we proceed with the analysis of the
linear predictors for the imputed dataset pydat− smk − imp− C23 as an example.
5.3. GENERALIZED ADDITIVE MODELS 89
(a) (b)
(c)
Figure 5.8: Linear predictors for one selected imputed dataset (pydat − smk − imp − C23) of
model GAMSQUAMLSS . (a) and (b) Linear predictor as a function of cumulative smoking amount
(packyears) and of attained age for men and women, respectively. (c) Linear predictor as a
function of cumulative smoking amount (pack years) and of years since quitting.
Figures 5.8(a) and (b) present the linear predictor as a function of cumulative smoking amount
(packyears) and of attained age for men and women, respectively. Figures 5.8(c), instead,
presents the linear predictor as a function of cumulative smoking amount (pack years) and of
years since quitting. Although (a) and (b) look very similar, the sex-dependence improved the
fit of ca. 200 points. The difference between females and males can be seen in the flattening of
the curves for higher ages, where for females the decrease is steeper.
To compare model results of GAMSQUAMLSS with those of M
SUQAM
3 and Stat
SQUAM
LSS we made
predictions for different scenarios: never smokers (females and males), current and past smoker
(females and males), which are presented in Figure 5.9.
The baseline hazards are both clearly smaller than the smoking-related hazards. Past smokers
show a reduction after quitting. The results from GAMSQUAMLSS are very similar of those of
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model StatSQUAMLSS (see Figure 5.5).
From baseline hazards and smoking-related hazards we calculated the respective EARs, which
are presented in Figures 5.10 and 5.11 for females and males. The ERRs can be found in
Appendix G.6, Figures G.5 and G.6
Females and males have very similar risks. Past smokers have a clear attenuation of the EAR,
which, however, never disappears. Also for risk estimation the results are very similar to those
of model StatSQUAMLSS (see Figures 5.6 and 5.7 for females and males, respectively). Only with
GAMs we can notice a decrease in the EARs for higher ages.
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(a)
(b)
Figure 5.9: Baseline hazard (a) and smoking-related hazards (b) for GAMSQUAMLSS (females in
green and males in blue) from model GAMSQUAMLSS . Age at begin of smoking was taken as 20
yr and age for stop smoking 60 yr. The smoking intensity was of 20 cigs/day. The boxplots
represent the variance of the 50 data sets.
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(a) Current female smoker (b) Past female smoker
(c) Current female smoker (d) Past female smoker
Figure 5.10: EARs (as cases per 10.000 persons per year) from GAMSQUAMLSS (in green),
StatSQUAMLSS (in black) and M
SUQAM
2 (in orange) for smoking induced SQUAM for (a) cur-
rent smoking females as a function of attained age, (b) past smoking females as a function of
attained age, (c) current smoking females as a function of smoking intensity and (d) past smok-
ing females as a function of smoking intensity. Age at begin of smoking was taken as 20 yr and
age for stop smoking 60 yr. In figures as function of attained age the smoking intensity was of
20 cigs/day. In figures as function of smoking intensity the attained age was of 70 years. The
boxplots represent the variance of the 50 data sheets.
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(a) Current male smoker (b) Past male smoker
(c) Current male smoker (d) Past male smoker
Figure 5.11: EARs (as cases per 10.000 persons per year) from GAMSQUAMLSS (in green),
StatSQUAMLSS (in black) and M
SUQAM
2 (in orange) for smoking induced SQUAM for (a) current
smoking male as a function of attained age, (b) past smoking male as a function of attained
age, (c) current smoking male as a function of smoking intensity and (d) past smoking male as
a function of smoking intensity. Age at begin of smoking was taken as 20 yr and age for stop
smoking 60 yr. In figures as function of attained age the smoking intensity was of 20 cigs/-
day. In figures as function of smoking intensity the attained age was of 70 years. The boxplots
represent the variance of the 50 data sheets.
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5.4 Summary of results
Result 2: SQUAM in the LSS cohort
In this Chapter we analysed the outcome of SQUAM in the LSS and following results could
be achieved
• No radiation sensitivity neither in the state-of-the-art statistical risk model StatSQUAMLSS
nor in model MSQUAM2
• Detailed description of the damage of cigarette smoke in modelMSQUAM2 in initiation
and promotion points to deleterious effects of smoking in the mutational spectrum
and in inflammation
• Lower risks for past smokers after quitting, but never disappears
• Detailed functional description of effects using GAMs
CHAPTER
6
LUNG ADENOCARCINOMA IN THE
ELDORADO COHORT
This chapter is dedicated to the analysis of lung adenocarcinoma in the Eldorado cohort. For
this cohort there is information about exposures to α- and γ- radiation, but no information
about cigarette smoke exposure is available. Because of this lack of knowledge, mechanistic
models are not appropriate, since the major effect causing lung cancer cannot be modelled on
a biological basis. Mechanistic models will hence not be developed for this cohort.
This chapter can be divided in two main sections: the first one is about development and
findings of state-of-the-art statistical risk models, the second one about generalized additive
models. The important finding coming from both models is that only the effects of γ radiation
exposure was found significant. For both models an effect of α particles was fitted, but the
results did not improve the goodness-of-fit.
Radiation risk estimation from both models will be finally presented and compared.
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6.1 State-of-the-art statistical risk models
For the analysis of the Eldorado cohort only state-of-the-art statistical risks models and GAMs
will be applied. In Appendix H.1 the model derivation of the preferred state-of-the-art statistical
risks model for LADC in the Eldorado cohort (StatLADCELDO) is explained with model equations
and model results (Table H.1). StatLADCELDO was selected using the AIC criterion. The form of
StatLADCELDO is presented in model (6.1), with parameters presented in Table 6.1.
hLADCELDO = hLADCELDO0 · (1 + ERRLADCELDO) (6.1)
with
hLADCELDO0 = eβ0+β1log(
age
60 )+β2log
2(age60 )+β3·calendaryear (6.2)
ERRLADCELDO = β4 ·Gamma. (6.3)
Table 6.1: Parameter estimates for model StatLADCELDO with 5 parameters. Central estimates are
given with 95% CI simulated from multi-variate normal uncertainty distributions conditioned
with the parameter correlation matrix (see section 3.5).
Parameter estimates of model StatLADCELDO
Name Meaning MI Mean (95% CI)
β0 baseline 1.00 (0.55, 1.45)
β1 baseline, attained age 3.32 (2.18, 4.45)
β2 baseline, attained age (squared) -17.88 (-23.48, -12.24)
β3 baseline, calendar year 0.79 (0.36, 1.21)
β4 radiation, ERR (10−2) 0.77 (0.27, 1.26)
Deviance 1477
AIC 1487
Remembering that the known exposures in the Eldorado cohort were two (α particles and γ
rays), it is important to note that for LADC only a significant parameter for the exposure to
γ rays could be fitted. An ERR for α particles was not significant when added to an ERR for
γ (see Table H.1). Note that a relation between γ exposure and LADC was already suggested
from the descriptive data analysis in Figure 2.6. In the baseline the first category of calendar
years was takes as reference, all other categories were grouped together.
Since for the γ radiation ERR no effect modifier could be found significant (see Table H.1),
we sought to proceed with a sensitivity analysis of the γ ERR. The ERR parameters were cal-
culated using in each fit the preferred model 6.1 StatLADCELDO but restricting the data to different
maximal levels of exposure: 100 mGy, 250 mGy, 500 mGy, 750 mGy, 1000 mGy, 1500 mGy
and complete dataset. The results can be found in Table 6.2.
Increasing the dataset there is a variability in the ERR-value, that remains however with the
uncertainty near a value of one.
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Table 6.2: Sensitivity analysis of the γ-ERR parameter of the model (H.1). The ERR parameters
were calculated restricting the data to different maximal levels of exposure (100 mGy, 250 mGy,
500 mGy, 750 mGy, 1000 mGy, 1500 mGy and complete dataset).
Sensitivity analysis of model H.1
Data (mGy) γ-ERR (SE) (10−2) % cases p-value
<= 100 1.66 (0.98) 81 0.09
<= 250 1.72 (0.69) 95 0.01
<= 500 1.26 (0.54) 97 0.02
<= 750 1.05 (0.46) 98 0.02
<= 1000 0.89 (0.42) 98 0.03
<= 1500 0.92 (0.40) 100 0.02
complete 0.77 (0.36) 100 0.03
6.2 Generalized additive models
To compare the goodness of fit of model StatLADCELDO we also applied a GAM. The preferred GAM
for LADC in the Eldorado cohort (GAMLADCELDO ) has the following form
gam_e ldorado_adeno <− gam( adeno~1 +s ( I ( age/60)) +ca l endar_two_adeno
+s ( I ( age/60) ,gamma5 ) ,
of fset = log (PYR/10000) ,
data = data_e ldo_males ,
family = poisson ( l ink = " log " ) ,
method = "ML" ,
opt imize r = c ( " outer " , " newton " ) )
The corresponding parameters can be found in Table 6.3.
The functional form of GAMLADCELDO is very similar to that of StatLADCELDO, but with a moderate
Table 6.3: Parameter estimates and estimated degrees of freedom for GAMLADCELDO . Central
estimates are given with SE, estimated degrees of freedom with reference degrees of freedom.
Parameter estimates of the GAM model
Meaning Mean (Standard deviation)
Intercept (10−1) 0.58 (3.23)
calendar year (cats 2+3+4+5) 0.70 (0.31)
Estimated degree of freedom (Reference df)
s(age/60) 3.63 (4.56)
s(I(age/60),gamma5) 3.69 (4.94)
Deviance 1462
AIC 1480
improvement of deviance and AIC (15 and 7 points, respectively). With the AIC one would
prefer the GAM’s description of the data. The improvement can be attributed to two facts: the
baseline can be better fitted due to the higher complexity of the penalised spline, the variation
of attained age with γ dose could be extrapolated from the data. The fitted functions of the
model can be found in Appendix H.2.
To better appreciate GAMLADCELDO we analysed the linear predictor of the model as a function of
attained age (yr) and γ dose (Gy) (Figure 6.1).
The shape of γ dose has multiple peaks (for low and middle exposure) and can hence be better
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Figure 6.1: Linear predictor of the GAM model for LADC in the Eldorado cohort with respect
to the variables attained age (yr) and γ dose (Gy).
represented by (penalized) splines, not used in state-of-the-art statistical risks models. The
shape of attained age in more similar to the linear quadratic expression used in state-of-the-art
statistical risks models, but can indeed be better fitted by complexer splines.
6.3 Risk assessment
The first analysis in risk assessment are baseline hazards and exposure-related hazards. In
Figure 6.2 baseline hazards and γ exposure related hazards (cases per 104 persons per year)
with different exposure intensities can be found. StatLADCELDO (solid lines) and GAMLADCELDO (dashed
lines) are compared.
(a) Baseline hazards (b) Baseline hazards and hazards
Figure 6.2: Cases per 104 persons per year for LADC baseline hazard (a) and baseline hazard
with radiation-related hazard (b) as a function of attained age (yr) by different γ exposures
comparing StatLADCELDO (solid lines) and GAMLADCELDO (dashed lines).
The baseline hazard of GAMLADCELDO is slightly higher than that of StatLADCELDO for ages 60 yr to
75 yr. In contrast, for radiation related hazard GAMLADCELDO shows lower risks than StatLADCELDO.
With higher baseline hazard but lower radiation related hazard we expect for GAMLADCELDO the
risks to be lower.
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Since all models derived for LADC in the Eldorado cohort are ERR models (cf. equation (3.20)),
ERR risk estimates present a better evaluation. In the next section only ERRs will be shown,
while the corresponding EARs can be found in Appendix H.3.
6.3.1 Excess relative risks
Looking at the functional forms of StatLADCELDO and GAMLADCELDO one can notice that the γ ERRs
are age-independent, but that they change with dose, with the functional form presented in
Figure 6.3.
Figure 6.3: Age-independent ERRs for LADC in the Eldorado cohort from StatLADCELDO (solid
lines) and GAMLADCELDO (dashed lines) as a function of γ-radiation exposure (Gy).
As expected, the values for GAMLADCELDO are almost lower for all γ doses and decrease for higher
dose. The ERR from StatLADCELDO increases linearly with γ dose. Because of its wave-like form,
the γ ERR description of GAMLADCELDO lacks biological plausibility.
6.4 Summary of results
Result 3: LADC in the Eldorado cohort
In this Chapter we analysed the outcome of LADC in the Eldorado cohort and following
results could be achieved
• Radiation sensitivity to α was not significant if combined with radiation sensitivity
to γ for both StatLADCELDO and GAMLADCELDO models
• Detailed functional description of effects using GAMs
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CHAPTER
7
LUNG SQUAMOUS CELL CARCINOMA
IN THE ELDORADO COHORT
This chapter is dedicated to the analysis of lung squamous cell carcinoma in the Eldorado
cohort. For this cohort there is information about exposures to α and γ radiation, but no infor-
mation about cigarette smoke exposure is known. Because of this lack of knowledge, molecular
mechanistic models are not appropriate, since one of the major effects to lung cancer would be
missed. Molecular mechanistic models will hence not be developed for this cohort.
This chapter can be divided in two main sections: the first one is about development and find-
ings of state-of-the-art statistical risk models, the second one about generalized additive models.
The important finding coming from both models is that only the effect of α radiation exposure
was found significant. For both models an effect of γ radiation was tested, but the results did
not improve the goodness of fit.
Radiation risk estimation from both models will be finally presented and compared.
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7.1 State-of-the-art statistical risk models
For the analysis of the Eldorado cohort only state-of-the-art statistical risks models and GAMs
will be applied. In Appendix I.1 the model derivation of the preferred state-of-the-art statistical
risks model for SQUAM in the Eldorado cohort (StatSQUAMELDO ) is explained with model equations
and model results (Table I.1). StatSQUAMELDO was selected using the AIC criterion. The form of
StatSQUAMELDO is presented in equation (7.1), with parameters presented in Table 7.1.
hSQUAMELDO = hSQUAMELDO0 · (1 + ERRSQUAMELDO) (7.1)
with
hSQUAMELDO0 = eβ0+β1log(
age
60 )+β2log
2(age60 )+β3·calendaryeargroup (7.2)
+ eβ4·calendaryear5+β5·(timesinceexposure)+β6·(timesinceexposure)2 (7.3)
ERRSQUAMELDO = β7 ·Radon · eβ8·(timesinceexposure).
Table 7.1: Parameter estimates for model StatSQUAMELDO with 9 parameters. Central estimates are
given with 95% CI simulated from multi-variate normal uncertainty distributions conditioned
with the parameter correlation matrix (see section 3.5).
Parameter estimates of model StatSQUAMELDO
Name Meaning MI Mean (95% CI)
β0 baseline 2.81 (2.30, 3.33)
β1 baseline, attained age 4.50 (3.59, 5.42)
β2 baseline, attained age (squared) -17.07 (-21.10, -13.07)
β3 baseline, calendar year (cats 2+3+4) 0.62 (0.34, 0.90)
β4 baseline, calendar year (cat 5) (10−2) 4.22 (-35.85, 44.23)
β5 baseline, time since last exposure (10−2) -8.75 (-11.61, -5.90)
β6 baseline, time since last exposure squared (10−3) 1.63 (1.20, 2.10)
β7 radiation, ERR (10−2) 1.85 (0.47, 3.23)
β8 radiation, time since last exposure (10−1) -0.51 (-0.78, -0.24)
Deviance 2517
AIC 2535
Remembering that the known exposures in the Eldorado cohort were two (α particles and γ
rays), it is important to note that for SQUAM only a significant parameter for the exposure to
α particles could be fitted. An ERR for γ rays was not significant (see Table I.1). These are op-
posite results as for LADC in the Eldorado cohort. A relation between α exposure and SQUAM
was already suggested from the descriptive data analysis, more specifically in Figure 2.6. In
the baseline the first category of calendar years was takes as reference, than categories 2, 3 and
4 were grouped together. Category 5 showed a significant difference from the others.
7.2 Generalized additive models
The preferred GAM for SQUAM in the Eldorado cohort (GAMSQUAMELDO ) was developed based
on model StatSQUAMELDO and has the following form
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gam_e ldorado_squam <− gam(squam~1 +s ( I ( age/60)) +ca l endar_two_squam
+calendar5 +radon5
+s ( time_s i n c e_l a s t_exp , I ( age/60)) ,
of fset = log (PYR/10000) ,
data = data_e ldo_males ,
family = poisson ( l ink = " log " ) ,
method = "ML" ,
opt imize r = c ( " outer " , " newton " ) )
The corresponding parameters are presented in Table 7.2.
Table 7.2: Parameter estimates and estimated degrees of freedom of model GAMSQUAMELDO . Cen-
tral estimates are given with SE, estimated degrees of freedom with reference degrees of freedom.
Parameter estimates of model GAMSQUAMELDO
Name Mean (Standard deviation)
Intercept 0.71 (0.25)
calendar year (cats 2+3+4) 0.59 (0.20)
calendar year (cat 5) -0.02 (0.29)
radon5 (10−2) 0.13 (0.02)
Name Estimated degree of freedom (Reference df)
s(age/60) 4.08 (5.05)
s(time since last exposure, age/60) 4.42 (5.97)
Deviance 2517
AIC 2542
The deviance of model GAMSQUAMELDO is equal to the deviance of the respective state-of-the-art
statistical risk model StatSQUAMELDO , while the AIC is 7 points higher. With AIC one would select
model StatSQUAMELDO . The higher AIC of model GAM
SQUAM
ELDO has to be attributed to the higher
complexity of the fitted penalised spline by the model (function presented in Figure I.1) that do
not improve the deviance enough to decrease the AIC. To better appreciate the results of model
GAMSQUAMELDO we analysed the linear predictors of the model as a function of attained age and
α dose (WLM) (Figure 7.1(a)) and of attained age and time since exposure (Figure 7.1(b)).
The attained age response has a shape similar to a linear quadratic one, normally used for
state-of-the-art-statistical risk models. The Time since exposure response, instead, presents a
wave-like behavior not present in state-of-the-art-statistical risk models.
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(a) Linear predictor Radon dose (WLM) - At-
tained age (yr)
(b) Linear predictor Time since la exposure
(yr) - Attaind age (yr)
Figure 7.1: Linear predictor of model GAMSQUAMELDO with respect to the variables radon dose
(WLM) and attained age (yr) (a) and Time since last exposure (yr) and attained age (yr) (b).
7.3 Risk assessment
To better understand the risks for SQUAM in the Eldorado cohort, we started the analysis
of risk assessment with baseline hazards and α related hazards for different exposures (100
and 1000 WLM) and for different ages at exposure (40 and 60 years), which are graphically
presented in Figure 7.2.
Baseline hazards and radiation related hazards both decrease for higher ages. For age at last
exposure 40 yr both models present very similar results, while for age at last exposure 60
yr model GAMSQUAMELDO presents higher baseline hazards but smaller radiation related hazards.
This implicates hence smaller risks for this model.
Since all models derived for SQUAM in the Eldorado cohort are ERR models (cf. equa-
tion (3.20)), ERR risk estimates present a better evaluation. In the next section only ERRs
will be shown, while the corresponding EARs can be found in Appendix I.3.
7.3.1 Excess relative risks
The ERRs from models StatSQUAMELDO (solid lines) and GAM
SQUAM
ELDO (dashed lines) are presented
in Figure 7.3.
In Figures 7.3(a) and (b) is it clear to see that, as expected, the risk extrapolation from
GAMSQUAMELDO is much lower than that of model Stat
SQUAM
ELDO . In Figures 7.3(c) and (d) we
can notice that the ERR from model GAMSQUAMELDO is independent on attained age. Since for
model StatSQUAMELDO the only risk modifier is the variable age at last exposure, we have different
curves for different attained ages only if the examined attained age is bigger than the fixed age
at last exposure. In Figures 7.3(c) and (d) the curves of model GAMSQUAMELDO can be interpreted
as a kind of interpolation of the results from the state-of-the-art statistical risk model.
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(a) Baseline hazards
(b) Baseline hazards and hazards for age at last expo-
sure 40 yr
(c) Baseline hazards and hazards for age at last expo-
sure 60 yr
Figure 7.2: Cases per 104 persons per year for SQUAM baseline hazard (a) and baseline hazard
with hazard for age at last exposure 40 yr (b) and 60 yr (c) as a function of attained age
(yr) by different radon exposures (WLM) comparing model StatSQUAMELDO (solid lines) and model
GAMSQUAMELDO (dashed lines).
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(a) ERR as a function of attained age for age at last
exposure 40 yr
(b) ERR as a function of attained age for age at last
exposure 60 yr
(c) ERR as a function of radon dose (WLM) for age
at last exposure 40 yr
(d) ERR as a function of radon dose (WLM) for age
at last exposure 60 yr
Figure 7.3: ERR for radon exposure (WLM) for SQUAM in the Eldorado cohort. The ERRs
from models StatSQUAMELDO are presented as solid lines wile those from model GAM
SQUAM
ELDO as
dashed ones. (a)-(b) Radiation ERR as a function of attained age for age at last exposure 60
and 60 yr, respectively. (c)-(d) Radiation ERR as a function of α dose (WLM) for age at last
exposure 60 and 60 yr, respectively.
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7.4 Summary of results
Result 4: SQUAM in the Eldorado cohort
In this Chapter we analysed the outcome of SQUAM in the Eldorado cohort and following
results could be achieved
• Radiation sensitivity only to α radiation exposure for both StatSQUAMELDO andGAM
SQUAM
ELDO
models
• Detailed functional description of effects using GAMs
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CHAPTER
8
SUMMARY AND DISCUSSION
8.1 Data selection and model application
The aim of this Thesis is to analyse carcinogenesis and the related risks in the lung under the
effects of smoking and two types of ionising radiation: γ waves and α particles. To explore this
question two radio-epidemiological cohorts were examined by modelling incidence rates: the
LSS and the Eldorado cohort [8, 18, 21, 33].
For the LSS Furukawa et al. [21] first and Cahoon et al. [8] next investigated the effects of
radiation and smoking on lung cancer incidence. Both studies detected a strong interaction
between radiation and cigarette smoking exposures. In [8] the models developed by [21] were
just reapplied to the LSS with extended followup and obtained congruent results. Egawa et al.
[18] extended the models developed by Furukawa et al. [21] to different subtypes of lung cancer:
LADC, SQUAM and small cell carcinoma. Only the first two are investigated in this Thesis. For
these subtypes the interaction of radiation and smoking was tested. Furukawa et al. [22] hence
investigated the question how to cope with cohort strata with unknown smoking information.
Three different approaches were compared:
1. create a separate category and fit an extra ERR for unknown smoking status,
2. ignore/delete strata with unknown smoking category, and
3. appeal imputation procedures to replace the missing information.
According to the analysis of [22] the best results can be obtained using imputed data, the
second best deleting the strata with unknown smoking information and as last one considering
the extra category. We confirmed this result with the descriptive data analysis of the LSS (see
Chapter 2.2), although imputation has to be used carefully. In the analyses of [8, 18, 21] the
considered procedure was the first one, the extra category. Based on the experience of Furukawa
et al. [22] we decided to use only imputed data sets.
For the Eldorado cohort there are already risk studies for all histological subtypes of lung
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cancer combined [33], but not for the different subtypes and for both γ and α exposures. For
this cohort, no information about cigarette smoking exposure is available. Smoking is the lead-
ing causes to lung cancer, irrespective of subtype (see Chapter 1.1). Zaballa and Eidemueller
[67] already applied mechanistic risk models to the Wismut cohort, another cohort of Uranium
miner with protracted exposure to α radiation but without information about cigarette smok-
ing. From this analysis it is clear that mechanistic models can be applied, but the interpretation
of the effects is complicated, since information on a major risk factor is missing. The effects
fitted for other covariables could be strongly affected by missing information. Because of this
fact, no mechanistic risk modeling has been applied in this Thesis to the Eldorado cohort, since
any biological interpretation would be speculative without cigarette smoking information.
8.2 Biology and modeling: lung adenocarcinoma in the Life
Span Study cohort
Lung adenocarcinoma management and outcomes largely rely on tumor genotype [49]. How-
ever, current prediction models of LADC do not provide molecularly stratified risks. We used
molecular data from Caucasian and Asian patients with LADC to reveal two broad molecular
fingerprints of the disease: one unique to patients with mutations in transmembrane recep-
tors (RMUT ) and another shared by patients with mutations in signal transduction genes and
by patients with no known oncogene mutations (TMUT ). These molecular findings were com-
bined with observational data of LADC incidence in Japanese atomic bomb survivors with
known radiation/smoking exposure but unknown mutation status, to develop the first molecu-
lar mechanistic model (MLADC3 ) for LADC risk prediction stratified by two modelled molecular
pathways. MLADC3 provides risk prediction including molecular subtypes that can be tested for
the LSS in the future, and explained for the first time the different mutation frequencies in
Western and Eastern populations based on smoke and radiation exposures.
Just like standard epidemiological risk models, MLADC3 accurately reproduced LADC inci-
dence in the LSS, albeit with moderately improved goodness-of-fit. Lubin and Caporaso [38]
analyzed a European lung cancer cohort with detailed smoking information using a generalized
linear model in logistic regression. In their Figure 4, the sex-independent exposure response for
LADC is measured in units of ERR/pack-year and shows remarkable agreement with our results
for current male smokers (Figure E.3). As a striking new feature, MLADC3 clearly identified the
two molecular pathways that emerged from the molecular analysis. Model predictions on the
expected number of cases in both pathways were compatible with molecular measurements of
KRAS and EGFR mutations in Japanese patients [57]. Importantly, the predictive power of
MLADC3 can be subject to rigorous validation by future measurements of the mutation status in
LADC tissue of LSS patients.
Previous molecular studies underpinned the biological plausibility of MLADC3 . KRAS muta-
tions are more common in smokers [10] and are suspected to confer resistance to radiotherapy
[62], which is consistent with the lack of a radiation response in the TMUT pathway in our
study. Thus, the main contribution of radiation to LADC incidence is imparted via the RMUT
pathway and a possible contribution from the TMUT pathway is too small for quantification.
To this date, the risk factor that drives LADC development in never smokers is unknown, while
these patients exhibit higher frequencies of EGFR mutations and EML4/ALK fusions [2, 56].
Here we show that radiation may drive disease development in these patients and provide a
risk prediction model for this molecular class of LADC. This observation corresponds to the
radiation response of the RMUT pathway as the most relevant radiation effect proposed by
8.2. BIOLOGY AND MODELING: LUNG ADENOCARCINOMA IN THE LIFE SPAN
STUDY COHORT 111
MLADC3 . Hence we link for the first time radiation exposure to a molecular subset of LADC
using molecular and epidemiologic evidence.
Smoking is linked with KRAS-mutant LADC and TCGA analyses showed enhanced muta-
tion rates in ever smokers of the TMUT pathway [10]. In a mechanistic model, this observation
should translate into an increase of the initiation rate in smokers. However, MLADC3 works
without such a plausible smoking effect because improvement in goodness-of-fit was inferior
compared to a smoking action on clonal expansion. Hence, the model points to te main biolog-
ical mechanism of smoking on LADC incidence to be associated with enhanced clonal growth.
Initiated cells exhibit a growth advantage over healthy cells due to reduced cell death possibly
caused by smoking-associated chronic inflammation. Hence our data build on the known linkage
between smoking and KRAS-mutant LADC by expanding this link to TMUT and OWT LADC,
and by pinning the effects of smoke in time: at early time-points of smoking exposure. These
results are relevant and important for the design of future chemoprevention strategies aimed to
halt disease progression in smokers.
MLADC3 also explains the higher susceptibility of women to smoke, evident by the current
LADC pandemic in women [25]. A study of EGFR and KRAS mutations in 3000 LADC of
Caucasian patients revealed a higher susceptibility of women to smoking exposure for KRAS-
mutant cancers [16]. These findings are in line with a stronger increase of the smoking risk in
the TMUT pathway for female light smokers compared to male light smokers. Our results are
concordant to the aforementioned study and can likely be explained by genetic predisposition
of women to persistent smoke-induced DNA damage, notwithstanding the possibility for sex-
related differences in innate immune responses to tobacco smoke, as those observed in inbred
strains of mice [54].
Risk prediction models, which are informed by adequate bioassays in addition to epidemio-
logical variables, can predict lung cancer risk with high accuracy [19]. They do lack, however,
a link between environmental agents and molecular risk stratification, which is provided by
MLADC3 . For example, this link suggests no elevated LADC risk even for heavy smokers in CT
screening. It can be exploited in retrospective assessment to pin down the agent causing LADC
based on the molecular profile of diseased tissue.
In conclusion, our invertigation of LADC in the LSS answers a longstanding question on the
biological origins of age-risk patterns for LADC from concomitant exposure to smoking and
radiation. Standard epidemiological models must inevitably rely on a vague description of
synergistic effects, which are commonly couched in mathematical terms as either ‘additive’ or
‘multiplicative’ sometimes with further generalizations [8, 18, 21]. For risk assessment studies
an effect is preferred based on statistical criteria of goodness-of-fit with scant biological justifi-
cation. We have shown here that smoking and radiation drive the development of LADC along
different molecular pathways with negligible interaction for doses below 4 Gy. Standard epidemi-
ological models do not mirror these findings which have an impact on risk predictions especially
in regions of the cohort dataspace with low case numbers. To conclude, the MLADC3 approach
provides a powerful tool for harnessing molecular data to improve studies of risk assessment
and prediction in radiation protection and clinical applications.
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8.3 No interaction between radiation and smoking exposures
for lung cancer subtypes in the Life Span study cohort
The major result from Furukawa et al. [21], the first analysis of lung cancer in the LSS, is that
radiation and smoking exposures act to this endpoint with clear significant interaction. Egawa
et al. [18] extended the models developed by Furukawa et al. [21] to different histological sub-
types of lung cancer: LADC, SQUAM and small cell carcinoma. Only the first two are of our
interest. For these subtypes the interaction of radiation and smoking was tested.
Based on AIC for lung cancer as endpoint the generalized multiplicative model (the multiplica-
tive model with interaction between smoking and radiation exposures) appeared to be the best
model. But this was not the cases for LADC or for SQUAM alone [18, 21]. For LADC the pre-
ferred model was a simple additive model (radiation and smoking add their influence without
any interaction), where for SQUAM the preferred model was a simply multiplicative (Table 4
in [18]). In [18] only the generalized multiplicative model was discussed, in order to compare
the new findings with those of [21] for all lung cancer subtypes combined. This misleading
representation is deceiving the community, which is convinced of the interaction of smoking
and radiation exposures also for subtypes. However, from the model results one cannot exclude
any interaction, which at the same time cannot be confirmed. The discrepancy between the
results of Furukawa et al. [21] and of Egawa et al. [18] could be due to two factors: decrease in
statistical power and superposition of effects. By splitting the total number of lung cancer in
histological subtypes, the statistical power for each subtype is decreased. Based on molecular
profiles we already know that the lung cancer subtypes can be considered as different diseases
(see Chapter 1.1). For all lung cancer types combined, the model results can be considered
as a superposition of effects pertaining to each subtype alone. Because radiation and smoking
affect the subtypes with differential sensitivity, the interaction observed in [21] may possibly be
considered as accidental.
An other important point for the analysis of [21] and [18] is that the strata in the data with
unknown smoking information were classified separately and specific ERRs for smoking were
fitted with a sex and age-dependent linear exponential shape. To test the radiation related
ERR, however, no differentiation between strta with known and unknown smoking information
was done. If the specific form used for the "unknown" smoking ERR is hence not good enough,
the not fitted rest effect can be attributed to radiation, influencing also the interaction terms.
We tested the influence of this oversight introducing extra ERR radiation related terms for the
unknown smoking cells. The magnitude of the interaction still persisted but with a dramatic
decrease.
Summarizing, with the recognition of the following facts
• possible superposition of effects in the analysis with endpoint lung ([21])
• actual absence of interaction already in [18]
• inadequate inclusion of the "unknown" smoking category for fitting of the radiation related
ERR in both [21] and [18]
we are not surprised that also in our analysis no interaction between radiation and smoking
could be found, in any lung cancer subtype.
In LADC the preferred molecular mechanistic models revealed the presence of two biologi-
cal pathways in observational data: the RMUT pathway comprised almost all spontaneous and
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radiation induced cases, the TMUT pathway contained very few spontaneous cases and is driven
almost exclusively by smoking. We cannot exclude an effect of smoking in RMUT , but we could
not detect it based on biological and statistical analysis. From the biological analysis KRAS-
mutant LADC and TCGA analysis showed enhanced mutation rates in ever smokers of the
TMUT pathway [10].
For SQUAM in the LSS no significant radiation response could be detected with any model.
In Egawa et al. [18] (their Table 4) for SQUAM the gender averaged radiation-related ERR
estimate is relatively small with border line significance. We also notice an unexpected high
value for the age at exposure variable and a markedly negative value for attained age. The
radiation risk is maximal after exposure at young age (a calendar year effect). We explored this
hypothesis analysing the non imputed complete data set with and without strata of the first
calendar year category. After this deletion the radiation-related ERR value was not significant
anymore, for all the three types of models applied to this cohort (state-of-the-art statistical risk
model of [21], molecular mechanistic models and GAMs). Together with K. Furukawa we con-
cluded that it is implausible that the total radiation response of a cohort can be supported by
only one category. We therefore proceed the analysis of SQUAM excluding strata with calendar
year category 1. Radiation-related risks for SQUAM in the LSS were hence possible but not
significant. Interestingly, for SQUAM the mechanistic models could fit the effects of cigarette
smoking in initiation and promotion, differently as for LADC, indicating one more time the
importance of the distinction between lung cancer subtypes.
8.4 Different radiation qualities act separately on different lung
cancer subtypes
Although no information about cigarette smoke exposure is available, the Eldorado cohort is a
peculiar data set for the analysis of radiation-related effects since those people were unfortu-
nately exposed to both γ and α ionising radiation. In this Thesis, for the first time in radiation
protection, different lung cancer subtypes were examined and compared after protracted ex-
posure to different radiation qualities. Lane et al. [33] already analysed the Eldorado cohort,
but neglecting the very important differentiation between subtypes. Kreuzer et al. [31], instead,
payed attention to the different subtypes in a analysis of the Wismut cohort, a cohort of German
Uranium miners, but not having an exposure to γ radiation and making only a case comparison.
We developed standard state-of-the-art statistical risk models for radiation protection and sta-
tistical generalised additive models to explore the effects of both γ and α ionising radiation to
LADC and SQUAM. Statistical generalized additive models have already succeed predicting
lung cancer case, with a markedly increment of the goodness of fit [12]. Because of their easy
way to cope with interactions, they are are precious instrument for our analysis.
For LADC both state-of-the-art statistical risk model and generalised additive models could
find a significant radiation effects only for γ radiation exposure. The effects of exposure to α
particles could be fitted but were not significant. For SQUAM, vice versa, both models could
find only a significant response to α radiation exposure, while responses of exposure to γ par-
ticles again were not significant. These findings are in line with the results of [31] and with our
results for the LSS, where for LADC radiation and smoking were acting on different molecular
pathways and for SQUAM no significant response to γ radiation could be found. Moreover,
these results may be explained biologically. It is known know that both α particles and cigarette
smoke affect mostly the epithelium of the lung causing mostly SQUAM (see Chapter 1.3) [37].
Vahakangas et al. [61] and Choi et al. [11] analysed genetic radiation markers for radon. The
following genes were significantly mutated: EGFR, TP53, NKX2.1 and PTEN. Since [11] anal-
ysed all lung cancer without subtypes, the presence of EGFR can be understood as stemming
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from LADC lung cases. Moreover, genes TP53 and PTEN are also the genes that were found
frequently mutated in [44] (see Chapter 1.1.2). Since almost all cases of both Choi et al. [11]
and [44] were smokers, we can conclude that the radiation markers for α exposure do not differ
from those of smoking. With the fact that α particles and cigarette smoke act additively/syn-
ergistically to the development of lung cancer [5, 34], it is not surprising that main effects of
both risk factors relate to the same subtype, SQUAM. γ waves, instead, penetrate the tissue
completely, damaging mostly all parts of the lung [37].
In syntheses, α radiation and smoking are the dominant risk factors for SQUAM, γ radiation
is not visible but can still be important.
A summary of the ERRs calculated per method and lung cancer subtype is presented in Fig-
ure 8.1. For SQUAM of both LSS and Eldorado cohorts an ERR for α exposure was not
Table 8.1: Summary of ERR for γ radiation at 1 Gy at age 70 yrs. n.a. means not available.
Values marked by a ? are estimates from only one imputed data sheet.
ERR for γ radiation at 1 Gy at age 70 yrs
Model LSS age at exposure 30 yr Eldorado
LADC SQUAM LADC SQUAM
Mech 0.48 (0.14 1.38) n.a. n.a. n.a.
Desc 1.23 (n.a.) 0.23 (0.91 SE)? 7.7 (2.7 12.6) -90.3610−5 (-21.3710−5 SE)?
GAM 0.83 (n.a.) n.a. 4.12 (n.a.) n.a.
significant. The ERRs of the three models for γ exposure are concordant in each cohort, but
differ in one order of magnitude between the cohorts. This difference may be due to the different
type of exposure: short and large for the LSS, protracted for the Eldorado.
8.5 Lung cancer subtypes are different diseases
Finally, we want to stress once a gain a main result that was relevant throughout this Thesis:
lung cancer cannot be analysed as a single endpoint, but the different histological subtypes have
to be considered separately. Of course with this split the statistical power for each endpoint
decreases. The results for the combined endpoint are, however, hard to interpret because of
a likely superposition of effects. As we have seen, different radiation qualities act differently
on the different subtypes, revealing different biological processes. Smoking was relevant to all
analysed subtypes, but had different effects with different magnitudes. A deeper understanding
of carcinogenesis in the lung with respect to radiation and smoking effects, can only be achieved
with the consideration of lung cancer subtypes as different disease entities.
8.6 Limitations of this analysis
Limitations of this analysis relate to both the data and to the models applied.
In epidemiological data there is always some uncertainty in data collection. The match with can-
cer registries is involved and personal information in some instances may be connected wrongly.
For some patients there is no clear cause of death.
As we have seen in the description of the cohorts, dosimetry is not an easy issue. New methods
to reconstruct the internal dose for the LSS are still being developed. For the dosimetry in
the Eldorado cohort, the protraction of the exposure plays a role. In the mine there are daily
fluctuations in the concentration of radioactive substances, and therefore in the received dose.
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No such detailed information is available. In the Eldorado cohort, some workers spent part of
their employment duration outside the mine but this information was not available. Only the
cumulative exposure during life was obtained. However, time-dependent information would be
important for mechanistic analysis.
The importance of smoking as a risk factor for LADC and SQUAM was a leitmotiv in this
Thesis. Uncertainty in this information, which was derived in the LSS primarily from surveys,
is hence a major issue. In the past, smoking was restricted for women in Japan, who however
smoked secretly and inhaled passive smoke. These facts definitely affect the results for female
smokers. A comparison of smoking effects in different cohorts was not possible in this Thesis
since no information was provided for the Eldorado cohort. This is still a point of major interest
that should be investigated.
Each of model types applied has merits and defects. State-of-the-art statistical risk models
for radiation protection generally can reproduce well the data after some model adaptations.
Functional forms of the covariables’ effects have to be assumed. The results do not have a biolog-
ical meaning. Mechanistic models can be interpreted biologically but are simplistic descriptions
of complex biological processes. Model derivation can be complicated and time consuming.
Statistical generalized additive models are easy to derive but some control is necessary to avoid
implausible results for risks estimates (wiggly functions). Therefore, the different models yield
complementary information on the different cancer types.
As we have seen in the biological analysis of LADC in Chapter 4, results from a Japanese
cohort may not be transferred easily to other ethnic groups. Comparing quantities can be
misleading, though a qualitative analysis should remain consistent. The type of radiation the
victims of the LSS were exposed to is also unique: a relatively uniform, high dose for a very
short time. A transfer of risk estimates from this cohort to, e.g., medically exposed patients
should be done with caution.
8.7 Outlook
From the findings of this Thesis several interesting questions arose.
For future data collection it is essential that attention is given to the different subtypes of
lung cancer. If possible, also genetic information of the cancer tissue should be taken. It is
important to understand that future epidemiological data analysis for lung cancer makes sense
only when differentiating between subtypes. A global analysis on lung cancer would just be a
superposition of the effects of the single subtypes, impeding the interpretation of the effects and
the anyway uncertain transfer to other ethnic groups. To consolidate the findings about lung
adenocarcinoma in the Life Span Study cohort, it would be helpful, if a portion of the tissue
samples collected from the lung cancer patients would be genetically analysed. In this way, the
radio-sensitivity of the RMUT pathway could be tested directly.
For analysis of lung cancer, information on smoking is central for a correct quantification of
other effects. Already a dichotomous information improves the analysis.
In this Thesis we exemplified how epidemiology and biology complement one another, to under-
stand and prevent diseases. We warmly recommend a better cooperation between the different
radiation fields: biology, epidemiology and treatment radiology. Moreover, because of the lack
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of cooperation between fields, a lot of common statistical routines were never applied to radi-
ation epidemiological data. Some steps in this direction were undertaken. In this Thesis for
the first time generalized additive models were applied in radiation risk analysis although those
models are a standard tool in pertinent statistical analysis. Present trends in statistics focus
a lot on machine learning. This could help to reduce the potential impact of the researcher,
which is appealing in a field under a strong societal controversy.
Risk assessment for radiation protection mostly relies on the results of state-of-the-art sta-
tistical risk models. For a more comprehensive investigation other modeling approaches, such
as biologically-based models or more general classes of statistical models (i.e. generalized addi-
tive models) provide valuable insight.
Concluding, we want to underline that a very large part of lung cancers could be avoided if
smoking was reduced in the population. Therefore, continuous efforts are necessary to prevent
smoking initiation, especially in young people, and to promote cessation of smoking. Radiation
showed to be a cause of adenocarcinoma, but secondary after smoking even in the victims of the
atomic bombs. Although the much higher risk of smoking is well known to the scientific com-
munity, public perception disagrees completely. People should be better educated in respecting
the natural phenomenon of radiation: it can be dangerous, indeed, it also saves lives daily, e.g.
in cancer radiotherapy or medical diagnostic.
Appendix
117

APPENDIX
A
DESCRIPTIVE DATA ANALYSIS OF THE
LIFE SPAN STUDY COHORT:
SUPPLEMENTARY INFORMATION
This Appendix Chapter contains supplementary information about the LSS cohort. Related to
Chapter 2.2.
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A.1 Comparison original vs. imputed data sets: raw data
Table A.1: Comparison of cases after imputation (Imp) with the cases of the original dataset
(OD) containing the category "unknown smoking information". Second, third and fourth columns
summaries imputed data with endpoint lung for the lung cancer types lung in general, LADC
and SQUAM, respectively. The fourth column is a summary of the imputed data with endpoint
SQUAM for the subtype SQUAM.
Lung total LADC SQUAM SQUAM
Cases in OD 1803 636 330 330
Never smokers in OD 298 167 16 16
Ever smokers in OD 804 260 193 193
Cases without 626 209 121 121
smoking info in OD
% cases without 38 33 37 37
smoking info in OD
Imputed never smokers 257 98 30 17
Imputed ever smokers 480 126 97 110
Never smokers after Imp 555 265 46 33
Ever smokers after Imp 1284 386 290 303
% imputed never smokers 44 35 65 50
% imputed ever smokers 35 31 32 35
Imputed never smokers
Never smokers OD
0.86 0.59 1.88 1.06
Imputed ever smokers
Ever smokers OD
0.60 0.48 0.50 0.57
Never smokers OD
Ever smokers OD
0.37 0.64 0.08 0.08
Never smokers after Imp
Ever smokers after Imp
0.43 0.69 0.16 0.11
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A.2 Smoking status of cases
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Figure A.1: Stated smoking status for LADC (left panels) and SQUAM (right panels) cases per
104 persons per year comparing three data sets: the original data set without unknown smoking
information (light blue), the original data set with unknown smoking information (dark blue) and
the 50 imputed data sheets (in orange). Panels (a) right and (b) right describe the distribution of
known and unknown smoking history in the original data set with unknown smoking information
(dark blue). Panels (a) left and (b) left instead depict the difference of the incidence between the
original data set without unknown smoking category and the 50 imputed sheets. The orange bars
are the person years weighted mean over the 50 imputed sheets. Panels (c) and (d) represent
the relative deviation of the imputed data sheets from the original data set without unknown
smoking. The relative deviation is calculated as incidence-ratio between original and imputed
dataset. The box-plots represent the distribution of the relative deviations of the 50 imputed
sheets. The blue horizontal line represents the value one, it means a correspondence between
original without unknown smoking category and imputed data set.
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A.3 Age distribution of cases by smoking status
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Figure A.2: Age distribution of LADC cases per 104 persons per year by smoking status (never
smokers left panels and ever smokers right panels) comparing two data sets: the original dataset
without unknown smoking information (light blue) and the 50 imputed dataset (in orange). Pan-
els (a) and (b), for never and ever smokers respectively, describe the difference of the incidence
between the original data set the 50 imputed data sheets. The orange bars are the person years
weighted mean over the 50 imputed data sheets. Panels (c) and (d) represent the relative de-
viation of the imputed sheets from the original dataset. The relative deviation is calculated as
incidence-ratio between original and imputed dataset. The box-plots represent the distribution
of the relative deviations of the 50 imputed data sheets. The blue horizontal line represents the
value one, it means a correspondence between original and imputed dataset.
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Figure A.3: Age distribution of SQUAM cases per 104 persons per year by smoking status (never
smokers left panels and ever smokers right panels) comparing two datasets: the original dataset
without unknown smoking information (light blue) and the 50 imputed dataset (in orange). Pan-
els (a) and (b), for never and ever smokers respectively, describe the difference of the incidence
between the original data set the 50 imputed data sheets. The orange bars are the person years
weighted mean over the 50 imputed data sheets. Panels (c) and (d) represent the relative de-
viation of the imputed sheets from the original dataset. The relative deviation is calculated as
incidence-ratio between original and imputed dataset. The box-plots represent the distribution
of the relative deviations of the 50 imputed data sheets. The blue horizontal line represents the
value one, it means a correspondence between original and imputed dataset.
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A.4 Smoking duration distribution of cases
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Figure A.4: Stated smoking duration for LADC (left panels) and SQUAM (right panels) cases
per 104 persons per year comparing three data sets: the original data set without unknown
smoking information (light blue), the original data set with unknown smoking information (dark
blue) and the 50 imputed data sheet (in orange). Panel (a) right and (b) right describe the
distribution of known and unknown smoking history in the original data set with unknown
smoking information (dark blue). Panel (a) left and (b) left instead depict the difference of the
incidence between the original data set without unknown smoking category and the 50 imputed
data sheets. The orange bars are the person years weighted mean over the 50 imputed data
sheets. Panels (c) and (d) represent the relative deviation of the imputed data sheets from the
original data set without unknown smoking. The relative deviation is calculated as incidence-
ratio between original and imputed data set. The box-plots represent the distribution of the
relative deviations of the 50 imputed data sheets. The blue horizontal line represents the value
one, it means a correspondence between original without unknown smoking category and imputed
data set.
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A.5 Smoking intensity distribution (cigs/day) of cases
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Figure A.5: Stated smoking intensity for LADC (left panels) and SQUAM (right panels) cases
per 104 persons per year comparing three data sets: the original data set without unknown
smoking information (light blue), the original data set with unknown smoking information (dark
blue) and the 50 imputed data sheet (in orange). Panel (a) right and (b) right describe the
distribution of known and unknown smoking history in the original data set with unknown
smoking information (dark blue). Panel (a) left and (b) left instead depict the difference of the
incidence between the original data set without unknown smoking category and the 50 imputed
data sheets. The orange bars are the person years weighted mean over the 50 imputed data
sheets. Panels (c) and (d) represent the relative deviation of the imputed data sheets from the
original data set without unknown smoking. The relative deviation is calculated as incidence-
ratio between original and imputed data set. The box-plots represent the distribution of the
relative deviations of the 50 imputed data sheets. The blue horizontal line represents the value
one, it means a correspondence between original without unknown smoking category and imputed
data set.
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A.6 Years since quitting distribution of cases
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Figure A.6: Stated years since quitting smoking for LADC (left panels) and SQUAM (right
panels) cases per 104 persons per year comparing three data sets: the original data set without
unknown smoking information (light blue), the original data set with unknown smoking infor-
mation (dark blue) and the 50 imputed data sheet (in orange). Panel (a) right and (b) right
describe the distribution of known and unknown smoking history in the original data set with
unknown smoking information (dark blue). Panel (a) left and (b) left instead depict the differ-
ence of the incidence between the original data set without unknown smoking category and the
50 imputed data sheets. The orange bars are the person years weighted mean over the 50 im-
puted data sheets. Panels (c) and (d) represent the relative deviation of the imputed data sheets
from the original data set without unknown smoking. The relative deviation is calculated as
incidence-ratio between original and imputed data set. The box-plots represent the distribution
of the relative deviations of the 50 imputed data sheets. The blue horizontal line represents the
value one, it means a correspondence between original without unknown smoking category and
imputed data set.
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A.7 Dose distribution of cases
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Figure A.7: Lung dose distribution (Gy) of LADC cases per 104 persons per year by smoking
status (never smokers left panels and ever smokers right panels) comparing two data sets: the
original data set without unknown smoking information (light blue) and the 50 imputed data
sheets (in orange). Panels (a) and (b), for never and ever smokers respectively, describe the
difference of the incidence between the original data set the 50 imputed data sheets. The orange
bars are the person years weighted mean over the 50 imputed data sheets. The red line divides
low from high dose. Panels (c) and (d) represent the relative deviation of the imputed data
sheets from the original data set. The relative deviation is calculated as incidence-ratio between
original and imputed data set. The box-plots represent the distribution of the relative deviations
of the 50 imputed data sheets. The blue horizontal line represents the value one, it means a
correspondence between original and imputed data set.
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(d) SQUAM ever smokers
Figure A.8: Lung dose distribution (Gy) of SQUAM cases per 104 persons per year by smoking
status (never smokers left panels and ever smokers right panels) comparing two data sets: the
original data set without unknown smoking information (light blue) and the 50 imputed data
sheets (in orange). Panels (a) and (b), for never and ever smokers respectively, describe the
difference of the incidence between the original data set the 50 imputed data sheets. The orange
bars are the person years weighted mean over the 50 imputed data sheets. The red line divides
low from high dose. Panels (c) and (d) represent the relative deviation of the imputed data
sheets from the original data set. The relative deviation is calculated as incidence-ratio between
original and imputed data set. The box-plots represent the distribution of the relative deviations
of the 50 imputed data sheets. The blue horizontal line represents the value one, it means a
correspondence between original and imputed data set.
APPENDIX
B
DESCRIPTIVE DATA ANALYSIS OF THE
ELDORADO COHORT:
SUPPLEMENTARY INFOMATION
This Appendix Chapter contains supplementary information of the Eldorado cohort. Related
to Chapter 2.3.
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130 B.1. LAGGED EXPOSURES VS. NON-LAGGED EXPOSURES
B.1 Lagged exposures vs. non-lagged exposures
(a) (b)
Figure B.1: Comparison of the variables Gamma5 (a) Radon5 (b) with the variables Gamma0
and Radon0, respectively. For both variables the lagged variables almost do not differ from the
not lagged ones.
B.2 Dose distribution of cases
(a) Gamma5 (b) Radon5
Figure B.2: LADC (in red) and SQUAM (in blue) per 104 persons per year of the Eldorado
cohort as a function of the variable Gamma5 (a) and Radon5 (b).
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B.3 Dose distribution of cases by facility
(a) LADC over Radon5 (b) SQUAM over Radon5
(c) LADC over Gamma5 (d) SQUAM over Gamma5
Figure B.3: Cases per 104 persons per year for LADC, left panels, and SQUAM, right panels,
as a function of Radon5, panels (a) and (b), and of Gamma5, panels (c) and (d), differentiating
between the different facilities: Port Hope (red), Port Radium (green), Beaver Lodge (blue) and
others (yellow).
132 B.4. DOSE DISTRIBUTION OF CASES BY AGE CATEGORIES
B.4 Dose distribution of cases by age categories
(a) LADC over Radon5 (b) SQUAM over Radon5
(c) LADC over Gamma5 (d) SQUAM over Gamma5
Figure B.4: Cases per 104 persons per year for LADC, left panels in red, and SQUAM, right
panels in blue, as a function of Radon5, panels (a) and (b), and of Gamma5, panels (c) and
(d), differentiating between different age categories of younger/equal than 65 years (soft colors)
and older than 65 years (dark colors).
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B.5 Dose distribution of cases by working duration categories
(a) LADC over Radon5 (b) SQUAM over Radon5
(c) LADC over Gamma5 (d) SQUAM over Gamma5
Figure B.5: Cases per 104 persons per year for LADC, left panels in orange, and SQUAM, right
panels in pink, as a function of Radon5, panels (a) and (b), and of Gamma5, panels (c) and
(d), differentiating between different working durations of less than 6 months (solid line) and
more than 6 months (dashed lines).
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B.6 Radon5 dose distribution of cases by Gamma5 categories
(a) LADC over Radon5 (b) SQUAM over Radon5
Figure B.6: LADC (a) and SQUAM (b) per 104 persons per year of the Eldorado cohort as a
function of the variable Radon5 differentiating between two categories of Gamma5: low dose in
soft colors (≤ 100 mG) and high dose in dark colors (> 100 mG).
APPENDIX
C
METHODS TO ANALYSE THE
COHORTS: SUPPLEMENTARY
INFORMATION
This Appendix Chapter contains supplementary information related to Chapter 3.
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136 C.1. SURVIVAL FUNCTION AND HAZARD FUNCTION
C.1 Survival function and hazard function
Proof. To prove Theorem 3.1.3 some more definitions are needed.
If the survival function S(t) is defined as the probability that at a given time t no investigated
event ki have already occurred, the cumulative distribution of the complementary event G(t)
can be defined as following
G(t) = P (T ≤ t). (C.1)
The probability for the events ki to occur in a given interval can be derived with the integral
over the density function g(t) and is given by
P ([a, b]) =
∫ b
a
g(t) dt. (C.2)
With the definition of the distribution function G(t) (C.1) the survival function can be rewritten
as
S(s) = P (T > s) = 1−G(s). (C.3)
Now we have all definition to rewrite the hazard function.
With the formula for conditional probabilities the hazard function can be rewritten as following:
h(s) = lim
∆s→0
P (s ≤ T < s + ∆s, T > s)
∆sP (T > s) = lim∆s→0
P (s ≤ T < s + ∆s)
∆sP (T > s) . (C.4)
Remembering equations (C.2) for the numerator of formula (C.4) and (C.3) for the denominator,
the formula of the hazard function can be approximated for small ∆s as
h(s) = lim
∆s→0
P (s ≤ T < s+ ∆s)
∆sP (T > s) =
g(s)∆s
∆s(1−G(s)) =
g(s)
1−G(s) .
Noting that the density function is the derivative of the distribution function we get the final
formula for the hazard function.
h(s) = g(s)1−G(s) = −
d
ds
ln(1−G(s)) = − d
ds
ln(S(s)).
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C.2 Derivation of the two stage clonal expansion model
Proof of Proposition 3.4.5
Proof. The first step is to substitute equations (3.40) of definition (3.4.4) into equation (3.38):
d
dt
Ψ(y, z, t) =
∞∑
j=0
∞∑
k=0
d
dt
P (j, k, t)yjzk
= −Xυ
 ∞∑
j=0
∞∑
k=0
(P (j, k, t)− P (j − 1, k, t))yjzk
 (C.5)
− α
 ∞∑
j=0
∞∑
k=0
(jP (j, k, t)− (j − 1)P (j − 1, k, t))yjzk
 (C.6)
− β
 ∞∑
j=0
∞∑
k=0
(jP (j, k, t)− (j + 1)P (j + 1, k, t))yjzk
 (C.7)
− µ
 ∞∑
j=0
∞∑
k=0
(jP (j, k, t)− jP (j + 1, k − 1, t))yjzk
 . (C.8)
Then we rewrite expression (C.5) to (C.8) in terms of the PGF.
• Expression (C.5)
−Xυ
 ∞∑
j=0
∞∑
k=0
(P (j, k, t)− P (j − 1, k, t))yjzk

=−Xυ

∞∑
j=0
∞∑
k=0
(P (j, k, t)yjzk −
∞∑
j=0
∞∑
k=0
P (j − 1, k, t))yjzk
︸ ︷︷ ︸
j′=j−1

=−Xυ

∞∑
j=0
∞∑
k=0
(P (j, k, t)yjzk
︸ ︷︷ ︸
Ψ(y,z,t)
− y
∞∑
j=0
∞∑
k=0
P (j′, k, t))yj′zk
︸ ︷︷ ︸
yΨ(y,z,t)

=−XυΨ(y, z, t)(1− y)
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• Expression (C.6)
− α
 ∞∑
j=0
∞∑
k=0
(jP (j, k, t)− (j − 1)P (j − 1, k, t))yjzk

=− α

∞∑
j=0
∞∑
k=0
(jP (j, k, t)yjzk −
∞∑
j=0
∞∑
k=0
(j − 1)P (j − 1, k, t))yjzk
︸ ︷︷ ︸
j′=j−1

=− α

y
∞∑
j=0
∞∑
k=0
(jP (j, k, t)yj−1zk
︸ ︷︷ ︸
∂
∂y
Ψ(y,z,t)
−y
∞∑
j=0
∞∑
k=0
j′P (j′, k, t))yj′zk

=− α

y
∂
∂y
Ψ(y, z, t)− y2
∞∑
j′=0
∞∑
k=0
j′P (j′, k, t))yj′−1zk
︸ ︷︷ ︸
∂
∂y
Ψ(y,z,t)

=α ∂
∂y
Ψ(y, z, t)(y2 − y)
• Expression (C.7)
− β
 ∞∑
j=0
∞∑
k=0
(jP (j, k, t)− (j + 1)P (j + 1, k, t))yjzk

=− β

∞∑
j=0
∞∑
k=0
(jP (j, k, t)yjzk
︸ ︷︷ ︸
y ∂
∂y
Ψ(y,z,t)
−
∞∑
j=0
∞∑
k=0
(j − 1)P (j − 1, k, t))yjzk
︸ ︷︷ ︸
∂
∂y
Ψ(y,z,t)

=β ∂
∂y
Ψ(y, z, t)(1− y)
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• Expression (C.8)
− µ
 ∞∑
j=0
∞∑
k=0
(jP (j, k, t)− jP (j, k − 1, t))yjzk

=− µ

∞∑
j=0
∞∑
k=0
(jP (j, k, t)yjzk
︸ ︷︷ ︸
y ∂
∂y
Ψ(y,z,t)
−
∞∑
j=0
∞∑
k=0
jP (j, k − 1, t))y(j−1)zk
︸ ︷︷ ︸
k′=k−1

=− µ

y
∂
∂y
Ψ(y, z, t)− yz
∞∑
j=0
∞∑
k′=0
jP (j, k′, t))y(j−1)zk′
︸ ︷︷ ︸
∂
∂y
Ψ(y,z,t)

=µ ∂
∂y
Ψ(y, z, t)(yz − y) .
These calculations lead to the final formula
∂
∂t
Ψ(y, z, t) = F (y, t)Ψ(y, z, t) +G(y, z, t) ∂
∂y
Ψ(y, z, t)
Ψ(y, z, t0) = 1 (C.9)
with
F (y, t) := (y − 1)Xν
G(y, z, t) := µyz + αy2 − [α+ β + µ]y + β
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C.3 Backward recursion of the two stage clonal expansion model
Table C.1: Recursion equations for the hazard h(t) at age t of the TSCE-model with piecewise-
constant parameters in k age-intervals.
Recursion algorithm for the hazard function with piecewise-constant
parameters of the TSCE
h(t) =
k∑
i=1
Ci
δi
1
fi(si−1)
∂
∂tfi(si−1)
Ci = Xνiµ0
δi := αiµ0
Ai = −12(γi +
√
γ2i + 4δiθi)
Bi = 12(−γi +
√
γ2i + 4δiθi)
θi = µiµ0
γi := αi − βi − µi
fi(si−1) = BieAi(si−1−t) −AieBi(si−1−t) first step i = k
fi(si−1) = (Bi − wi(si))eAi(si−1−si) + (wi(si)−Ai)eBi(si−1−si) all steps i 6= k
∂
∂tfi(si−1) = AiBi(eBi(si−1−t) − eAi(si−1−t)) first step i = k
∂
∂tfi(si−1) = −
∂
∂twi(si)(eAi(si−1−si) − eBi(si−1−si)) all steps i 6= k
wi(si) = 0 first step i = k
∂
∂twi(si) = δiθi first step i = k
wi−1(si−1) = δi−1δi wi(si−1) all steps i 6= k
∂
∂twi−1(si−1) =
δi−1
δi
∂
∂twi(si−1) all steps i 6= k
wi(si−1) = AiBi(e
Ai(si−1−t)−eBi(si−1−t))
BieAi(si−1−t)−AieBi(si−1−t) first step i = k
wi(si−1) = AiBi(e
Ai(si−1−si)−eBi(si−1−si))−wi(si)(AieAi(si−1−si)−BieBi(si−1−si))
(Bi−wi(si))eAi(si−1−si)+(wi(si)−Ai)eBi(si−1−si) all steps i 6= k
∂
∂twi(si−1) =
AiBi(Ai−Bi)2eAi(si−1−t)eBi(si−1−t))
(BieAi(si−1−t)−AieBi(si−1−t))2 first step i = k
∂
∂twi(si−1) =
∂
∂twi(si)
(Ai−Bi)2eAi(si−1−si)eBi(si−1−si)
[(Bi−wi(si))eAi(si−1−si)+(wi(si)−Ai)eBi(si−1−si)]2 all steps i 6= k
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C.4 Backward recursion of the hybrid three stage clonal expan-
sion model
Table C.2: Recursion equations for the hazard h(t) at age t of the H3SCE-modelwith piecewise-
constant parameters in k age-intervals.
Recursion algorithm for the hazard function with piecewise-constant
parameters of the H3SCE-model
h(t) =
k∑
i=1
C2i
δ2i
(si−1 + si)
2
1
li(si−1,t)
∂
∂t li(si−1, t)
C2i = Nν0iν1iµ21
δ2i := α2iµ2i
Di = −12(γ2i +
√
γ22i + 4δ2iθ2i)
Ei = 12(−γ2i +
√
γ22i + 4δ2iθ2i)
θ2i =
µ2i
µ20
γ2i := α2i − β2i − µ2i
li(si−1) = EieDi(si−1−t) −DieEi(si−1−t) first step i = k
li(si−1) = (Ei − w2i(si))eDi(si−1−si) + (w2i(si)−Di)eEi(si−1−si) all steps i 6= k
∂
∂t li(si−1) = DiEi(eEi(si−1−t) − eDi(si−1−t)) first step i = k
∂
∂t li(si−1) = −
∂
∂tw2i(si)(eDi(si−1−si) − eEi(si−1−si)) all steps i 6= k
w2i(si) = 0 first step i = k
∂
∂tw2i(si) = δ2iθ2i first step i = k
w2i−1(si−1) =
δ2i−1
δ2i
w2i(si−1) all steps i 6= k
∂
∂tw2i−1(si−1) =
δ2i−1
δ2i
∂
∂tw2i(si−1) all steps i 6= k
w2i(si−1) =
DiEi(eDi(si−1−t)−eEi(si−1−t))
EieDi(si−1−t)−DieEi(si−1−t) first step i = k
w2i(si−1) =
DiEi(eDi(si−1−si)−eEi(si−1−si))−w2i (si)(DieDi(si−1−si)−EieEi(si−1−si))
(Ei−w2i (si))eDi(si−1−si)+(w2i (si)−Di)eEi(si−1−si)
all steps i 6= k
∂
∂tw2i(si−1) =
DiEi(Di−Ei)2eDi(si−1−t)eEi(si−1−t))
(EieDi(si−1−t)−DieEi(si−1−t))2 first step i = k
∂
∂tw2i(si−1) =
∂
∂tw2i(si)
(Di−Ei)2eDi(si−1−si)eEi(si−1−si)
[(Ei−w2i (si))eDi(si−1−si)+(w2i (si)−Di)eEi(si−1−si)]2
all steps i 6= k
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APPENDIX
D
MATLAB CODE FOR TWO AND THREE
STAGE CLONAL EXPANSION MODELS
function [ sumh_tot ] = r e cu r s i on (u , par )
n = s ize (u , 2 ) ;
d e l t a = exp( par ( 2 ) ) ;
theta = 1 ;
%%
del ta_beginning = 1 ;
de l ta_beg inn ing 1 = de l t a ;
%dw at the beg inn ing i s AB=\d e l t a ∗ the ta ,
%then i t becomes the func t i on wr i t t en down
dwk_ui_1 = −de l t a .∗ theta ;
%w at the beg inn ing i s =0, then i t becomes the func t i on wr i t t en down
wk_ui_1 = 0 .∗ ones ( s ize (u , 1 ) , 1 ) ;
%% hazard at the beginning , s e t t i n g the f i r s t va lue f o r the sum
sumh = 0 ;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% LOOP %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
for i=n:−1 :2
X = exp( par (3 ) ) ;
gamma = par ( 1 ) ;
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A = ( − 1 . /2 ) . ∗ . . .
(gamma + sqrt ( (gamma.^2)+4 .∗ de l t a .∗ theta ) ) . ’ ;
B = ( 1 . / 2 ) . ∗ . . .
(−gamma + sqrt ( (gamma.^2)+4 .∗ de l t a .∗ theta ) ) . ’ ;
expA = 1+ expm1 (A. ∗ ( u ( : , i −1) −u ( : , i ) ) ) ;
expB = 1+ expm1 (B. ∗ ( u ( : , i −1) −u ( : , i ) ) ) ;
%% wr i t i n g down the t h i n g s f o r the df i_ui_1
%boundary cond i t i on f i r s t s t ep d e r i v a t i v e : we have 1
dwi_ui = ( de l t a . / de l ta_beg inn ing1 ) . ∗ dwk_ui_1 ;
df i_ui_1 = −dwi_ui . ∗ ( expA. ’−expB . ’ ) ;
%% wr i t i n g down a l l t h ing f o r func t i on f i_ui_1
%boundary cond i t i on f i r s t s t ep : we have 0
wi_ui = ( de l t a . / de l ta_beginning ) . ∗wk_ui_1 . ’ ;
f i_ui_1 = (B. ’ −wi_ui ) . ∗ expA . ’ +(wi_ui −A. ’ ) . ∗ expB . ’ ;
%% wr i t i n g down the hazard
%two s t a g e c l o na l expansion model
sumh = ( (X. ∗ ( df i_ui_1 ) ) . / ( d e l t a . ∗ ( f i_ui_1 ) ) ) +sumh ;
%hybr id t h r ee s t a g e c l ona l expansion model
sumh = ( ( u ( : , i −1) +u ( : , i ) ) . / 2 ) . . .
. ∗ ( (X. ∗ ( df i_ui_1 ) ) . / ( d e l t a . ∗ ( f i_ui_1 ) ) ) +sumh ;
%% de f i n i g the new d e l t a f o r the i n i t i a l c ond i t i on s f o r i not= k
del ta_beginning = de l t a ;
%a f t e r t h i s loop we have d e l t a i , and the next loop w i l l be wi th i−1
%−> de l t a ( i −1)/ d e l t a ( i )
de l ta_beg inn ing 1 = de l t a ;
% de f i n i g the new wi ( ui −1) f o r the i n i t i a l c ond i t i on s f o r i not= k
wk_ui_1 = (A.∗B. ∗ ( expA−expB) . . .
−wi_ui . ’ . ∗ (A.∗ expA −B.∗ expB ) ) . / f i_ui_1 . ’ ;
% de f i n i g the new dwi ( ui −1) f o r the i n i t i a l c ond i t i on s f o r i not= k
dwk_ui_1 = (( dwi_ui . ’ . ∗ (A−B) . ^2 .∗ expA .∗ expB ) . . .
. / ( f i_ui_1 . ’ ) . ^ 2 ) . ’ ;
end
sumh_tot = sumh ;
APPENDIX
E
RISK ASSESSMENT FOR LUNG
ADENOCARCINOMA IN THE LIFE
SPAN STUDY COHORT
This Appendix Chapter contains supplementary information related to Chapter 4.
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146 E.1. DEVIANCE COMPARISON
E.1 Deviance comparison
Figure E.1: Comparison of the deviance of models StatLADCLSSC , MLADC3 and GAMLADCLSS . Box-
plots represent the variation between the 50 imputed data sets. Mean values for GA, state-
of-the-art descriptive and mechanistic models, respectively: 5054.257, 5057.7 and 5050.4.
GAMSQUAMLSS gives a slightly better fit of the data compared to the other two modalities. No
outliers are presented in the model. The difference in the deviance between the data sets in one
model has to be attributed to the fact that with imputation each data set has a different number
of strata.
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E.2 The radiation related excess relative risk for exposed never
smokers
In the case of a two path model, where the pathways are mutually exclusive the rad-ERR reads
ERRγ =
htot(nGy, 0 sigsday )
htot(0Gy, 0 sigsday )
− 1 (E.1)
=
hRMUT (nGy) + hTMUT (0 sigsday )
hRMUT (0Gy) + hTMUT (0 sigsday )
− 1 (E.2)
= hRMUT (nGy)− hRMUT (0Gy)
hRMUT (0Gy) + hTMUT (0 sigsday )
(E.3)
with n > 0, where htot, hRMUT and hTMUT represents the total hazard of the model, the hazard
in the RMUT pathway and the hazard in the TMUT pathway, respectively. This formula applies
only because radiation and smoking act on two different pathways independently.
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SMOKERS
(a) Never smokers exposed at age 30 yr
(b) Never smokers exposed at age 30 yr
Figure E.2: Excess Relative Risk (ERR) from the preferred mechanistic model MLADC3 (Mech)
for LADC in the LSS cohort for never smokers exposed to radiation at 30 yr. Radiation only
affects the RMUT pathway independent of sex and smoking status. (a) For attained ages 50,
60 and 70 yr the ERR responds non-linearly to doses in the range 0 - 4 Gy. However, on the
biological level radiation action is modeled by a linear increase of the clonal expansion rate in
the RMUT pathway which lasts for life. (b) For lung doses of 0.5, 1 and 2 Gy the ERR from the
preferred mechanistic model peaks at decreasing age with increasing value. The ERR estimate
at 1 Gy from StatLADCLSS 4.1 (Desc) is shown for comparison.
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E.3 The smoking-related excess relative risk for unexposed smok-
ers
In the case of a two path model, where the pathways are mutually exclusive the smoking-ERR
reads
ERRsmk =
htot(0Gy,m sigsday )
htot(0Gy, 0 sigsday )
− 1 (E.4)
=
hRMUT (0Gy) + hTMUT (m sigsday )
hRMUT (0Gy) + hTMUT (0 sigsday )
− 1 (E.5)
=
hTMUT (m sigsday )− hTMUT (0
sigs
day )
hRMUT (0Gy) + hTMUT (0 sigsday )
(E.6)
with m > 0, where htot, hRMUT and hTMUT represents the total hazard of the model, the hazard
in the RMUT pathway and the hazard in the TMUT pathway, respectively. This formula applies
only because radiation and smoking act on two different pathways independently.
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SMOKERS
(a) Lifelong female smokers starting at age 20 yr (b) Lifelong male smokers starting at age 20 yr
(c) Lifelong female smokers of 5 cigs/day
starting at age 20 yr
(d) Lifelong male smokers of 20 cigs/day
starting at age 20 yr
Figure E.3: Excess Relative Risk (ERR) from the preferred mechanistic model MLADC3 (Mech)
for smoking-induced LADC in the LSS cohort for unexposed lifelong smokers starting at age
20 yr. Smoking only affects the TMUT pathway with a markedly different response in both sexes
but independent of radiation exposure. Panels (a) and (b) depict the ERR for attained ages of
50, 60 and 70 yr which is determined by the sex-dependent linear-exponential response of the
clonal expansion rate in the TMUT pathway. The implausibly strong attenuation of the EAR
for females smoking more the 10 cigs/day is possibly caused by a reporting bias. Panels (c) and
(d) depict the ERR over age for 5 cigs/day (males and females) and 20 cigs/day (males only).
Female smokers of 5 cigs/day and males smokers of 20 cigs/day possess about the same risk.
ERR estimates from StatLADCLSS (Desc) are shown for comparison.
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E.4 Excess absolute rates for a smoking irradiated person
(a) Females with smoking intensity 5 cigs/day (b) Smoking females with lung dose 1 Gy
(c) Related to Figure 5. Smoking females at attained
age 70 yr exposed to radiation at age 30 yr
Figure E.4: Bivariate EARs (cases in 10,000 persons per year) for smoking-induced and
radiation-induced LADC from the preferred mechanistic modelMLADC3 for lifelong female smok-
ers starting at age 20 yr and exposed to radiation at age 30 yr. To eliminate the influence for
city of residence person-year weighted city means are used. (a) Dependence on attained age and
lung dose for comparison with Figure 4.13(a). (b) Dependence on attained age and smoking
intensity. For a lung dose of 1 Gy comparison with Figure 4.12(a) reveals that the radiation
effect on the EAR is negligible. (c) Additive effect of radiation and smoking at attained age
70 yr.
152 E.4. EXCESS ABSOLUTE RATES FOR A SMOKING IRRADIATED PERSON
(a) Males with smoking intensity 20 cigs/day (b) Smoking males with lung dose 1 Gy
(c) Smoking males at attained age 70 yr exposed to ra-
diation at age 30 yr
Figure E.5: Bivariate EARs (cases in 10,000 persons per year) for smoking-induced and
radiation-induced for LADC from the preferred mechanistic model MLADC3 for lifelong male
smokers starting at age 20 yr and exposed to radiation at age 30 yr. To eliminate the influence
for city of residence person-year weighted city means are used. (a) Dependence on attained age
and lung dose for comparison with Figure 4.13(b). (b) Dependence on attained age and smoking
intensity. For a lung dose of 1 Gy comparison with Figure 4.12(b) reveals that the radiation
effect on the EAR is negligible especially for heavy smokers. (c) Additive effect of radiation and
smoking at attained age 70 yr.
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154 F.1. VARIABILITY OF ESTIMATED DEGREES OF FREEDOM
F.1 Variability of estimated degrees of freedom
(a) (b)
Figure F.1: Results of GAMLADCLSS . Boxplot of the values of estimated degree of freedom for (a)
function s(I(age/70), d10gy) and (b) function s(I(age/70), I(packyrs/50)). The edf parameter
are the only parameters with a high variability. This fact has to be attributed to the variation
of the multiple imputation process and to the flexibility of splines, that adapt to different data
sets.
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F.2 ERRs of all three models
(a) ERR from GAMLADCLSS for radiation induced LADC
as a function of attained age (yr)
(b) ERR from GAMLADCLSS for smoking induced LADC
as a function of lung dose (Gy)
Figure F.2: Excess relative risks (ERR) from GAMLADCLSS for radiation-induced LADC for (a)
a person exposed to 1 Gy lung dose at age 30 yr as a function of age, (b) a 70 years old person
exposed at age 30 yr as a function of lung dose (Gy). The boxplots represent the variance
of the 50 datasets by GAMLADCLSS . StatLADCLSS is presented in black, while MLADC3 in blue for
comparison.
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(a) ERR from GAMLADCLSS for smoking induced LADC as a func-
tion of attained age (yr)
(b) ERR from GAMLADCLSS for smoking induced LADC as a func-
tion of smoking intensity (cigs/day)
Figure F.3: Excess relative risks (ERR) from GAMLADCLSS for smoking-induced LADC for a
current smoker that began at age 20 yr, never stopped (a) with smoking amount of 1 packyear
as a function of attained age, (b) with varying smoking intensity. The boxplots represent the
variance of the 50 datasets by GAMLADCLSS . StatLADCLSS is presented in black, while MLADC3 in
blue for comparison.
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F.3 Spline functions
(a) (b)
Figure F.4: Graphical evaluation of some results of GAMLADCLSS as 3D plots for the imputed
dataset 39. (a) Function of age and lung dose s(I(age/70), d10gy). (b) Function of age and
smoking amount (packyears) s(I(age/70), I(packyrs/50)).
158 F.3. SPLINE FUNCTIONS
APPENDIX
G
SQUAMOUS CELL CARCINOMA IN THE
LIFE SPAN STUDY COHORT:
SUPPLEMENTARY INFORMATION
This Appendix Chapter contains supplementary information related to Chapter 5.
159
160 G.1. SIMPLE ADDITIVE MODEL
G.1 Simple additive model
Simple additive model of Egawa et al. [18].
hSQUAMLSS = hSQUAMLSS0 · (1 + ERR
SQUAMLSS
smk + ERR
SQUAMLSS
rad ) (G.1)
with
hSQUAMLSS0 = eβ0F/1M+β2(city−1)+β3
agexp−30
10 +β4F/5M log(
age
70 )+β6F/7M log
2(age70 )
ERRSQUAMLSSsmk = β8
packyrs
50 · e
β9
smokedY ears
50 +β10(
smokedyears
50 )
2+β11log(yearsQuitting+1)
ERRSQUAMLSSrad = β12 ·Gamma · e
β13
agexp−30
10 +β14log(
age
70 ) · (1 +msex)
G.2 Development of the state-of-the-art statistical risk model
hSQUAMLSS = hSQUAMLSS0 · (1 + ERR
SQUAMLSS
smk + ERR
SQUAMLSS
rad ) (G.2)
with
hSQUAMLSS0 = eβ0F/1M+β2(city−1)+β3
agexp−30
10 +β4F/5M log(
age
70 )+β6F/7M log
2(age70 )
ERRSQUAMLSSsmk = β8
packyrs
50 · e
β9
smokedY ears
50 +β10(
smokedyears
50 )
2+β11log(yearsQuitting+1)
ERRSQUAMLSSrad = β12 ·Gamma
Table G.1: Interesting parameters of some models fitted to one imputed dataset for the derivation
of the best state-of-the-art statistical risk model (of the form of a (general) additive model) for
SQUAM in the LSS cohort. Only smoking modifiers were tested since already the radiation ERR
was not significant. The imputed data set pydat− smk − imp− C23 was used.
Derivation of the state-of-the-art stat. risk model
ERR γ SE ERR smk. SE Risk modif. Value SE Dev.
3120.9
17.81 4.26 2913.5
0.51 0.26 3114.8
0.23 0.91 17.78 4.29 2913.4
0.13 0.85 20.19 4.92 smk. dur. lin. 1.42 0.51 2901.5
0.08 0.85 20.92 5.14 smk. dur. lin. 1.56 0.50 2900.1
smk. dur. quad. 0.37 0.10
0.15 0.89 20.44 5.00 smk. dur. lin. 0.63 0.55 2895.3
smk. dur. quad. 0.26 0.11
years quitting -0.22 0.10
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G.3 Deviance comparison
Figure G.1: Comparison of the deviance of models StatSQUAMLSSC , M
SQUAM
2 and GAM
SQUAM
LSS .
Boxplots represent the variation between the 50 imputed data sets. Mean values for mechanistic,
state-of-the-art descriptive and GA models, respectively: 2909.563, 2907.926 and 2902.386.
GAMSQUAMLSS gives a slightly better fit of the data compared to the other two modalities. No
outliers are presented in the model. The difference in the deviance between the data sets in one
model has to be attributed to the fact that with imputation each data set has a different amount
of strata.
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G.4 Excess relative risks for smoking
(a)
(b)
Figure G.2: ERRs from MSQUAM2 (Mech) for smoking-induced SQUAM for lifelong and past
female smokers (left and right panels, respectively) starting at age 20 yr and for past smokers at
quitting age 60 yr. (a) ERRs as a function of age attained for different smoking intensities: 5, 10
and 20 cigs/day. For both lifelong and past smokers the ERR increases with smoking intensity.
For past smokers a kink at age of quit smoking is visible, the ERR decreases hence exponentially.
Past smokers have slightly lower risks as lifelong smokers. The undulated behavior is determined
by the linear response to smoking intensity of the initiating parameter X. (b) ERRs as a function
of smoking intensity (cigs/day) for different ages: 60, 70 and 80 years. For both lifelong and
past smokers the ERR increases with age. In this cases past smokers have clearly lower risks as
lifelong smokers.
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(a)
(b)
Figure G.3: ERRs from MSQUAM2 (Mech) for smoking-induced SQUAM for lifelong and past
male smokers (left and right panels, respectively) starting at age 20 yr and for past smokers at
quitting age 60 yr. (a) ERRs as a function of age attained for different smoking intensities: 5, 10
and 20 cigs/day. For both lifelong and past smokers the ERR increases with smoking intensity.
For past smokers a kink at age of quit smoking is visible, the ERR decreases hence exponentially.
Past smokers have slightly lower risks as lifelong smokers. The undulated behavior is determined
by the linear response to smoking intensity of the initiating parameter X. (b) ERRs as a function
of smoking intensity (cigs/day) for different ages: 60, 70 and 80 years. For both lifelong and
past smokers the ERR increases with age. In this cases past smokers have clearly lower risks as
lifelong smokers.
164 G.5. SPLINE FUNCTIONS
G.5 Spline functions
(a) s(I(ageMen/70)) (b) s(I(ageW omen/70))
(c) s(I(packyrs/50)) (d) s(smkqyrs)
Figure G.4: Spline functions fitted for one selected imputed dataset (pydat− smk− imp−C23)
in model GAMSQUAMLSS . (a) Spline for attained age for men, (b) spline for attained age for
women, (c) spline for cumulative smoking amount (pack years) and (d) spline for the years since
quitting. Although functions s(I(ageMen/70)) and s(I(ageWomen/70)) look very similar, the
gender differentiation improved the fit of ca. 200 points.
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G.6 ERRs of all three models
(a) Current female smoker (b) Past female smoker
(c) Current female smoker (d) Past female smoker
Figure G.5: ERRs from GAMSQUAMLSS (in green), Stat
SQUAM
LSS (in black) and M
SUQAM
2 (in
orange) for smoking induced SQUAM for (a) current smoking females as a function of attained
age, (b) past smoking females as a function of attained age, (c) current smoking females as a
function of smoking intensity and (d) past smoking females as a function of smoking intensity.
Age at begin of smoking was taken as 20 yr and age for stop smoking 60 yr. In figures as
function of attained age the smoking intensity was of 20 cigs/day. In figures as function of
smoking intensity the attained age was of 70 years. The boxplots represent the variance of the
50 data sheets.
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(a) Current male smoker (b) Past male smoker
(c) Current male smoker (d) Past male smoker
Figure G.6: ERRs from GAMSQUAMLSS (in green), Stat
SQUAM
LSS (in black) and M
SUQAM
2 (in
orange) for smoking induced SQUAM for (a) current smoking male as a function of attained
age, (b) past smoking male as a function of attained age, (c) current smoking male as a function
of smoking intensity and (d) past smoking male as a function of smoking intensity. Age at begin
of smoking was taken as 20 yr and age for stop smoking 60 yr. In figures as function of attained
age the smoking intensity was of 20 cigs/day. In figures as function of smoking intensity the
attained age was of 70 years. The boxplots represent the variance of the 50 data sheets.
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168 H.1. DEVELOPMENT OF THE STATE-OF-THE-ART STATISTICAL RISK MODEL
H.1 Development of the state-of-the-art statistical risk model
hLADCELDO = hLADCELDO0 · (1 + ERRLADCELDOγ + ERRLADCELDOα ) (H.1)
with
hLADCELDO0 = eβ0+β1log(
age
60 )+β2log
2(age60 )+β3·calendaryear (H.2)
ERRLADCELDOγ = β4 ·Gammaeβ5log(
age
60 )+β6·dose rate+β7·time since last exp (H.3)
ERRLADCELDOα = β8 ·Radon. (H.4)
Table H.1: Interesting parameters of some models fitted for the derivation of the best state-of-
the-art statistical risk model model for LADC in the Eldorado cohort.
Derivation of the state-of-the-art stat. risk model
ERR γ (10−2) SE (10−2) ERR radon SE Risk modif. Value SE Dev.
1490.8
0.20 0.12 1484.4
0.77 0.36 1477.3
0.66 0.34 0.17 0.13 1474.8
0.89 0.43 age -2.0782 3.1645 1476.8
0.81 0.44 dose rate -0.0007 0.0039 1477.2
0.15 0.13 agelast 0.06 0.02 1474.7
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H.2 Spline functions
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(b) Attained age-gamma spline
Figure H.1: Fitted spline of the GAM model for attained age (yr) (a) and for the interaction
attained age-gamma exposure (Gy) (b).
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H.3 Excess absolute rates
(a) EAR as a function of attained age (b) EAR as a function of gamma dose (Gy)
Figure H.2: EAR for γ exposure (Gy) (cases in 104 persons per year) for LADC in the Eldorado
cohort. Statistical models are presented as solid lines and GAM models as dashed lines. (a) The
radiation EAR as a function of attained age is linear with age. (b) The EAR as a function of
gamma dose (Gy) is independent of age.
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172 I.1. DEVELOPMENT OF THE STATE-OF-THE-ART STATISTICAL RISK MODEL
I.1 Development of the state-of-the-art statistical risk model
hSQUAMELDO = hSQUAMELDO0 · (1 + ERRSQUAMELDOγ + ERRSQUAMELDOα ) (I.1)
with
hSQUAMELDO0 = eβ0+β1log(
age
60 )+β2log
2(age60 )+β3·calendaryeargroup (I.2)
+ eβ4·calendaryear5+β5·(timesinceexposure)+β6·(timesinceexposure)2 (I.3)
ERRSQUAMELDOα = β7 ·Radoneβ8log(
age
60 )+β9·dose rate+β10·time since last exp
ERRSQUAMELDOγ = β11 ·Gamma. (I.4)
Table I.1: Interesting parameters of some models fitted for the derivation of the best state-of-
the-art statistical risk model for SQUAM in the Eldorado cohort.
Derivation of the stat. model for SQUAM in the Eldorado cohort
ERR γ SE ERR radon SE Risk modif. Value SE Dev.
(10−5) (10−5) (10−2) (10−2) (10−2)
2570.4
-8.86 49.58 2570.4
0.43 0.12 2524.4
-90.36 21.37 0.44 0.12 2521.6
0.43 0.15 age -2.80 10−09 1.88 2524.4
0.47 0.16 dose rate -0.26 10−3 0.71 10−3 2523.9
1.85 1.00 agelast -0.51 10−1 0.19 10−1 2517.1
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I.2 Spline functions
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Figure I.1: Fitted spline of the GAM model for attained age (yr) (a) and for the interaction
attained age-time since last exposure (b).
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I.3 Excess absolute rates
(a) EAR as a function of attained age for age quitting
40 yr
(b) EAR as a function of attained age for age quitting
60 yr
(c) EAR as a function of radon dose (WLM) for age
quitting 40 yr
(d) EAR as a function of radon dose (WLM) for age
quitting 60 yr
Figure I.2: EAR for radon exposure (WLM) (cases in 143 persons per year) for SQUAM in
the Eldorado cohort. Statistical models are presented as solid lines and GAM models as dashed
lines. (a) Radiation EAR as a function of attained age is linear with age. (b) The EAR as a
function of gamma dose (Gy) is independent of age.
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between the original data set without unknown smoking category and the 50
imputed sheets. The orange bars are the person years weighted mean over the
50 imputed sheets. Panels (c) and (d) represent the relative deviation of the
imputed data sheets from the original data set without unknown smoking. The
relative deviation is calculated as incidence-ratio between original and imputed
dataset. The box-plots represent the distribution of the relative deviations of
the 50 imputed sheets. The blue horizontal line represents the value one, it
means a correspondence between original without unknown smoking category
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nal data set the 50 imputed data sheets. The orange bars are the person years
weighted mean over the 50 imputed data sheets. Panels (c) and (d) represent the
relative deviation of the imputed sheets from the original dataset. The relative
deviation is calculated as incidence-ratio between original and imputed dataset.
The box-plots represent the distribution of the relative deviations of the 50 im-
puted data sheets. The blue horizontal line represents the value one, it means a
correspondence between original and imputed dataset. . . . . . . . . . . . . . . . 122
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the original dataset without unknown smoking information (light blue) and the
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set the 50 imputed data sheets. The orange bars are the person years weighted
mean over the 50 imputed data sheets. Panels (c) and (d) represent the rel-
ative deviation of the imputed sheets from the original dataset. The relative
deviation is calculated as incidence-ratio between original and imputed dataset.
The box-plots represent the distribution of the relative deviations of the 50 im-
puted data sheets. The blue horizontal line represents the value one, it means a
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A.4 Stated smoking duration for LADC (left panels) and SQUAM (right panels) cases
per 104 persons per year comparing three data sets: the original data set without
unknown smoking information (light blue), the original data set with unknown
smoking information (dark blue) and the 50 imputed data sheet (in orange).
Panel (a) right and (b) right describe the distribution of known and unknown
smoking history in the original data set with unknown smoking information (dark
blue). Panel (a) left and (b) left instead depict the difference of the incidence
between the original data set without unknown smoking category and the 50 im-
puted data sheets. The orange bars are the person years weighted mean over the
50 imputed data sheets. Panels (c) and (d) represent the relative deviation of the
imputed data sheets from the original data set without unknown smoking. The
relative deviation is calculated as incidence-ratio between original and imputed
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between the original data set without unknown smoking category and the 50 im-
puted data sheets. The orange bars are the person years weighted mean over the
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the 50 imputed data sheets. The blue horizontal line represents the value one,
it means a correspondence between original without unknown smoking category
and imputed data set. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
A.6 Stated years since quitting smoking for LADC (left panels) and SQUAM (right
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A.7 Lung dose distribution (Gy) of LADC cases per 104 persons per year by smoking
status (never smokers left panels and ever smokers right panels) comparing two
data sets: the original data set without unknown smoking information (light
blue) and the 50 imputed data sheets (in orange). Panels (a) and (b), for never
and ever smokers respectively, describe the difference of the incidence between
the original data set the 50 imputed data sheets. The orange bars are the person
years weighted mean over the 50 imputed data sheets. The red line divides low
from high dose. Panels (c) and (d) represent the relative deviation of the imputed
data sheets from the original data set. The relative deviation is calculated as
incidence-ratio between original and imputed data set. The box-plots represent
the distribution of the relative deviations of the 50 imputed data sheets. The
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E.1 Comparison of the deviance of models StatLADCLSSC ,MLADC3 and GAMLADCLSS . Box-
plots represent the variation between the 50 imputed data sets. Mean values for
GA, state-of-the-art descriptive and mechanistic models, respectively: 5054.257,
5057.7 and 5050.4. GAMSQUAMLSS gives a slightly better fit of the data compared
to the other two modalities. No outliers are presented in the model. The differ-
ence in the deviance between the data sets in one model has to be attributed to
the fact that with imputation each data set has a different number of strata. . . 146
E.2 Excess Relative Risk (ERR) from the preferred mechanistic modelMLADC3 (Mech)
for LADC in the LSS cohort for never smokers exposed to radiation at 30 yr.
Radiation only affects the RMUT pathway independent of sex and smoking sta-
tus. (a) For attained ages 50, 60 and 70 yr the ERR responds non-linearly to
doses in the range 0 - 4 Gy. However, on the biological level radiation action is
modeled by a linear increase of the clonal expansion rate in the RMUT pathway
which lasts for life. (b) For lung doses of 0.5, 1 and 2 Gy the ERR from the
preferred mechanistic model peaks at decreasing age with increasing value. The
ERR estimate at 1 Gy from StatLADCLSS 4.1 (Desc) is shown for comparison. . . . . 148
E.3 Excess Relative Risk (ERR) from the preferred mechanistic modelMLADC3 (Mech)
for smoking-induced LADC in the LSS cohort for unexposed lifelong smokers
starting at age 20 yr. Smoking only affects the TMUT pathway with a markedly
different response in both sexes but independent of radiation exposure. Panels
(a) and (b) depict the ERR for attained ages of 50, 60 and 70 yr which is deter-
mined by the sex-dependent linear-exponential response of the clonal expansion
rate in the TMUT pathway. The implausibly strong attenuation of the EAR for
females smoking more the 10 cigs/day is possibly caused by a reporting bias.
Panels (c) and (d) depict the ERR over age for 5 cigs/day (males and females)
and 20 cigs/day (males only). Female smokers of 5 cigs/day and males smok-
ers of 20 cigs/day possess about the same risk. ERR estimates from StatLADCLSS
(Desc) are shown for comparison. . . . . . . . . . . . . . . . . . . . . . . . . . . 150
E.4 Bivariate EARs (cases in 10,000 persons per year) for smoking-induced and
radiation-induced LADC from the preferred mechanistic model MLADC3 for life-
long female smokers starting at age 20 yr and exposed to radiation at age 30 yr.
To eliminate the influence for city of residence person-year weighted city means
are used. (a) Dependence on attained age and lung dose for comparison with
Figure 4.13(a). (b) Dependence on attained age and smoking intensity. For a
lung dose of 1 Gy comparison with Figure 4.12(a) reveals that the radiation effect
on the EAR is negligible. (c) Additive effect of radiation and smoking at attained
age 70 yr. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
E.5 Bivariate EARs (cases in 10,000 persons per year) for smoking-induced and
radiation-induced for LADC from the preferred mechanistic model MLADC3 for
lifelong male smokers starting at age 20 yr and exposed to radiation at age 30
yr. To eliminate the influence for city of residence person-year weighted city
means are used. (a) Dependence on attained age and lung dose for comparison
with Figure 4.13(b). (b) Dependence on attained age and smoking intensity. For
a lung dose of 1 Gy comparison with Figure 4.12(b) reveals that the radiation
effect on the EAR is negligible especially for heavy smokers. (c) Additive effect
of radiation and smoking at attained age 70 yr. . . . . . . . . . . . . . . . . . . . 152
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F.1 Results of GAMLADCLSS . Boxplot of the values of estimated degree of freedom for
(a) function s(I(age/70), d10gy) and (b) function s(I(age/70), I(packyrs/50)).
The edf parameter are the only parameters with a high variability. This fact has
to be attributed to the variation of the multiple imputation process and to the
flexibility of splines, that adapt to different data sets. . . . . . . . . . . . . . . . . 154
F.2 Excess relative risks (ERR) from GAMLADCLSS for radiation-induced LADC for
(a) a person exposed to 1 Gy lung dose at age 30 yr as a function of age, (b) a
70 years old person exposed at age 30 yr as a function of lung dose (Gy). The
boxplots represent the variance of the 50 datasets by GAMLADCLSS . StatLADCLSS is
presented in black, while MLADC3 in blue for comparison. . . . . . . . . . . . . . 155
F.3 Excess relative risks (ERR) from GAMLADCLSS for smoking-induced LADC for a
current smoker that began at age 20 yr, never stopped (a) with smoking amount
of 1 packyear as a function of attained age, (b) with varying smoking intensity.
The boxplots represent the variance of the 50 datasets by GAMLADCLSS . StatLADCLSS
is presented in black, while MLADC3 in blue for comparison. . . . . . . . . . . . . 156
F.4 Graphical evaluation of some results of GAMLADCLSS as 3D plots for the imputed
dataset 39. (a) Function of age and lung dose s(I(age/70), d10gy). (b) Function
of age and smoking amount (packyears) s(I(age/70), I(packyrs/50)). . . . . . . 157
G.1 Comparison of the deviance of models StatSQUAMLSSC , M
SQUAM
2 and GAM
SQUAM
LSS .
Boxplots represent the variation between the 50 imputed data sets. Mean val-
ues for mechanistic, state-of-the-art descriptive and GA models, respectively:
2909.563, 2907.926 and 2902.386. GAMSQUAMLSS gives a slightly better fit of
the data compared to the other two modalities. No outliers are presented in the
model. The difference in the deviance between the data sets in one model has
to be attributed to the fact that with imputation each data set has a different
amount of strata. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
G.2 ERRs from MSQUAM2 (Mech) for smoking-induced SQUAM for lifelong and past
female smokers (left and right panels, respectively) starting at age 20 yr and
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